title,scope_regionality,region,location_1,location_2,location_3,location_4,location_5,location_6,location_raw,organisation_1,organisation_2,organisation_3,organisation_4,organisation_5,organisation_6,organisation_7,organisation_8,organisation_raw,registry_url,information_url,type,subject_frame,subject_information,scope_population,scope_age,age_max,age_min,sample_design,sample_analysis_unit,sample_size_obtained,sample_size_rounded,start_date,end_date,resource_url_1,resource_url_2,resource_url_3,resource_url_4,resource_url_5,results_seroprevalence_information,results_publication_url,results_publication_date,results_publication_type,analysis_data_source,analysis_target,analysis_isotype,analysis_test,analysis_test_manufacturer_1,analysis_test_manufacturer_2,analysis_test_manufacturer_3,analysis_test_manufacturer_4,analysis_test_manufacturer_5,analysis_test_manufacturer_6,analysis_test_manufacturer_7,analysis_test_manufacturer_raw,results_seroprevalence_adjustment,results_seroprevalence_sensitivity,results_seroprevalence_specificity,results_seroprevalence_positive,results_seroprevalence_positive_95pct_lower,results_seroprevalence_positive_95pct_upper,record_created,record_modified,results_underreporting
Rheinland Corona Studie,Local/Regional,North Rhine-Westphalia,Bonn,Bonn Beuel,Bonn Hardtberg,,,,"Bonn Beuel, Bonn Hardtberg and surrounding areas",Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),,,,,,,,Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),,https://www.rheinland-studie.de/die-studie/die-corona-studie.html,Cross sectional and selective longitudinal,Household and Community Samples,Participants already included in the Rhineland-Study,General population,Adults,,30,Cohort-sample - Sampling from existing cohort study in the general population,Participants,4755,4800,2020-04-24,2020-06-30,https://doi.org/10.1101/2020.08.24.20181206,https://doi.org/10.1038/s41467-021-22351-5,,,,Adjusted antibody-prevalence among participants of the Rheinland-Corona-study,https://doi.org/10.1038/s41467-021-22351-5,2021-04-09,Peer-reviewed Publikation,whole blood,anti -S1 domain,IgG,"ELISA ",EUROIMMUN,,,,,,,EUROIMMUN,Not adjusted,0.868,1,0.0097,0.0072,0.013,2021-11-01,2021-09-18,4.2
COVID-19 Case-Cluster-Study,Local/Regional,North Rhine-Westphalia,Gangelt,,,,,,Gangelt,"Universitätsklinikum Bonn, Institut für Virologie",Universitätsklinikum Bonn,,,,,,,"Institut für Virologie, Universitätsklinikum Bonn",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00021306,,Cross sectional and selective longitudinal,Household and Community Samples,Residents of Gangelt and their household members,General population,Multiple,90,1,Random sampling (central registration-based),Participants,919,900,2020-03-31,2020-04-06,https://doi.org/10.1101/2020.05.04.20090076,https://doi.org/10.1038/s41467-020-19509-y,https://doi.org/10.1101/2022.01.26.22269805,,,Seroprevalence of Gangelts` citizen,https://doi.org/10.1038/s41467-020-19509-y,2020-11-17,Peer-reviewed Publikation,whole blood,,IgG,"ELISA ",EUROIMMUN,,,,,,,EUROIMMUN,Adjusted for test-specificity/test-sensitivity and population-weighted,0.909,0.991,0.141,0.112,0.173,2021-07-30,2021-10-28,5
COVID-19 Case-Cluster-Study,Local/Regional,North Rhine-Westphalia,Gangelt,,,,,,Gangelt,"Universitätsklinikum Bonn, Institut für Virologie",Universitätsklinikum Bonn,,,,,,,"Institut für Virologie, Universitätsklinikum Bonn",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00021306,,Cross sectional and selective longitudinal,Household and Community Samples,Residents of Gangelt and their household members,General population,Multiple,90,1,Random sampling (central registration-based),Participants,587,600,2020-10-01,2020-10-31,,,,,,Seroprevalence of Gangelts` citizen for October 2020,https://doi.org/10.1101/2022.01.26.22269805,2022-01-28,Preprint,whole blood,,IgG,"ELISA ",EUROIMMUN,ROCHE N,,,,,,EUROIMMUN; ROCHE N,Adjusted for test-specificity/test-sensitivity,0.909,0.991,0.181,0.137,0.23,2022-02-15,2022-02-15,
COVID-19 Case-Cluster-Study,Local/Regional,North Rhine-Westphalia,Gangelt,,,,,,Gangelt,"Universitätsklinikum Bonn, Institut für Virologie",Universitätsklinikum Bonn,,,,,,,"Institut für Virologie, Universitätsklinikum Bonn",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00021306,,Cross sectional and selective longitudinal,Household and Community Samples,Residents of Gangelt and their household members,General population,Multiple,90,1,Random sampling (central registration-based),Participants,488,500,2021-01-01,2021-01-31,,,,,,Seroprevalence of Gangelts` citizen for January 2021,https://doi.org/10.1101/2022.01.26.22269805,2022-01-28,Preprint,whole blood,,IgG,"ELISA ",EUROIMMUN,ROCHE N,,,,,,EUROIMMUN; ROCHE N,Adjusted for test-specificity/test-sensitivity,0.909,0.991,0.21,0.162,0.261,2022-02-15,2022-02-15,
COVID-19 Case-Cluster-Study,Local/Regional,North Rhine-Westphalia,Gangelt,,,,,,Gangelt,"Universitätsklinikum Bonn, Institut für Virologie",Universitätsklinikum Bonn,,,,,,,"Institut für Virologie, Universitätsklinikum Bonn",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00021306,,Cross sectional and selective longitudinal,Household and Community Samples,Residents of Gangelt and their household members,General population,Multiple,90,1,Random sampling (central registration-based),Participants,406,400,2021-04-01,2021-04-30,,,,,,Seroprevalence of Gangelts` citizen for April 2021,https://doi.org/10.1101/2022.01.26.22269805,2022-01-28,Preprint,whole blood,,IgG,"ELISA ",EUROIMMUN,ROCHE N,,,,,,EUROIMMUN; ROCHE N,Adjusted for test-specificity/test-sensitivity,0.909,0.991,0.359,0.3,0.42,2022-02-15,2022-02-15,
Prospective Covid-19 cohort study Munich (KoCo19),Local/Regional,Bavaria,Munich,,,,,,Munich,Ludwig-Maximilians-Universität (LMU) München,Helmholtz Zentrum München,Tropeninstitut der Ludwig-Maximilians-Universität (LMU) München,,,,,,Tropeninstitut der Ludwig-Maximilians-Universität (LMU) München; Helmholtz Zentrum München,https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00021698,www.koco19.de,Longitudinal/Prospectice cohort study,Household and Community Samples,Munich households,General population,Multiple,,14,Random sampling (not central registration-based),Participants,5313,5300,2020-04-05,2020-06-12,https://doi.org/10.1186/s12889-020-09164-9,https://doi.org/10.3390/ijerph18073572,https://doi.org/10.1186/s12879-021-06589-4,http://www.klinikum.uni-muenchen.de/Abteilung-fuer-Infektions-und-Tropenmedizin/download/de/KoCo19/Runde-4/KoCo19_Zusammenfassung_Runde4.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,
Prospektive Covid-19 Kohorte München (KoCo19),Local/Regional,Bavaria,Munich,,,,,,Munich,Ludwig-Maximilians-Universität (LMU) München,Helmholtz Zentrum München,Tropeninstitut der Ludwig-Maximilians-Universität (LMU) München,,,,,,Tropeninstitut der Ludwig-Maximilians-Universität (LMU) München; Helmholtz Zentrum München,https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00021698,www.koco19.de,Longitudinal/Prospectice cohort study,Household and Community Samples,Munich households,General population,Multiple,,14,Random sampling (not central registration-based),Participants,5313,5300,2020-04-05,2020-06-12,,,,,,Seroprevalence from the first wave of the survey in Munich households.,https://doi.org/10.3390/ijerph18073572,2021-03-30,Peer-reviewed Publikation,whole blood,anti Nucleocapsid,Total antibody,Elektrochemolumineszenz (ECL)-Immunassay; LIPS,ROCHE N,,,,,,,ROCHE N,Adjusted for test-specificity/test-sensitivity and population-weighted,0.886,0.997,0.018,0.013,0.024,2021-08-11,2021-10-11,4
Prospektive Covid-19 Kohorte München (KoCo19),Local/Regional,Bavaria,Munich,,,,,,Munich,Ludwig-Maximilians-Universität (LMU) München,Helmholtz Zentrum München,Tropeninstitut der Ludwig-Maximilians-Universität (LMU) München,,,,,,Tropeninstitut der LMU und Helmholtz Zentrum München,https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00021699,www.koco19.de,Longitudinal/Prospectice cohort study,Household and Community Samples,Munich households,General population,Multiple,,14,Random sampling (not central registration-based),Participants,4433,4400,2020-11-02,2021-01-31,,,,,,Seroprevalence from the second wave of the survey in Munich households (infection-induced),https://doi.org/10.1186/s12879-021-06589-4,2021-09-08,Peer-reviewed Publikation,capillary blood,anti Nucleocapsid,Total antibody,Elektrochemolumineszenz (ECL)-Immunassay; LIPS,ROCHE N,,,,,,,ROCHE N,Adjusted for test-specificity/test-sensitivity and population-weighted,0.992,0.987,0.036,0.029,0.043,,2021-10-29,2
Prospektive Covid-19 Kohorte München (KoCo19),Local/Regional,Bavaria,Munich,,,,,,Munich,Ludwig-Maximilians-Universität (LMU) München,Helmholtz Zentrum München,Tropeninstitut der Ludwig-Maximilians-Universität (LMU) München,,,,,,Tropeninstitut der Ludwig-Maximilians-Universität (LMU) München; Helmholtz Zentrum München,https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00021698,www.koco19.de,Longitudinal/Prospectice cohort study,Household and Community Samples,Munich households,General population,Multiple,,14,Random sampling (not central registration-based),Participants,,,2021-03-15,2021-04-15,,,,,,Seroprevalence from the third wave of the survey in Munich households (infection-induced),http://www.klinikum.uni-muenchen.de/Abteilung-fuer-Infektions-und-Tropenmedizin/de/COVID-19/KoCo19/index.html,2021-07-19,Institutional report,capillary blood,anti Nucleocapsid,Total antibody,Elektrochemolumineszenz (ECL)-Immunassay; LIPS,ROCHE N,,,,,,,ROCHE N,Adjusted for test-specificity/test-sensitivity and population-weighted,,,0.065,,,2021-08-11,2021-10-29,
Prospektive Covid-19 Kohorte München (KoCo19),Local/Regional,Bavaria,Munich,,,,,,Munich,Ludwig-Maximilians-Universität (LMU) München,Helmholtz Zentrum München,Tropeninstitut der Ludwig-Maximilians-Universität (LMU) München,,,,,,Tropeninstitut der Ludwig-Maximilians-Universität (LMU) München; Helmholtz Zentrum München,https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00021698,www.koco19.de,Longitudinal/Prospectice cohort study,Household and Community Samples,Munich households,General population,Multiple,,14,Random sampling (not central registration-based),Participants,,,2021-07-15,2021-10-15,,,,,,Seroprevalence from the fourth wave of the survey in Munich households (infection-induced),http://www.klinikum.uni-muenchen.de/Abteilung-fuer-Infektions-und-Tropenmedizin/download/de/KoCo19/Runde-4/KoCo19_Zusammenfassung_Runde4.pdf,2021-10-28,Institutional report,capillary blood,anti Nucleocapsid,Total antibody,Elektrochemolumineszenz (ECL)-Immunassay; LIPS,ROCHE N,,,,,,,ROCHE N,Adjusted for test-specificity/test-sensitivity and population-weighted,,,0.079,,,2021-11-03,,
"Prospektive Kohorten-Studie zur Ermittlung der Seroprävalenz für SARS-CoV2- Antikörper bei Mitarbeiterinnen und Mitarbeitern
am Klinikum rechts der Isar der Technischen Universität München (SeCoMRI)",Local/Regional,Bavaria,Munich,,,,,,Munich,Technische Universität München,Klinikum rechts der Isar,,,,,,,Klinikum rechts der Isar der Technischen Universität (TU) München,,https://www.mri.tum.de/news/grosse-mitarbeiter-studie-am-klinikum-rechts-der-isar-gestartet,Cross sectional,Healthcare workers and caregivers,Employees of the hospital Rechts der Isar and medical students of the TU München,Selected population groups,Adults,,18,Entire sample,Participants,4554,4600,2020-04-14,2020-05-29,https://doi.org/10.1101/2020.10.04.20206136,http://dx.doi.org/10.2139/ssrn.3678599,https://doi.org/10.3201/eid2803.204436,,,,,,,,,,,,,,,,,,,,,,,,,,2022-03-23,
Prospective molecular biological and serological examination for the detection of SARS-CoV-2 (COVID-19) in employees of a hospital of regular care in Germany (ProCoV),Local/Regional,Schleswig-Holstein,Reinbek,,,,,,Reinbek,"St. Adolf-Stift, Reinbek",Krankenhaus Reinbek,,,,,,,"Krankenhaus Reinbek St. Adolf-Stift, Reinbek",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00021270,"https://www.krankenhaus-reinbek.de/aktuelles/2020-05-11/nicht-nur-eine-gefuehlte-sondern-eine-tatsaechliche-sicherheit-fuer-die ",Longitudinal/Prospectice cohort study,Healthcare workers and caregivers,Employees of the hospital Reinbeck St. Adolf-Stift,Selected population groups,Adults,90,18,Entire sample,Participants,871,900,2020-04-14,2020-06-16,https://doi.org/10.1016/j.ijid.2020.10.026,https://doi.org/10.1101/2021.03.29.21254538,https://doi.org/10.3390/ijerph182010972,,,,,,,,,,,,,,,,,,,,,,,,,,,
Study on SARS-CoV-2-Serology (COVID-19) in Bremen's public sector,Local/Regional,Bremen,Bremen,,,,,,Bremen,Performa Nord,Zentrum für Gesunde Arbeit der Freien Hansestadt Bremen,"Zentrum für Gesunde Arbeit der Freien Hansestadt Bremen, Arbeitsmedizinischer Dienst",,,,,,"Performa Nord, Zentrum für Gesunde Arbeit, Arbeitsmedizinischer Dienst
",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00021289,,Cross sectional,Non-essential workers and unemployed persons,Employees in several organizational areas of Bremen's public service sector,Selected population groups,Multiple,67,16,Convenience sample,Participants,281,300,2020-03-31,2020-05-16,https://www.asu-arbeitsmedizin.com/node/153868/print,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
COVID-19 Contact Study - Immunoreaction after possible SARS-CoV-2 / COVID-19 contact (CoCo Study),Local/Regional,Lower Saxony,Hannover,,,,,,Hannover,Medizinische Hochschule Hannover,,,,,,,,Medizinische Hochschule Hannover,https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00021152,www.cocostudie.de,Longitudinal/Prospectice cohort study,Healthcare workers and caregivers,Employees from the health care sector at Hannover Medical School,Selected population groups,Adults,,18,Convenience sample,Participants,,1000,2020-03-23,2020-04-17,https://doi.org/10.1007/s15010-020-01461-0,https://doi.org/10.1007/s40121-020-00334-1,https://doi.org/10.1101/2020.12.02.20242479,,,,,,,,,,,,,,,,,,,,,,,,,,,
Mütter-Screening in einem COVID-19-Niedrig-Pandemiegebiet: Bestimmung SARS-CoV-2 spezifischer Antikörper bei 401 Rostocker Müttern mittels ELISA und Immunfluoreszenz-Bestätigungstest,Local/Regional,Mecklenburg-Western Pomerania,Rostock,,,,,,Rostock,"Universitätsmedizin Rostock, Zentrum für Innere Medizin, Abteilung für Infektionskrankheiten und Tropenmedizin","Universitätsmedizin Rostock, Institut für Medizinische Mikrobiologie, Virologie und Hygiene","Bernhard Nocht Institut für Tropenmedizin, Hamburg ","Universitätsmedizin Rostock ",,,,,"Abt. für Tropenmedizin und Infektionskrankheiten und Institut für Medizinische Mikrobiologie, Virologie und Hygiene, Universitätsmedizin Rostock; Bernhard Nocht Institut für Tropenmedizin, Hamburg  ",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00021614,https://www.med.uni-rostock.de/medien/pressemitteilungen/aktuelles/news/rostocker-studie-soll-die-covid-infektionen-bei-kindern-und-familien-aufklaeren,Longitudinal/Prospectice cohort study,Household and Community Samples,Mothers of children under the age of 10,Selected population groups,Adults,,18,Convenience sample,Participants,401,400,2020-04-20,2020-04-22,https://doi.org/10.1055/a-1197-4293,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Prospektive Covid 19 Kohorte Tirschenreuth (TiKoCo 19),Local/Regional,Bavaria,Tirschenreuth,,,,,,Tirschenreuth,Universitätsklinikum  Regensburg,Universitätsklinikum Erlangen,"Institut für klinische Mikrobiologie und Hygiene, Universitätsklinikum  Regensburg","Virologisches Institut, Universitätsklinikum Erlangen",,,,,"Institut für klinische Mikrobiologie und Hygiene, Universitätsklinikum Regensburg; Virologisches Institut, Universitätsklinikum Erlangen",,https://www.uni-regensburg.de/pressearchiv/pressemitteilung/1066465.html,Longitudinal/Prospectice cohort study,Household and Community Samples,Residents of the rural district Tirschenreuth,General population,Multiple,,14,Random sampling (central registration-based),Participants,4200,4200,2020-06-15,,https://www.kreis-tir.de/buergerservice/aktuelles/news/news/detail/News/erste-runde-der-blutabnahmen-erfolgreich-abgeschlossen/,https://doi.org/10.1101/2021.03.29.21254343,https://doi.org/10.3390/v13061118,https://doi.org/10.3390/v14061168,,,,,,,,,,,,,,,,,,,,,,,,,,
Prospektive Covid 19 Kohorte Tirschenreuth (TiKoCo 19),Local/Regional,Bavaria,Tirschenreuth,,,,,,Tirschenreuth,Universitätsklinikum  Regensburg,Universitätsklinikum Erlangen,"Institut für klinische Mikrobiologie und Hygiene, Universitätsklinikum  Regensburg","Virologisches Institut, Universitätsklinikum Erlangen",,,,,"Institut für klinische Mikrobiologie und Hygiene, Universitätsklinikum  Regensburg und Virologisches Institut, Universitätsklinikum Erlangen",,https://www.ukr.de/service/aktuelles/06346.php,Longitudinal/Prospectice cohort study,Household and Community Samples,Residents of the rural district Tirschenreuth,General population,Multiple,,14,Random sampling (central registration-based),Participants,4201,4200,2020-06-28,2020-07-10,,,,,,Residents of the rural district Tirschenreuth,https://doi.org/10.3390/v13061118,2021-06-10,Peer-reviewed Publikation,whole blood,multiple,IgG,"ELISA ",EUROIMMUN,In-house,ROCHE N,YHLO,,,,"EUROIMMUN; In-house, ROCHE N, YHLO",,,,0.086,0.0777,0.0945,,2021-11-01,5
Prospektive Covid 19 Kohorte Tirschenreuth (TiKoCo 19),Local/Regional,Bavaria,Tirschenreuth,,,,,,Tirschenreuth,Universitätsklinikum  Regensburg,Universitätsklinikum Erlangen,"Institut für klinische Mikrobiologie und Hygiene, Universitätsklinikum  Regensburg","Virologisches Institut, Universitätsklinikum Erlangen",,,,,"Institut für klinische Mikrobiologie und Hygiene, Universitätsklinikum  Regensburg und Virologisches Institut, Universitätsklinikum Erlangen",,https://www.ukr.de/service/aktuelles/06346.php,Longitudinal/Prospectice cohort study,Household and Community Samples,Residents of the rural district Tirschenreuth,General population,Multiple,,14,Random sampling (central registration-based),Participants,4203,4200,2020-06-28,2020-07-10,,,,,,Seroprevalence of antibodies against the nucleocapsid among residents of Tirschenreuth for the period of June and July 2020,https://doi.org/10.3390/v14061168,2022-05-27,Peer-reviewed Publikation,whole blood,anti Nucleocapsid,Total antibody,"ELISA ",ROCHE N,,,,,,,ROCHE N,Adjusted for test-specificity/test-sensitivity and population-weighted,,,0.0918,0.0834,0.1009,,2022-06-06,5.35
Prospektive Covid 19 Kohorte Tirschenreuth (TiKoCo 19),Local/Regional,Bavaria,Tirschenreuth,,,,,,Tirschenreuth,Universitätsklinikum  Regensburg,Universitätsklinikum Erlangen,"Institut für klinische Mikrobiologie und Hygiene, Universitätsklinikum  Regensburg","Virologisches Institut, Universitätsklinikum Erlangen",,,,,"Institut für klinische Mikrobiologie und Hygiene, Universitätsklinikum  Regensburg und Virologisches Institut, Universitätsklinikum Erlangen",,https://www.ukr.de/service/aktuelles/06346.php,Longitudinal/Prospectice cohort study,Household and Community Samples,Residents of the rural district Tirschenreuth,General population,Multiple,,14,Random sampling (central registration-based),Participants,3513,3500,2020-11-16,2020-11-27,,,,,,Seroprevalence of antibodies against the nucleocapsid among residents of Tirschenreuth for the period of November 2020,https://doi.org/10.3390/v14061168,2022-05-27,Peer-reviewed Publikation,whole blood,anti Nucleocapsid,Total antibody,"ELISA ",ROCHE N,,,,,,,ROCHE N,Adjusted for test-specificity/test-sensitivity and population-weighted,,,0.0997,0.0903,0.1101,,2022-06-01,1
Prospektive Covid 19 Kohorte Tirschenreuth (TiKoCo 19),Local/Regional,Bavaria,Tirschenreuth,,,,,,Tirschenreuth,Universitätsklinikum  Regensburg,Universitätsklinikum Erlangen,"Institut für klinische Mikrobiologie und Hygiene, Universitätsklinikum  Regensburg","Virologisches Institut, Universitätsklinikum Erlangen",,,,,"Institut für klinische Mikrobiologie und Hygiene, Universitätsklinikum  Regensburg und Virologisches Institut, Universitätsklinikum Erlangen",,https://www.ukr.de/service/aktuelles/06346.php,Longitudinal/Prospectice cohort study,Household and Community Samples,Residents of the rural district Tirschenreuth,General population,Multiple,,14,Random sampling (central registration-based),Participants,3374,3400,2021-04-19,2021-04-30,,,,,,Seroprevalence of antibodies against the nucleocapsid among residents of Tirschenreuth for the period of April 2021,https://doi.org/10.3390/v14061168,2022-05-27,Peer-reviewed Publikation,whole blood,anti Nucleocapsid,Total antibody,"ELISA ",ROCHE N,,,,,,,ROCHE N,Adjusted for test-specificity/test-sensitivity and population-weighted,,,0.1543,0.1425,0.1669,,2022-06-01,1.14
Prospektive Covid 19 Kohorte Tirschenreuth (TiKoCo 19),Local/Regional,Bavaria,Tirschenreuth,,,,,,Tirschenreuth,Universitätsklinikum  Regensburg,Universitätsklinikum Erlangen,"Institut für klinische Mikrobiologie und Hygiene, Universitätsklinikum  Regensburg","Virologisches Institut, Universitätsklinikum Erlangen",,,,,"Institut für klinische Mikrobiologie und Hygiene, Universitätsklinikum  Regensburg und Virologisches Institut, Universitätsklinikum Erlangen",,https://www.ukr.de/service/aktuelles/06346.php,Longitudinal/Prospectice cohort study,Household and Community Samples,Residents of the rural district Tirschenreuth,General population,Multiple,,14,Random sampling (central registration-based),Participants,3374,3400,2021-04-19,2021-04-30,,,,,,Seroprevalence of antibodies against the spike protein among residents of Tirschenreuth for the period of April 2021,https://doi.org/10.3390/v14061168,2022-05-27,Peer-reviewed Publikation,whole blood,anti -S1 domain,IgG,"ELISA ",EUROIMMUN,,,,,,,EUROIMMUN,Adjusted for test-specificity/test-sensitivity and population-weighted,,,0.4579,0.4411,0.4747,,2022-06-01,1.14
Immunitätsstudie gegen SARS-CoV-2,Local/Regional,Hesse,Fulda,,,,,,Fulda,Universitätsmedizin Marburg,Universitätsmedizin Marburg - Campus Fulda,,,,,,,Universitätsmedizin Marburg - Campus Fulda - Medizinische Klinik 4,,https://www.klinikum-fulda.de/wp-content/uploads/2020/04/20200423-Pressemeldung-Antikörperstudie-1-0.pdf,Repeated cross-sectional,Other groups,Employees of the hospital Fulda and employees of the retail segment in Fulda,Selected population groups,Adults,,18,Entire sample,Participants,1780,1800,2020-04-09,2020-04-16,http://dx.doi.org/10.1055/a-1198-1243,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SARS-CoV-2 Infektionen bei Gesundheitspersonal in Krankenhäusern in Deutschland (SGK),Local/Regional,Berlin,Berlin,,,,,,Unfallklinikum Berlin-Marzahn,"Robert Koch-Institut, Berlin",,,,,,,,"Robert Koch-Institut, Berlin",,,Repeated cross-sectional,Healthcare workers and caregivers,Health care personnel in selected areas at the Unfallkrankenhaus Berlin,Selected population groups,Adults,,18,Entire sample,Participants,1477,1500,2020-05-15,2020-12-16,https://www.bg-kliniken.de/unfallkrankenhaus-berlin/ueber-uns/bg-klinikum-unfallkrankenhaus-berlin/aktuelles/detail/das-unfallkrankenhaus-berlin-im-dienst-der-wissenschaft/,https://doi.org/10.1186/s12879-022-07057-3,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Die Ausbreitung des neuen Coronavirus (SARS-CoV-2) und die gesundheitlichen Folgen (CoKoS),Local/Regional,Baden-Wuerttemberg,Stuttgart,,,,,,Stuttgart,Gesundheitsamt Stuttgart,Klinikum Stuttgart,Universitätsklinik Tübingen,,,,,,"Gesundheitsamt Stuttgart, Klinikum Stuttgart, Universitätsklinik Tübingen",,https://www.klinikum-stuttgart.de/aktuell-im-klinikum/presse/presseinformation/studie-zur-verbreitung-des-corona-virus-in-stuttgart,Longitudinal/Prospectice cohort study,Household and Community Samples,Stuttgart general population (sample A) and participants with a known past infection (sample B),General population and selected population groups,Multiple,,5,Random sampling (central registration-based),Participants,,1400,2020-05-15,,https://doi.org/10.1007/s15010-022-01830-x,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Die Ausbreitung des neuen Coronavirus (SARS-CoV-2) und die gesundheitlichen Folgen (CoKoS),Local/Regional,Baden-Wuerttemberg,Stuttgart,,,,,,Stuttgart,Gesundheitsamt Stuttgart,Klinikum Stuttgart,Universitätsklinik Tübingen,,,,,,"Gesundheitsamt Stuttgart, Klinikum Stuttgart, Universitätsklinik Tübingen",,"https://www.stuttgarter-zeitung.de/inhalt.forschungsprojekt-in-stuttgart-antikoerper-studie-zu-corona-in-der-stadt.50b185f5-ab99-4f1a-9268-00ed87f97bf2.html
https://www.klinikum-stuttgart.de/aktuell-im-klinikum/presse/presseinformation/studie-zur-verbreitung-des-corona-virus-in-stuttgart",Longitudinal/Prospectice cohort study,Household and Community Samples,Stuttgart general population (sample A) and participants with a known past infection (sample B),General population,Multiple,,5,Random sampling (not central registration-based),Participants,,5000,2020-05-15,2020-07-14,,,,,,Seroprevalence of antibodies against the spike protein among inhabitants of Stuttgart for the period of June to July 2021,https://doi.org/10.1007/s15010-022-01830-x,2022-06-01,Peer-reviewed Publikation,capillary blood,anti -S1 domain,IgG,"ELISA ",EUROIMMUN,,,,,,,EUROIMMUN,,,,0.716,,,,2022-06-13,
Die Ausbreitung des neuen Coronavirus (SARS-CoV-2) und die gesundheitlichen Folgen (CoKoS),Local/Regional,Baden-Wuerttemberg,Stuttgart,,,,,,Stuttgart,Gesundheitsamt Stuttgart,Klinikum Stuttgart,Universitätsklinik Tübingen,,,,,,"Gesundheitsamt Stuttgart, Klinikum Stuttgart, Universitätsklinik Tübingen",,"https://www.stuttgarter-zeitung.de/inhalt.forschungsprojekt-in-stuttgart-antikoerper-studie-zu-corona-in-der-stadt.50b185f5-ab99-4f1a-9268-00ed87f97bf2.html
https://www.klinikum-stuttgart.de/aktuell-im-klinikum/presse/presseinformation/studie-zur-verbreitung-des-corona-virus-in-stuttgart",Longitudinal/Prospectice cohort study,Household and Community Samples,Stuttgart general population (sample A) and participants with a known past infection (sample B),General population,Multiple,,5,Random sampling (not central registration-based),Participants,,5000,2020-05-15,2020-07-14,,,,,,Seroprevalence of antibodies against the spike protein among inhabitants of Stuttgart for the period of June to July 2021,https://doi.org/10.1007/s15010-022-01830-x,2022-06-01,Peer-reviewed Publikation,capillary blood,anti Nucleocapsid,IgG,"ELISA ",EUROIMMUN,,,,,,,EUROIMMUN,,,,0.048,,,,2022-06-13,
Serologische Untersuchungen bei Blutspendern des Großraumes Magdeburg auf Antikörper gegen SARS-CoV-2 (SeMaCo),Local/Regional,Saxony-Anhalt,Magdeburg,,,,,,Magdeburg,Otto-von-Guericke-Universität Magdeburg,,,,,,,,"Medizinische Fakultät, Otto-von-Guericke-Universität Magdeburg",,http://www.itib.ovgu.de/Forschung+_+Lehre.html,Repeated cross-sectional,Blood donors,Blood donors from Magdeburg and the surrounding area,General population,Adults,,18,Blood donation,Participants,268,300,2021-01-20,2021-01-31,,,,,,Seroprevalence among blood donors for the period January 2021,https://www.karger.com/Article/Pdf/518751,2021-09-07,Presentation,whole blood,,,,N/A,,,,,,,N/A,,,,0.037,,,2022-04-25,2022-05-10,
Serologische Untersuchungen bei Blutspendern des Großraumes Magdeburg auf Antikörper gegen SARS-CoV-2 (SeMaCo),Local/Regional,Saxony-Anhalt,Magdeburg,,,,,,Magdeburg,Otto-von-Guericke-Universität Magdeburg,,,,,,,,"Medizinische Fakultät, Otto-von-Guericke-Universität Magdeburg",,http://www.itib.ovgu.de/Forschung+_+Lehre.html,Repeated cross-sectional,Blood donors,Blood donors from Magdeburg and the surrounding area,General population,Adults,,18,Blood donation,Participants,566,600,2021-02-01,2021-02-28,,,,,,Seroprevalence among blood donors for the period February 2021,https://www.karger.com/Article/Pdf/518751,2021-09-07,Presentation,whole blood,,,,N/A,,,,,,,N/A,,,,0.074,,,2022-04-25,2022-05-10,
Serologische Untersuchungen bei Blutspendern des Großraumes Magdeburg auf Antikörper gegen SARS-CoV-2 (SeMaCo),Local/Regional,Saxony-Anhalt,Magdeburg,,,,,,Magdeburg,Otto-von-Guericke-Universität Magdeburg,,,,,,,,"Medizinische Fakultät, Otto-von-Guericke-Universität Magdeburg",,http://www.itib.ovgu.de/Forschung+_+Lehre.html,Repeated cross-sectional,Blood donors,Blood donors from Magdeburg and the surrounding area,General population,Adults,,18,Blood donation,Participants,888,900,2021-03-01,2021-03-31,,,,,,Seroprevalence among blood donors for the period March 2021,https://www.karger.com/Article/Pdf/518751,2021-09-07,Presentation,whole blood,,,,N/A,,,,,,,N/A,,,,0.12,,,2022-04-25,2022-05-10,
Serologische Untersuchungen bei Blutspendern des Großraumes Magdeburg auf Antikörper gegen SARS-CoV-2 (SeMaCo),Local/Regional,Saxony-Anhalt,Magdeburg,,,,,,Magdeburg,Otto-von-Guericke-Universität Magdeburg,,,,,,,,"Medizinische Fakultät, Otto-von-Guericke-Universität Magdeburg",,http://www.itib.ovgu.de/Forschung+_+Lehre.html,Repeated cross-sectional,Blood donors,Blood donors from Magdeburg and the surrounding area,General population,Adults,,18,Blood donation,Participants,514,500,2021-04-01,2021-04-30,,,,,,Seroprevalence among blood donors for the period April 2021,https://www.karger.com/Article/Pdf/518751,2021-09-07,Presentation,whole blood,,,,N/A,,,,,,,N/A,,,,0.253,,,2022-04-25,2022-05-10,
Serologische Untersuchungen bei Blutspendern des Großraumes Magdeburg auf Antikörper gegen SARS-CoV-2 (SeMaCo),Local/Regional,Saxony-Anhalt,Magdeburg,,,,,,Magdeburg,Otto-von-Guericke-Universität Magdeburg,,,,,,,,"Medizinische Fakultät, Otto-von-Guericke-Universität Magdeburg",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00023263,http://www.itib.ovgu.de/Forschung+_+Lehre.html,Repeated cross-sectional,Blood donors,Blood donors from Magdeburg and the surrounding area,General population,Adults,,18,Blood donation,Participants,2236,2200,2021-01-20,2021-04-30,https://www.med.uni-magdeburg.de/Kommunikation+_+Presse/Marketing_+Kommunikation+und+Medien/Presse/Pressemitteilungen/Universit%C3%A4tsmedizin+Magdeburg/UMMD+_+03_06_2021+Erste+Ergebnisse+der+Magdeburger+Antik%C3%B6rperstudie+zu+COVID_19_+Von+einer+breiten+Immunit%C3%A4t+noch+weit+entfernt-p-22890.html,https://www.karger.com/Article/Pdf/518751,,,,Seroprevalence among all participating blood donors January to April 2021,https://www.karger.com/Article/Pdf/518751,2022-09-07,Presentation,whole blood,,,,N/A,,,,,,,N/A,,,,0.129,,,2021-09-03,2022-05-10,
Serologische Untersuchungen bei Blutspendern des Großraumes Magdeburg auf Antikörper gegen SARS-CoV-2 (SeMaCo),Local/Regional,Saxony-Anhalt,Magdeburg,,,,,,Magdeburg,Otto-von-Guericke-Universität Magdeburg,,,,,,,,"Medizinische Fakultät, Otto-von-Guericke-Universität Magdeburg",,http://www.itib.ovgu.de/Forschung+_+Lehre.html,Repeated cross-sectional,Blood donors,Blood donors from Magdeburg and the surrounding area,General population,Adults,,18,Blood donation,Participants,1895,1900,2021-01-18,2021-04-30,,,,,,Seroprevalence among unvaccinated blood donors January to April 2021,https://www.med.uni-magdeburg.de/Kommunikation+_+Presse/Marketing_+Kommunikation+und+Medien/Presse/Pressemitteilungen/Universit%C3%A4tsmedizin+Magdeburg/UMMD+_+03_06_2021+Erste+Ergebnisse+der+Magdeburger+Antik%C3%B6rperstudie+zu+COVID_19_+Von+einer+breiten+Immunit%C3%A4t+noch+weit+entfernt-p-22890.html,2021-06-03,Press release,whole blood,,,,N/A,,,,,,,N/A,,,,0.06,,,2021-09-03,2021-10-17,
Seroprävalenz COVID-19 Düsseldorf: junge Düsseldorfer/-innen (SERODUS I),Local/Regional,North Rhine-Westphalia,Dusseldorf,,,,,,Dusseldorf,Universitätsklinikum Düsseldorf,Stadt Düsseldorf,,,,,,,Universitätsklinikum Düsseldorf und Stadt Düsseldorf,,https://www.uniklinik-duesseldorf.de/patienten-besucher/klinikeninstitutezentren/institut-fuer-medizinische-soziologie/das-institut/forschung/serodus,Cross sectional,Household and Community Samples,Residents of Düsseldorf,General population,Adults,30,18,Random sampling (central registration-based),Participants,2186,2200,2020-11-02,2020-11-27,https://doi.org/10.1016/j.puhe.2022.03.009,,,,,Seroprevalence of 18 to 30 year old residents of Düsseldorf,https://doi.org/10.1016/j.puhe.2022.03.009,2022-03-23,Peer-reviewed Publikation,whole blood,anti Nucleocapsid,Total antibody,Elektrochemolumineszenz (ECL)-Immunassay; LIPS,ROCHE,,,,,,,ROCHE,Adjusted for test-specificity/test-sensitivity,0.995,0.998,0.031,0.024,0.04,,2022-05-10,1.7
SARS-CoV-2-KIDS study,Nationwide,Nationwide,Germany,,,,,,"14 paediatric clinics from all over Germany, focus on North Rhine-Westphalia",Germany,,,,,,,,14 large paediatric clinics,,https://www.umm.de/medien/pressemitteilungen/pressemitteilung/news/sars-cov-2-kids-studie-grosse-multizentrische-studie-mit-kindern-und-jugendlichen/,Repeated cross-sectional,Persons seeking care for non-COVID reasons,Children and adolescents up to 17 years of age from participating children's hospitals,Selected population groups,Children/adolescents ≤18 years,17,0,Convenience sample,Participants,,,2020-06-01,2020-09-30,,,,,,Seroprevalence in children and adolescents up to the age of 17 for the period June - September 2020,https://doi.org/10.1038/s41467-022-30482-6,2022-06-06,Peer-reviewed Publikation,whole blood,anti -S1 domain,IgG,"ELISA ",EUROIMMUN,,,,,,,EUROIMMUN,Population-weighted,,,0.02,0.016,0.025,2022-01-10,2022-02-11,
SARS-CoV-2-KIDS study,Nationwide,Nationwide,Germany,,,,,,"14 paediatric clinics from all over Germany, focus on North Rhine-Westphalia",Germany,,,,,,,,14 large paediatric clinics,,https://www.umm.de/medien/pressemitteilungen/pressemitteilung/news/sars-cov-2-kids-studie-grosse-multizentrische-studie-mit-kindern-und-jugendlichen/,Repeated cross-sectional,Persons seeking care for non-COVID reasons,Children and adolescents up to 17 years of age from participating children's hospitals,Selected population groups,Children/adolescents ≤18 years,17,0,Convenience sample,Participants,,,2020-10-01,2021-03-31,,,,,,Seroprevalence in children and adolescents up to the age of 17 for the period October 2020 - March 2021,https://doi.org/10.1038/s41467-022-30482-6,2022-06-06,Peer-reviewed Publikation,whole blood,anti -S1 domain,IgG,"ELISA ",EUROIMMUN,,,,,,,EUROIMMUN,Population-weighted,,,0.108,0.087,0.129,2022-01-10,2022-02-11,
SARS-CoV-2-KIDS study,Nationwide,Nationwide,Germany,,,,,,"14 paediatric clinics from all over Germany, focus on North Rhine-Westphalia",Germany,,,,,,,,14 large paediatric clinics,,https://www.umm.de/medien/pressemitteilungen/pressemitteilung/news/sars-cov-2-kids-studie-grosse-multizentrische-studie-mit-kindern-und-jugendlichen/,Repeated cross-sectional,Persons seeking care for non-COVID reasons,Children and adolescents up to 17 years of age from participating children's hospitals,Selected population groups,Children/adolescents ≤18 years,17,0,Convenience sample,Participants,10358,10400,2020-06-01,2021-05-31,https://doi.org/10.2139/ssrn.3965378,https://doi.org/10.1038/s41467-022-30482-6,,,,,,,,,,,,,,,,,,,,,,,,,,2021-12-03,2021-12-07,
Saarlandweite Coronavirus-Antikörper-Prävalenzstudie (SaarCoPS),Local/Regional,Saarland,Saarland,,,,,,Saarland,"Ministerium für Soziales, Gesundheit, Frauen und Familie",Staatliche Medizinaluntersuchungsstelle des Saarlandes,Universitätsklinikum des Saarlandes," Institut für Virologie, Universitätsklinikum des Saarlandes",,,,,"Ministerium für Soziales, Gesundheit, Frauen und Familie; Staatliche Medizinaluntersuchungsstelle des Saarlandes, Institut für Virologie, Universitätsklinikum des Saarlandes 
",,https://www.uniklinikum-saarland.de/de/einrichtungen/kliniken_institute/infektionsmedizin/virologie/saarcops/,Longitudinal/Prospectice cohort study,Household and Community Samples,Residents of Saarland,General population,Adults,95,18,Random sampling (central registration-based),Participants,2940,2900,2020-07-22,2020-10-15,https://www.uniklinikum-saarland.de/de/aktuelles/einzelansicht_news/aktuellesseite/article/saarlaendische-antikoerperstudie-zur-coronavirus-infektion-abgeschlossen-institut-fuer-virologie-am/,https://doi.org/10.1038/s43856-022-00100-z,,,,Seroprevalence of the adult population from the federal state of Saarland for the period from July 2020 to Octobre 2020,https://doi.org/10.1038/s43856-022-00100-z,2022-05-18,Peer-reviewed Publikation,whole blood,multiple,Multiple antibodies,Mehrere/andere,ROCHE N,,,,,,,Roche N,Adjusted for test-specificity/test-sensitivity and population-weighted,,,0.0102,0.0064,0.0144,,2022-06-06,2.68
Fr1da-COVID19: Messung der Entwicklung von Immunität gegen SARS-CoV-2 in einer Kinderkohorte in Bayern (2019-2022 ),Local/Regional,Bavaria,Bavaria,,,,,,Bavaria,"Helmholtz Zentrum München, Institut für Diabetesforschung",Helmholtz Zentrum München,,,,,,,"Institut für Diabetesforschung, Helmholtz Zentrum München",,https://www.typ1diabetes-frueherkennung.de/informationen-fuer-aerzte/fr1daplus-sars-cov-2.html,Repeated cross-sectional,Household and Community Samples,Participating children of the Fr1da study (children's cohort for early detection of type 1 diabetes),General population,Children/adolescents ≤18 years,10,2,Cohort-sample - Sampling from existing cohort study in the general population,Participants,,75000,2020-01-01,,https://doi.org/10.1016/j.medj.2020.10.003,,,,,,,,,,,,,,,,,,,,,,,,,,,,2021-09-27,
Fr1da-COVID19: Messung der Entwicklung von Immunität gegen SARS-CoV-2 in einer Kinderkohorte in Bayern (2019-2022 ),Local/Regional,Bavaria,Bavaria,,,,,,Bavaria,"Helmholtz Zentrum München, Institut für Diabetesforschung",Helmholtz Zentrum München,,,,,,,"Institut für Diabetesforschung, Helmholtz Zentrum München",,https://www.typ1diabetes-frueherkennung.de/informationen-fuer-aerzte/fr1daplus-sars-cov-2.html,Repeated cross-sectional,Household and Community Samples,Participating children (1 - 10 years of age) of the Fr1da study (children's cohort for early detection of type 1 diabetes) from Jan 2020 to Aug 2020,General population,Children/adolescents ≤18 years,10,1,Cohort-sample - Sampling from existing cohort study in the general population,Participants,15523,15500,2020-01-01,2020-08-31,,,,,,Total seroprevalence of children 1 to 10 years old participating in the Fr1da study for the period from January to August 2020,https://doi.org/10.1016/j.medj.2021.03.019,2021-05-14,Peer-reviewed Publikation,capillary blood,multiple,Total antibody,Elektrochemolumineszenz (ECL)-Immunassay; LIPS,Author designed,,,,,,,Author designed,Adjusted for test-specificity/test-sensitivity,0.973,1,0.0068,0.0056,0.0082,,2021-10-17,
Fr1da-COVID19: Messung der Entwicklung von Immunität gegen SARS-CoV-2 in einer Kinderkohorte in Bayern (2019-2022 ),Local/Regional,Bavaria,Bavaria,,,,,,Bavaria,"Helmholtz Zentrum München, Institut für Diabetesforschung",Helmholtz Zentrum München,,,,,,,"Institut für Diabetesforschung, Helmholtz Zentrum München",,https://www.typ1diabetes-frueherkennung.de/informationen-fuer-aerzte/fr1daplus-sars-cov-2.html,Repeated cross-sectional,Household and Community Samples,Participating children (1 - 10 years of age) of the Fr1da study (children's cohort for early detection of type 1 diabetes) from Sept 2020 to Feb 2021,General population,Children/adolescents ≤18 years,10,1,Cohort-sample - Sampling from existing cohort study in the general population,Participants,11380,11400,2020-09-01,2021-02-28,,,,,,Total seroprevalence of children 1 to 10 years old participating in the Fr1da study for the period from September 2020 to February 2021,https://doi.org/10.1016/j.medj.2021.03.019,2021-05-14,Peer-reviewed Publikation,capillary blood,multiple,Total antibody,Elektrochemolumineszenz (ECL)-Immunassay; LIPS,Author designed,,,,,,,Author designed,Adjusted for test-specificity/test-sensitivity,0.973,1,0.0392,0.0357,0.0429,,2021-10-17,
Fr1da-COVID19: Messung der Entwicklung von Immunität gegen SARS-CoV-2 in einer Kinderkohorte in Bayern (2019-2022 ),Local/Regional,Bavaria,Bavaria,,,,,,Bavaria,"Helmholtz Zentrum München, Institut für Diabetesforschung",Helmholtz Zentrum München,,,,,,,"Institut für Diabetesforschung, Helmholtz Zentrum München",,https://www.typ1diabetes-frueherkennung.de/informationen-fuer-aerzte/fr1daplus-sars-cov-2.html,Repeated cross-sectional,Household and Community Samples,Participating children (1 - 10 years of age) of the Fr1da study (children's cohort for early detection of type 1 diabetes) in July 2020,General population,Children/adolescents ≤18 years,18,1,Cohort-sample - Sampling from existing cohort study in the general population,Participants,,,2020-03-01,2020-03-31,,,,,,Under reporting factor of children 1 to 18 years old participating in the Fr1da study for March 2020,https://doi.org/10.1016/j.medj.2020.10.003,,,,,,,,,,,,,,,,,,,,,,2022-02-15,2
Fr1da-COVID19: Messung der Entwicklung von Immunität gegen SARS-CoV-2 in einer Kinderkohorte in Bayern (2019-2022 ),Local/Regional,Bavaria,Bavaria,,,,,,Bavaria,"Helmholtz Zentrum München, Institut für Diabetesforschung",Helmholtz Zentrum München,,,,,,,"Institut für Diabetesforschung, Helmholtz Zentrum München",,https://www.typ1diabetes-frueherkennung.de/informationen-fuer-aerzte/fr1daplus-sars-cov-2.html,Repeated cross-sectional,Household and Community Samples,Participating children (1 - 10 years of age) of the Fr1da study (children's cohort for early detection of type 1 diabetes) in July 2020,General population,Children/adolescents ≤18 years,18,1,Cohort-sample - Sampling from existing cohort study in the general population,Participants,,,2020-04-01,2020-07-31,,,,,,Under reporting factor of children 1 to 18 years old participating in the Fr1da study for April to Juli 2020,https://doi.org/10.1016/j.medj.2020.10.003,,,,,,,,,,,,,,,,,,,,,,2022-02-15,7.5
Seroprevalence of SARS-CoV-2 antibodies in a quarantined community after a COVID-19 outbreak (Co-NAN),Local/Regional,Thuringia,Neustadt am Rennsteig,,,,,,Neustadt am Rennsteig,Universitätsklinikum Jena,,,,,,,,Universitätsklinikum Jena,https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022416,,Longitudinal/Prospectice cohort study,Household and Community Samples,Residents of Neustadt am Rennsteig,General population,Multiple,97,1,Entire sample,Participants,620,600,2020-05-13,2020-05-22,https://doi.org/10.1101/2020.07.15.20154112,https://doi.org/10.1016/j.cmi.2020.11.009,,,,Residents of Neustadt am Rennsteig,https://doi.org/10.1016/j.cmi.2020.11.009,2020-11-20,Peer-reviewed Publikation,whole blood,multiple,IgG,Mehrere/andere,EPITOPE,DIASORIN,SNIBE,SEROPRAX,EUROIMMUN,ABBOTT,ROCHE,EPITOPE; DIASORIN; SNIBE; SEROPRAX; EUROIMMUN; ABBOTT; ROCHE,Adjusted for test-specificity/test-sensitivity and population-weighted,,,0.115,0.091,0.142,2021-07-11,2021-10-08,2
Hamburg City Health Study (HCHS): Covid-19 Modul,Local/Regional,Hamburg,Hamburg,,,,,,Hamburg,Universitätsklinikum Hamburg-Eppendorf,,,,,,,,Universitätsklinikum Hamburg-Eppendorf (UKE),,https://www.uke.de/allgemein/presse/pressemitteilungen/detailseite_93825.html,Cross sectional,Household and Community Samples,Particpants of the Hamburg City Health Study,General population,Adults,74,45,Cohort-sample - Sampling from existing cohort study in the general population,Participants,6000,6000,2020-04-29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Covid-19 Children Health Investigation of Latent Disease in Hamburg (C19.CHILD HAMBURG),Local/Regional,Hamburg,Hamburg,,,,,,Hamburg,Universitätsklinikum Hamburg-Eppendorf,,,,,,,,"Klinik für Kinder- und Jugendmedizin und Institut für Mikrobiologie, Universitätsklinikum Eppendorf",,http://c19child.hamburg,Cross sectional and selective longitudinal,Persons seeking care for non-COVID reasons,Inpatients and outpatients of all Hamburg children's hospitals,General population and selected population groups,Children/adolescents ≤18 years,17,0,Convenience sample,Participants,4657,4700,2020-05-11,2020-06-30,https://www.uke.de/allgemein/presse/pressemitteilungen/detailseite_95874.html,"https://doi.org/10.1101/2022.02.11.22270611 ",https://doi.org/10.1055/s-0042-1742988,,,Total seroprevalence of outpatients and inpatients of the Hamburg pedriatric hospitals for the period of May to June 2020,"https://doi.org/10.1101/2022.02.11.22270611 ",2022-02-11,Preprint,whole blood,multiple,Total antibody,Mehrere/andere,DIASORIN,ROCHE,,,,,,DIASORIN; Roche,,,,0.0144,,,,2022-05-04,
Covid-19 Children Health Investigation of Latent Disease in Hamburg (C19.CHILD HAMBURG),Local/Regional,Hamburg,Hamburg,,,,,,Hamburg,Universitätsklinikum Hamburg-Eppendorf,,,,,,,,"Klinik für Kinder- und Jugendmedizin und Institut für Mikrobiologie, Universitätsklinikum Eppendorf",,http://c19child.hamburg,Cross sectional and selective longitudinal,Persons seeking care for non-COVID reasons,Inpatients and outpatients of all Hamburg children's hospitals 0 - 9 years old,General population and selected population groups,Children/adolescents ≤18 years,5,0,Convenience sample,Participants,,0,2020-05-11,2020-06-30,,,,,,Seroprevalence of outpatients and inpatients of the Hamburg pedriatric hospitals aged 0 to 5 years old for the period of May to June 2020,"https://doi.org/10.1101/2022.02.11.22270611 ",2022-02-11,Preprint,whole blood,multiple,Total antibody,Mehrere/andere,DIASORIN,ROCHE,,,,,,DIASORIN; Roche,,,,0.0058,0.0036,0.008,,2022-05-04,
Covid-19 Children Health Investigation of Latent Disease in Hamburg (C19.CHILD HAMBURG),Local/Regional,Hamburg,Hamburg,,,,,,Hamburg,Universitätsklinikum Hamburg-Eppendorf,,,,,,,,"Klinik für Kinder- und Jugendmedizin und Institut für Mikrobiologie, Universitätsklinikum Eppendorf",,http://c19child.hamburg,Cross sectional and selective longitudinal,Persons seeking care for non-COVID reasons,Inpatients and outpatients of all Hamburg children's hospitals 10 - 18 years old,General population and selected population groups,Children/adolescents ≤18 years,12,6,Convenience sample,Participants,,0,2020-05-11,2020-06-30,,,,,,Seroprevalence of outpatients and inpatients of the Hamburg pedriatric hospitals aged 6 to 12 years old for the period of May to June 2020,"https://doi.org/10.1101/2022.02.11.22270611 ",2022-02-11,Preprint,whole blood,multiple,Total antibody,Mehrere/andere,DIASORIN,ROCHE,,,,,,DIASORIN; Roche,,,,0.0184,0.0099,0.027,,2022-05-04,
Covid-19 Children Health Investigation of Latent Disease in Hamburg (C19.CHILD HAMBURG),Local/Regional,Hamburg,Hamburg,,,,,,Hamburg,Universitätsklinikum Hamburg-Eppendorf,,,,,,,,"Klinik für Kinder- und Jugendmedizin und Institut für Mikrobiologie, Universitätsklinikum Eppendorf",,http://c19child.hamburg,Cross sectional and selective longitudinal,Persons seeking care for non-COVID reasons,Inpatients and outpatients of all Hamburg children's hospitals (total seroprevalence),General population and selected population groups,Children/adolescents ≤18 years,17,13,Convenience sample,Participants,,0,2020-05-11,2020-06-30,,,,,,Seroprevalence of outpatients and inpatients of the Hamburg pedriatric hospitals aged 13 to 17 years old for the period of May to June 2020,"https://doi.org/10.1101/2022.02.11.22270611 ",2022-02-11,Preprint,whole blood,multiple,Total antibody,Mehrere/andere,DIASORIN,ROCHE,,,,,,DIASORIN; Roche,,,,0.0194,0.011,0.0278,,2022-05-04,
Blutspende-Studie Hamburg,Local/Regional,Hamburg,Hamburg,,,,,,Hamburg,"Universitätsklinikum Hamburg-Eppendorf, Institut für Transfusionsmedizin",Universitätsklinikum Hamburg-Eppendorf (UKE),,,,,,,"Institut für Transfusionsmedizin, Universitätsklinikum Hamburg-Eppendorf (UKE)",,,Cross sectional,Blood donors,Blood donors from Hamburg,General population,Adults,,18,Blood donation,Samples of participants,300,300,2020-04-06,2020-04-10,https://www.uke.de/allgemein/presse/pressemitteilungen/detailseite_95424.html,,,,,Seroprevalence among blood donors in Hamburg for the period of April 2020,https://www.uke.de/allgemein/presse/pressemitteilungen/detailseite_95424.html,2020-06-09,Webseite,whole blood,multiple,Multiple antibodies,Mehrere/andere,ROCHE N,DIASORIN,EUROIMMUN,WANTAI,,,,ROCHE N; DIASORIN; EUROIMMUN; WANTAI,,0.864,0.998,0.003,,,,2021-10-17,
Blutspende-Studie Hamburg,Local/Regional,Hamburg,Hamburg,,,,,,Hamburg,"Universitätsklinikum Hamburg-Eppendorf, Institut für Transfusionsmedizin",Universitätsklinikum Hamburg-Eppendorf (UKE),,,,,,,"Institut für Transfusionsmedizin, Universitätsklinikum Hamburg-Eppendorf (UKE)",,,Cross sectional,Blood donors,Blood donors from Hamburg,General population,Adults,,18,Blood donation,Samples of participants,288,300,2020-05-04,2020-05-06,,,,,,Seroprevalence among blood donors in Hamburg for the period of May 2020,https://www.uke.de/allgemein/presse/pressemitteilungen/detailseite_95424.html,2020-06-09,Webseite,whole blood,multiple,Multiple antibodies,Mehrere/andere,ROCHE N,DIASORIN,EUROIMMUN,WANTAI,,,,ROCHE N; DIASORIN; EUROIMMUN; WANTAI,,0.864,0.998,0.007,,,,2021-10-17,
Blutspende-Studie Hamburg,Local/Regional,Hamburg,Hamburg,,,,,,Hamburg,"Universitätsklinikum Hamburg-Eppendorf, Institut für Transfusionsmedizin",Universitätsklinikum Hamburg-Eppendorf (UKE),,,,,,,"Institut für Transfusionsmedizin, Universitätsklinikum Hamburg-Eppendorf (UKE)",,,Cross sectional,Blood donors,Blood donors from Hamburg,General population,Adults,,18,Blood donation,Samples of participants,326,300,2020-06-02,2020-06-05,,,,,,Seroprevalence among blood donors in Hamburg for the period of June 2020,https://www.uke.de/allgemein/presse/pressemitteilungen/detailseite_95424.html,2020-06-09,Webseite,whole blood,multiple,Multiple antibodies,Mehrere/andere,ROCHE N,DIASORIN,EUROIMMUN,WANTAI,,,,ROCHE N; DIASORIN; EUROIMMUN; WANTAI,,0.864,0.998,0.003,,,,2021-10-17,
SARS-CoV-2 spezifische Immunität und Serokonversion von medizinischem Personal mit COVID-19 Exposititon,Local/Regional,North Rhine-Westphalia,Essen,,,,,,Essen,"Institut für Virologie, Essen",Universitätsklinikum Essen,,,,,,,"Klinik für Infektiologie, Institut für Virologie, Essen",,,Cross sectional and selective longitudinal,Healthcare workers and caregivers,"Employees of the hospital ",Selected population groups,Adults,,18,Convenience sample,Participants,,800,2020-03-01,,https://doi.org/10.1016/j.jcv.2020.104437,https://doi.org/10.3390/ijerph18094540,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Screening for COVID-19 and Monitoring of Serological Responses to SARS-CoV-2 in Healthcare Workers (SeCo),Local/Regional,Mecklenburg-Western Pomerania,Greifswald,,,,,,Greifswald,Universitätsmedizin Greifswald,Friedrich-Loeffler-Institut,Friedrich-Loeffler-Institut für Medizinische Mikrobiologie,"Friedrich-Loeffler-Institut, Zentralbereich Hygiene",,,,,"Universitätsmedizin Greifswald, Friedrich-Loeffler-Institut für Medizinische Mikrobiologie und Zentralbereich Hygiene",https://clinicaltrials.gov/ct2/show/record/NCT04370119,,Longitudinal/Prospectice cohort study,Healthcare workers and caregivers,Employees of the University Medical Center Greifswald,Selected population groups,Adults,,18,Convenience sample,Participants,,4000,2020-04-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Serial cross-sectional seroprevalence study of SARS-CoV-2 infection during and after the COVID-19 epidemic in Heidelberg and the Rhein-Neckar region,Local/Regional,Baden-Wuerttemberg,Rhine-Neckar district,Heidelberg,,,,,"Heidelberg, Rhine-Neckar district",Universitätsklinikum Heidelberg,,,,,,,,"Universitätsklinikum Heidelberg, Sektion Tropenmedizin",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00021709,,Repeated cross-sectional,Household and Community Samples,Residents of Heidelberg and the Rhine-Neckar district,General population,Multiple,,5,Random sampling (central registration-based),Participants,1500,1500,2020-05-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"Study on the Evaluation of the Infectious Process of SARS-CoV-2 in Teachers and Students in Saxony (COVID-19) (SCHULERHEBUNG ""CORONA"")",Local/Regional,Saxony,Dresden,Zwickau,Leipzig,Werdau,Borna,,"Dresden, Zwickau, Leipzig, Werdau and Borna",Universität Leipzig,Universitätsklinik Leipzig,LIFE Child,,,,,,"LIFE Child, Medizinische Fakultät der Universität Leipzig, Institut für Virologie der Universitätsklinik Leipzig",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022032,https://home.uni-leipzig.de/lifechild/schulerhebung-corona/,Repeated cross-sectional,"School, Kindergarten/Daycare",Students and teachers from primary and secondary schools in Saxony,General population and selected population groups,Multiple,67,7,"Multistage, partial random sampling",Participants,,3000,2020-05-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2021-09-27,
"Study on the Evaluation of the Infectious Process of SARS-CoV-2 in Teachers and Students in Saxony (COVID-19) (SCHULERHEBUNG ""CORONA"")",Local/Regional,Saxony,Dresden,Zwickau,Leipzig,Werdau,Borna,,"Dresden, Zwickau, Leipzig, Werdau and Borna",Universität Leipzig,Universitätsklinik Leipzig,LIFE Child,,,,,,"LIFE Child, Medizinische Fakultät der Universität Leipzig, Institut für Virologie der Universitätsklinik Leipzig",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022032,,Repeated cross-sectional,"School, Kindergarten/Daycare",Students secondary schools in Saxony,General population,Children/adolescents ≤18 years,17,,"Multistage, partial random sampling",Participants,,,2020-11-01,2020-11-30,,,,,,Seroprevelence among students in secondary schools in Saxony for the period of November 2020,https://home.uni-leipzig.de/lifechild/schulerhebung-corona/,,Webseite,whole blood,,IgG,,ABBOTT N,,,,,,,ABBOTT N,,,,0.018,,,,2021-09-27,
"Study on the Evaluation of the Infectious Process of SARS-CoV-2 in Teachers and Students in Saxony (COVID-19) (SCHULERHEBUNG ""CORONA"")",Local/Regional,Saxony,Dresden,Zwickau,Leipzig,Werdau,Borna,,"Dresden, Zwickau, Leipzig, Werdau and Borna",Universität Leipzig,Universitätsklinik Leipzig,LIFE Child,,,,,,"LIFE Child, Medizinische Fakultät der Universität Leipzig, Institut für Virologie der Universitätsklinik Leipzig",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022032,,Repeated cross-sectional,"School, Kindergarten/Daycare",Students and teachers from primary and secondary schools in Saxony May to June 2020,General population and selected population groups,Multiple,67,7,"Multistage, partial random sampling",Participants,2344,2300,2020-05-27,2020-06-30,,,,,,Seroprevalence among students and teachers from primary and secondary schools in Saxony for the period from May to June 2020,https://home.uni-leipzig.de/lifechild/schulerhebung-corona/,,Webseite,whole blood,,IgG,,ABBOTT N,,,,,,,ABBOTT N,,,,0.006,,,,2021-09-27,
"Study on the Evaluation of the Infectious Process of SARS-CoV-2 in Teachers and Students in Saxony (COVID-19) (SCHULERHEBUNG ""CORONA"")",Local/Regional,Saxony,Dresden,Zwickau,Leipzig,Werdau,Borna,,"Dresden, Zwickau, Leipzig, Werdau and Borna",Universität Leipzig,Universitätsklinik Leipzig,LIFE Child,,,,,,"LIFE Child, Medizinische Fakultät der Universität Leipzig, Institut für Virologie der Universitätsklinik Leipzig",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022032,,Repeated cross-sectional,"School, Kindergarten/Daycare",Students and teachers from primary and secondary schools in Saxony September 2020,General population and selected population groups,Multiple,67,7,"Multistage, partial random sampling",Participants,2191,2200,2020-09-01,2020-09-30,,,,,,Seroprevalence among students and teachers from primary and secondary schools in Saxony for the period of September 2020,https://home.uni-leipzig.de/lifechild/schulerhebung-corona/,,Webseite,whole blood,,IgG,,ABBOTT N,,,,,,,ABBOTT N,,,,0.006,,,,2021-09-27,
"Study on the Evaluation of the Infectious Process of SARS-CoV-2 in Teachers and Students in Saxony (COVID-19) (SCHULERHEBUNG ""CORONA"")",Local/Regional,Saxony,Dresden,Zwickau,Leipzig,Werdau,Borna,,"Dresden, Zwickau, Leipzig, Werdau and Borna",Universität Leipzig,Universitätsklinik Leipzig,LIFE Child,,,,,,"LIFE Child, Medizinische Fakultät der Universität Leipzig, Institut für Virologie der Universitätsklinik Leipzig",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022032,,Repeated cross-sectional,"School, Kindergarten/Daycare",Students from primary schools in Saxony November 2020,General population,Children/adolescents ≤18 years,17,,"Multistage, partial random sampling",Participants,,,2020-11-01,2020-11-30,,,,,,Seroprevelance among students from primary schools in Saxony for the period of November 2020,https://home.uni-leipzig.de/lifechild/schulerhebung-corona/,,Webseite,whole blood,,IgG,,ABBOTT N,,,,,,,ABBOTT N,,,,0.005,,,,2021-09-27,
"Study on the Evaluation of the Infectious Process of SARS-CoV-2 in Teachers and Students in Saxony (COVID-19) (SCHULERHEBUNG ""CORONA"")",Local/Regional,Saxony,Dresden,Zwickau,Leipzig,Werdau,Borna,,"Dresden, Zwickau, Leipzig, Werdau and Borna",Universität Leipzig,Universitätsklinik Leipzig,LIFE Child,,,,,,"LIFE Child, Medizinische Fakultät der Universität Leipzig, Institut für Virologie der Universitätsklinik Leipzig",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022032,https://home.uni-leipzig.de/lifechild/schulerhebung-corona/,Repeated cross-sectional,"School, Kindergarten/Daycare",Students and teachers from primary and secondary schools in Saxony November 2020,General population and selected population groups,Multiple,67,7,"Multistage, partial random sampling",Participants,2194,2200,2020-11-01,2020-11-30,,,,,,Total seroprevelance among students from primary and secondary schools in Saxony for the period of November 2020,https://home.uni-leipzig.de/lifechild/schulerhebung-corona/,,Webseite,whole blood,,IgG,,ABBOTT N,,,,,,,ABBOTT N,,,,0.014,,,,2021-09-27,
Multi-local and serial cross-sectional prevalence study on antibodies against SARS-CoV-2 (COVID-19) in Germany - Aachen (MuSPAD),Local/Regional,North Rhine-Westphalia,Aachen,,,,,,Aachen,Helmholtz Zentrum für Infektionsforschung (HZI),,,,,,,,"Helmholtz Zentrum für Infektionsforschung (HZI), Braunschweig",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022335,https://hzi-c19-antikoerperstudie.de/,Cross sectional and selective longitudinal,Household and Community Samples,Residents of Aachen,General population,Adults,,18,Random sampling (central registration-based),Participants,2023,2000,2020-09-09,2021-02-22,https://doi.org/10.1101/2021.05.04.21256597,https://doi.org/10.3238/arztebl.m2021.0364,,,,,,,,,,,,,,,,,,,,,,,,,,,2022-03-23,
Multi-local and serial cross-sectional prevalence study on antibodies against SARS-CoV-2 (COVID-19) in Germany - Aachen (MuSPAD),Local/Regional,North Rhine-Westphalia,Aachen,,,,,,Aachen,Helmholtz Zentrum für Infektionsforschung (HZI),,,,,,,,Helmholtz Zentrum für Infektionsforschung (HZI),https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022335,https://hzi-c19-antikoerperstudie.de/,Cross sectional and selective longitudinal,Household and Community Samples,Residents of Aachen,General population,Adults,99,18,Random sampling (central registration-based),Participants,1888,1900,2021-01-27,2021-02-22,,,,,,Seroprevalence from the second wave of the survey in Aachen,https://doi.org/10.3238/arztebl.m2021.0364,2021-11-05,Peer-reviewed Publikation,whole blood,anti -S1 domain,IgG,"ELISA ",EUROIMMUN,,,,,,,EUROIMMUN,Adjusted for test-specificity/test-sensitivity and population-weighted,0.883,0.992,0.054,0.044,0.065,,2022-03-23,1.8
Multi-local and serial cross-sectional prevalence study on antibodies against SARS-CoV-2 (COVID-19) in Germany - Aachen (MuSPAD),Local/Regional,North Rhine-Westphalia,Aachen,,,,,,Aachen,Helmholtz Zentrum für Infektionsforschung (HZI),,,,,,,,"Helmholtz Zentrum für Infektionsforschung (HZI), Braunschweig",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022335,https://hzi-c19-antikoerperstudie.de/,Cross sectional and selective longitudinal,Household and Community Samples,Residents of Aachen,General population,Adults,99,18,Random sampling (central registration-based),Participants,2023,2000,2020-09-09,2020-10-09,,,,,,Seroprevalence from the first wave of the survey in Aachen,https://doi.org/10.3238/arztebl.m2021.0364,2021-11-05,Peer-reviewed Publikation,whole blood,anti -S1 domain,IgG,"ELISA ",EUROIMMUN,,,,,,,EUROIMMUN,Adjusted for test-specificity/test-sensitivity and population-weighted,0.883,0.992,0.023,0.017,0.031,,2022-03-23,4.9
Multi-local and serial cross-sectional prevalence study on antibodies against SARS-CoV-2 (COVID-19) in Germany - Chemnitz (MuSPAD),Local/Regional,Saxony,Chemnitz,,,,,,Chemnitz,Helmholtz Zentrum für Infektionsforschung (HZI),,,,,,,,"Helmholtz Zentrum für Infektionsforschung (HZI), Braunschweig",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022335,https://hzi-c19-antikoerperstudie.de/,Cross sectional and selective longitudinal,Household and Community Samples,Residents of Chemnitz,General population,Adults,,18,Random sampling (central registration-based),Participants,2701,2700,2021-03-03,2021-08-17,https://doi.org/10.1101/2021.05.04.21256597,https://doi.org/10.3238/arztebl.m2021.0364,,,,,,,,,,,,,,,,,,,,,,,,,,,2022-03-23,
Multi-local and serial cross-sectional prevalence study on antibodies against SARS-CoV-2 (COVID-19) in Germany - Chemnitz (MuSPAD),Local/Regional,Saxony,Chemnitz,,,,,,Chemnitz,Helmholtz Zentrum für Infektionsforschung (HZI),,,,,,,,Helmholtz Zentrum für Infektionsforschung (HZI),,https://hzi-c19-antikoerperstudie.de/,Cross sectional and selective longitudinal,Household and Community Samples,Residents of Chemnitz,General population,Adults,99,19,Random sampling (central registration-based),Participants,358,400,2021-07-21,2021-08-17,,,,,,Seroprevalence from the second wave of the survey in Chemnitz,https://doi.org/10.3238/arztebl.m2021.0364,2021-11-05,Peer-reviewed Publikation,whole blood,anti -S1 domain,IgG,"ELISA ",EUROIMMUN,,,,,,,EUROIMMUN,Adjusted for test-specificity/test-sensitivity and population-weighted,0.883,0.992,0.324,0.274,0.378,2021-09-21,2022-03-23,
Multi-local and serial cross-sectional prevalence study on antibodies against SARS-CoV-2 (COVID-19) in Germany - Chemnitz (MuSPAD),Local/Regional,Saxony,Chemnitz,,,,,,Chemnitz,Helmholtz Zentrum für Infektionsforschung (HZI),,,,,,,,"Helmholtz Zentrum für Infektionsforschung (HZI), Braunschweig",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022335,https://hzi-c19-antikoerperstudie.de/,Cross sectional and selective longitudinal,Household and Community Samples,Residents of Chemnitz,General population,Adults,99,18,Random sampling (central registration-based),Participants,2701,2700,2021-03-03,2021-03-31,,,,,,Seroprevalence from the first wave of the survey in Chemnitz,https://doi.org/10.3238/arztebl.m2021.0364,2021-11-05,Peer-reviewed Publikation,whole blood,anti -S1 domain,IgG,"ELISA ",EUROIMMUN,,,,,,,EUROIMMUN,Adjusted for test-specificity/test-sensitivity and population-weighted,0.883,0.992,0.131,0.115,0.149,,2022-03-23,2.9
Multi-local and serial cross-sectional prevalence study on antibodies against SARS-CoV-2 (COVID-19) in Germany - Freiburg (MuSPAD),Local/Regional,Baden-Wuerttemberg,Freiburg,,,,,,Freiburg,Helmholtz Zentrum für Infektionsforschung (HZI),,,,,,,,"Helmholtz Zentrum für Infektionsforschung (HZI), Braunschweig",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022335,https://hzi-c19-antikoerperstudie.de/,Cross sectional and selective longitudinal,Household and Community Samples,Residents of Freiburg,General population,Adults,,18,Random sampling (central registration-based),Participants,2867,2900,2020-08-05,2020-12-15,https://doi.org/10.1101/2021.05.04.21256597,https://doi.org/10.3238/arztebl.m2021.0364,,,,,,,,,,,,,,,,,,,,,,,,,,,2022-03-23,
Multi-local and serial cross-sectional prevalence study on antibodies against SARS-CoV-2 (COVID-19) in Germany - Freiburg (MuSPAD),Local/Regional,Baden-Wuerttemberg,Freiburg,,,,,,Freiburg,Helmholtz Zentrum für Infektionsforschung (HZI),,,,,,,,Helmholtz Zentrum für Infektionsforschung (HZI),https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022335,https://hzi-c19-antikoerperstudie.de/,Cross sectional and selective longitudinal,Household and Community Samples,Residents of Freiburg,General population,Adults,99,18,Random sampling (central registration-based),Participants,1788,1800,2020-11-18,2020-12-15,,,,,,Seroprevalence from the second wave of the survey in Freiburg,https://doi.org/10.3238/arztebl.m2021.0364,2021-11-05,Peer-reviewed Publikation,whole blood,anti -S1 domain,IgG,"ELISA ",EUROIMMUN,,,,,,,EUROIMMUN,Adjusted for test-specificity/test-sensitivity and population-weighted,0.883,0.992,0.024,0.021,0.037,,2022-03-23,2.2
Multi-local and serial cross-sectional prevalence study on antibodies against SARS-CoV-2 (COVID-19) in Germany - Freiburg (MuSPAD),Local/Regional,Baden-Wuerttemberg,Freiburg,,,,,,Freiburg,Helmholtz Zentrum für Infektionsforschung (HZI),,,,,,,,"Helmholtz Zentrum für Infektionsforschung (HZI), Braunschweig",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022335,https://hzi-c19-antikoerperstudie.de/,Cross sectional and selective longitudinal,Household and Community Samples,Residents of Freiburg,General population,Adults,99,18,Random sampling (central registration-based),Participants,2867,2900,2020-08-05,2020-09-02,,,,,,Seroprevalence from the first wave of the survey in Freiburg,https://doi.org/10.3238/arztebl.m2021.0364,2021-11-05,Peer-reviewed Publikation,whole blood,anti -S1 domain,IgG,"ELISA ",EUROIMMUN,,,,,,,EUROIMMUN,Adjusted for test-specificity/test-sensitivity and population-weighted,0.883,0.992,0.015,0.011,0.02,,2022-03-23,3
Multi-local and serial cross-sectional prevalence study on antibodies against SARS-CoV-2 (COVID-19) in Germany - Hannover (MuSPAD),Local/Regional,Lower Saxony,Hannover,,,,,,Hannover,Helmholtz Zentrum für Infektionsforschung (HZI),,,,,,,,"Helmholtz Zentrum für Infektionsforschung (HZI), Braunschweig",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022335,https://hzi-c19-antikoerperstudie.de/,Cross sectional and selective longitudinal,Household and Community Samples,Participants of the NAKO Health Study from Hannover,General population,Adults,,18,Cohort-sample - Sampling from existing cohort study in the general population,Participants,,3000,2021-06-16,2021-07-13,https://hannover.nako.de/2021/05/28/3-000-nako-teilnehmende-aus-hannover-haben-die-moeglichkeit-an-der-zusatzstudie-muspad-in-der-nako-teilzunehmen/,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Multi-local and serial cross-sectional prevalence study on antibodies against SARS-CoV-2 (COVID-19) in Germany - Magdeburg (MuSPAD),Local/Regional,Saxony-Anhalt,Magdeburg,,,,,,Magdeburg,Helmholtz Zentrum für Infektionsforschung (HZI),,,,,,,,"Helmholtz Zentrum für Infektionsforschung (HZI), Braunschweig",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022335,https://hzi-c19-antikoerperstudie.de/,Cross sectional and selective longitudinal,Household and Community Samples,Residents of Magdeburg,General population,Adults,,18,Random sampling (central registration-based),Participants,2713,2700,2020-11-18,2020-12-15,https://doi.org/10.1101/2021.05.04.21256597,https://doi.org/10.3238/arztebl.m2021.0364,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Multi-local and serial cross-sectional prevalence study on antibodies against SARS-CoV-2 (COVID-19) in Germany - Magdeburg (MuSPAD),Local/Regional,Saxony-Anhalt,Magdeburg,,,,,,Magdeburg,Helmholtz Zentrum für Infektionsforschung (HZI),,,,,,,,"Helmholtz Zentrum für Infektionsforschung (HZI), Braunschweig",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022335,https://hzi-c19-antikoerperstudie.de/,Cross sectional and selective longitudinal,Household and Community Samples,Residents of Magdeburg,General population,Adults,99,18,Random sampling (central registration-based),Participants,1118,1100,2021-04-07,2021-05-05,,,,,,Seroprevalence from the second wave of the survey in Magdeburg,https://doi.org/10.3238/arztebl.m2021.0364,2021-11-05,Peer-reviewed Publikation,whole blood,anti -S1 domain,IgG,"ELISA ",EUROIMMUN,,,,,,,EUROIMMUN,Adjusted for test-specificity/test-sensitivity and population-weighted,0.883,0.992,0.06,0.037,0.097,2021-11-15,2022-03-23,
Multi-local and serial cross-sectional prevalence study on antibodies against SARS-CoV-2 (COVID-19) in Germany - Magdeburg (MuSPAD),Local/Regional,Saxony-Anhalt,Magdeburg,,,,,,Magdeburg,Helmholtz Zentrum für Infektionsforschung (HZI),,,,,,,,"Helmholtz Zentrum für Infektionsforschung (HZI), Braunschweig",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022335,https://hzi-c19-antikoerperstudie.de/,Cross sectional and selective longitudinal,Household and Community Samples,Residents of Magdeburg,General population,Adults,99,18,Random sampling (central registration-based),Participants,2713,2700,2020-11-18,2020-12-15,,,,,,Seroprevalence from the first wave of the survey in Magdeburg,https://doi.org/10.3238/arztebl.m2021.0364,2021-11-05,Peer-reviewed Publikation,whole blood,anti -S1 domain,IgG,"ELISA ",EUROIMMUN,,,,,,,EUROIMMUN,Adjusted for test-specificity/test-sensitivity and population-weighted,0.883,0.992,0.024,0.019,0.031,,2022-03-23,5.1
Multi-local and serial cross-sectional prevalence study on antibodies against SARS-CoV-2 (COVID-19) in Germany - Osnabrück (MuSPAD),Local/Regional,Lower Saxony,Osnabrück,,,,,,Osnabrück,Helmholtz Zentrum für Infektionsforschung (HZI),,,,,,,,"Helmholtz Zentrum für Infektionsforschung (HZI), Braunschweig",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022335,https://hzi-c19-antikoerperstudie.de/,Cross sectional and selective longitudinal,Household and Community Samples,Residents of Osnabrück,General population,Adults,,18,Random sampling (central registration-based),Participants,1611,1600,2020-10-15,2020-11-15,https://doi.org/10.1101/2021.05.04.21256597,https://doi.org/10.3238/arztebl.m2021.0364,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Multi-local and serial cross-sectional prevalence study on antibodies against SARS-CoV-2 (COVID-19) in Germany - Osnabrück (MuSPAD),Local/Regional,Lower Saxony,Osnabrück,,,,,,Osnabrück,Helmholtz Zentrum für Infektionsforschung (HZI),,,,,,,,Helmholtz Zentrum für Infektionsforschung (HZI),https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022335,https://hzi-c19-antikoerperstudie.de/,Cross sectional and selective longitudinal,Household and Community Samples,Residents of Osnabrück,General population,Adults,99,18,Random sampling (central registration-based),Participants,1611,1600,2021-03-03,2021-03-30,,,,,,Seroprevalence from the second wave of the survey in Osnabrück,https://doi.org/10.3238/arztebl.m2021.0364,2021-11-05,Peer-reviewed Publikation,whole blood,anti -S1 domain,IgG,"ELISA ",EUROIMMUN,,,,,,,EUROIMMUN,Adjusted for test-specificity/test-sensitivity and population-weighted,0.883,0.992,0.041,0.032,0.052,,2022-03-23,1.3
Multi-local and serial cross-sectional prevalence study on antibodies against SARS-CoV-2 (COVID-19) in Germany - Osnabrück (MuSPAD),Local/Regional,Lower Saxony,Osnabrück,,,,,,Osnabrück,Helmholtz Zentrum für Infektionsforschung (HZI),,,,,,,,"Helmholtz Zentrum für Infektionsforschung (HZI), Braunschweig",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022335,https://hzi-c19-antikoerperstudie.de/,Cross sectional and selective longitudinal,Household and Community Samples,Residents of Osnabrück,General population,Adults,99,18,Random sampling (central registration-based),Participants,2923,2900,2020-10-14,2020-11-10,,,,,,Seroprevalence from the first wave of the survey in Osnabrück,https://doi.org/10.3238/arztebl.m2021.0364,2021-11-05,Peer-reviewed Publikation,whole blood,anti -S1 domain,IgG,"ELISA ",EUROIMMUN,,,,,,,EUROIMMUN,Adjusted for test-specificity/test-sensitivity and population-weighted,0.883,0.992,0.013,0.01,0.018,,2022-03-23,2.6
Multi-local and serial cross-sectional prevalence study on antibodies against SARS-CoV-2 (COVID-19) in Germany - Reutlingen (MuSPAD),Local/Regional,Baden-Wuerttemberg,Reutlingen,,,,,,Reutlingen,Helmholtz Zentrum für Infektionsforschung (HZI),,,,,,,,"Helmholtz Zentrum für Infektionsforschung (HZI), Braunschweig",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022335,https://hzi-c19-antikoerperstudie.de/,Cross sectional and selective longitudinal,Household and Community Samples,Residents of Reutlingen,General population,Adults,,18,Random sampling (central registration-based),Participants,2360,2400,2020-07-01,2020-07-28,https://doi.org/10.1101/2021.05.04.21256597,https://doi.org/10.3238/arztebl.m2021.0364,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Multi-local and serial cross-sectional prevalence study on antibodies against SARS-CoV-2 (COVID-19) in Germany - Reutlingen (MuSPAD),Local/Regional,Baden-Wuerttemberg,Reutlingen,,,,,,Reutlingen,Helmholtz Zentrum für Infektionsforschung (HZI),,,,,,,,Helmholtz Zentrum für Infektionsforschung (HZI),https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022335,https://hzi-c19-antikoerperstudie.de/,Cross sectional and selective longitudinal,Household and Community Samples,Residents of Reutlingen,General population,Adults,99,18,Random sampling (central registration-based),Participants,2360,2400,2020-10-14,2020-11-10,,,,,,Seroprevalence from the second wave of the survey in Reutlingen,https://doi.org/10.3238/arztebl.m2021.0364,2021-11-05,Peer-reviewed Publikation,whole blood,anti -S1 domain,IgG,"ELISA ",EUROIMMUN,,,,,,,EUROIMMUN,Adjusted for test-specificity/test-sensitivity and population-weighted,0.883,0.992,0.028,0.021,0.037,,2022-03-23,3.5
Multi-local and serial cross-sectional prevalence study on antibodies against SARS-CoV-2 (COVID-19) in Germany - Reutlingen (MuSPAD),Local/Regional,Baden-Wuerttemberg,Reutlingen,,,,,,Reutlingen,Helmholtz Zentrum für Infektionsforschung (HZI),,,,,,,,"Helmholtz Zentrum für Infektionsforschung (HZI), Braunschweig",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022335,https://hzi-c19-antikoerperstudie.de/,Cross sectional and selective longitudinal,Household and Community Samples,Residents of Reutlingen,General population,Adults,99,18,Random sampling (central registration-based),Participants,2407,2400,2020-07-01,2020-07-28,,,,,,Seroprevalence from the first wave of the survey in Reutlingen,https://doi.org/10.3238/arztebl.m2021.0364,2021-11-05,Peer-reviewed Publikation,whole blood,anti -S1 domain,IgG,"ELISA ",EUROIMMUN,,,,,,,EUROIMMUN,Adjusted for test-specificity/test-sensitivity and population-weighted,0.883,0.992,0.026,0.02,0.033,,2022-03-23,4.1
Multi-local and serial cross-sectional prevalence study on antibodies against SARS-CoV-2 (COVID-19) in Germany - Vorpommern-Greifswald (MuSPAD),Local/Regional,Mecklenburg-Western Pomerania,Greifswald,,,,,,Western Pomerania - Greifswald,Helmholtz Zentrum für Infektionsforschung (HZI),,,,,,,,"Helmholtz Zentrum für Infektionsforschung (HZI), Braunschweig",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022335,https://hzi-c19-antikoerperstudie.de/,Cross sectional and selective longitudinal,Household and Community Samples,Residents of Vorpommern-Greifswald,General population,Adults,,18,Random sampling (central registration-based),Participants,954,1000,2021-05-12,2021-06-08,,https://doi.org/10.3238/arztebl.m2021.0364,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Multi-local and serial cross-sectional prevalence study on antibodies against SARS-CoV-2 (COVID-19) in Germany - Vorpommern-Greifswald (MuSPAD),Local/Regional,Mecklenburg-Western Pomerania,Greifswald,,,,,,Western Pomerania - Greifswald,Helmholtz Zentrum für Infektionsforschung (HZI),,,,,,,,"Helmholtz Zentrum für Infektionsforschung (HZI), Braunschweig",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022335,https://hzi-c19-antikoerperstudie.de/,Cross sectional and selective longitudinal,Household and Community Samples,Residents of Vorpommern-Greifswald,General population,Adults,99,18,Random sampling (central registration-based),Participants,954,1000,2021-05-12,2021-06-08,,,,,,Seroprevalence from the first wave of the survey in Vorpommern-Greifswald,https://doi.org/10.3238/arztebl.m2021.0364,2021-11-05,Peer-reviewed Publikation,whole blood,anti -S1 domain,IgG,"ELISA ",EUROIMMUN,,,,,,,EUROIMMUN,Adjusted for test-specificity/test-sensitivity and population-weighted,0.883,0.992,0.116,0.094,0.143,,2022-03-23,
Prävalenz von SARS-CoV-2-Infektionen und neutralisierenden Antikörpern bei Mitarbeitern eines Industrieunternehmens in Frankfurt am Main,Local/Regional,Hesse,Frankfurt am Main,,,,,,Frankfurt am Main,"Universität Marburg, Institut für Virologie",Infraserv GmbH & Co.,Höchst KG,"Universitätsklinikum Frankfurt, Institut für Medizinische Virologie",Gesundheitsamt Frankfurt,Universität Marburg,Universitätsklinikum Frankfurt,,"Institut für Virologie Marburg; Infraserv GmbH & Co. Höchst KG; Institut für Medizinische Virologie, Frankfurt; Gesundheitsamt Frankfurt",,,Cross sectional,Non-essential workers and unemployed persons,Employees of Infraserv Höchst,Selected population groups,Adults,,18,Convenience sample,Participants,998,1000,2020-04-06,2020-04-14,https://doi.org/10.1101/2020.05.20.20107730,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
COVID19/ SARS-CoV-2 seroconversion in kids (CorKid),Local/Regional,North Rhine-Westphalia,Bochum,Herne,Gütersloh,Ruhr Area,,,"Ruhr area (Bochum, Herne, Gütersloh)",Universitätskinderklinik Bochum,"St. Josef-Hospital, Klinikum der Ruhr-Universität-Bochum",,,,,,,"Universitätskinderklinik Bochum, St. Josef-Hospital, Klinikum der Ruhr-Universität-Bochum",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022434,https://corkid.de/,Cross sectional and selective longitudinal,Persons seeking care for non-COVID reasons,"Children (6 months and older) and adolescents presenting for scheduled screening at participating pediatric practices in Gütersloh, and their families",General population,Children/adolescents ≤18 years,18,0,Convenience sample,Participants,,3000,2020-06-01,2020-06-30,,,,,,"Underreporting factor of children and adolescents who visited a pediatrician's practice in Gütersloh, Herne or Bochum for screening in the period June 2020",https://doi.org/10.3390/idr13040088,2021-11-12,Peer-reviewed Publikation,,anti Nucleocapsid,Multiple antibodies,Elektrochemolumineszenz (ECL)-Immunassay; LIPS,ROCHE N,,,,,,,ROCHE N,Population-weighted,,,,,,,2022-02-11,2
COVID19/ SARS-CoV-2 seroconversion in kids (CorKid),Local/Regional,North Rhine-Westphalia,Bochum,Herne,Gütersloh,Ruhr Area,,,"Ruhr area (Bochum, Herne, Gütersloh)",Universitätskinderklinik Bochum,"St. Josef-Hospital, Klinikum der Ruhr-Universität-Bochum",,,,,,,"Universitätskinderklinik Bochum, St. Josef-Hospital, Klinikum der Ruhr-Universität-Bochum",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022434,https://corkid.de/,Cross sectional and selective longitudinal,Persons seeking care for non-COVID reasons,"Children (6 months and older) and adolescents presenting for scheduled screening at participating pediatric practices, and their families",General population,Children/adolescents ≤18 years,18,0,Convenience sample,Participants,2090,2100,2020-06-15,2021-02-15,https://doi.org/10.1101/2021.10.21.21265322,https://doi.org/10.3390/idr13040088,,,,,,,,,,,,,,,,,,,,,,,,,,,2022-02-01,
COVID19/ SARS-CoV-2 seroconversion in kids (CorKid),Local/Regional,North Rhine-Westphalia,Gütersloh,Ruhr Area,,,,,Ruhr Area (Gütersloh),Universitätskinderklinik Bochum,"St. Josef-Hospital, Klinikum der Ruhr-Universität-Bochum",,,,,,,"Universitätskinderklinik Bochum, St. Josef-Hospital, Klinikum der Ruhr-Universität-Bochum",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022434,https://corkid.de/,Cross sectional and selective longitudinal,Persons seeking care for non-COVID reasons,"Children (6 months and older) and adolescents presenting for scheduled screening at participating pediatric practices in Gütersloh, and their families",General population,Children/adolescents ≤18 years,18,0,Convenience sample,Participants,819,800,2021-02-01,2021-02-15,,,,,,Underreporting factor of children and adolescents who visited a pediatrician's practice in Bochum for screening in the period February 2021,https://doi.org/10.3390/idr13040088,2021-11-12,Peer-reviewed Publikation,,anti Nucleocapsid,Multiple antibodies,Elektrochemolumineszenz (ECL)-Immunassay; LIPS,ROCHE N,,,,,,,ROCHE N,Population-weighted,,,,,,,2022-01-27,4
COVID19/ SARS-CoV-2 seroconversion in kids (CorKid),Local/Regional,North Rhine-Westphalia,Bochum,Herne,Ruhr Area,,,,Ruhr Area (Bochum and Herne),Universitätskinderklinik Bochum,"St. Josef-Hospital, Klinikum der Ruhr-Universität-Bochum",,,,,,,"Universitätskinderklinik Bochum, St. Josef-Hospital, Klinikum der Ruhr-Universität-Bochum",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022434,https://corkid.de/,Cross sectional and selective longitudinal,Persons seeking care for non-COVID reasons,"Children (6 months and older) and adolescents presenting for scheduled screening at participating pediatric practices in Bochum or Herne, and their families",General population,Children/adolescents ≤18 years,18,0,Convenience sample,Participants,1271,1300,2021-02-01,2021-02-15,,,,,,Underreporting factor of children and adolescents who visited a pediatrician's practice in Gütersloh or Herne for screening in the period February 2021,https://doi.org/10.3390/idr13040088,2021-11-12,Peer-reviewed Publikation,,anti Nucleocapsid,Multiple antibodies,Elektrochemolumineszenz (ECL)-Immunassay; LIPS,ROCHE N,,,,,,,ROCHE N,Population-weighted,,,,,,,2022-01-27,3
COVID19/ SARS-CoV-2 seroconversion in kids (CorKid),Local/Regional,North Rhine-Westphalia,Bochum,Herne,Gütersloh,Ruhr Area,,,"Ruhr area (Bochum, Herne, Gütersloh)",Universitätskinderklinik Bochum,"St. Josef-Hospital, Klinikum der Ruhr-Universität-Bochum",,,,,,,"Universitätskinderklinik Bochum, St. Josef-Hospital, Klinikum der Ruhr-Universität-Bochum",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022434,https://corkid.de/,Cross sectional and selective longitudinal,Persons seeking care for non-COVID reasons,"Children (6 months and older) and adolescents presenting for scheduled screening at participating pediatric practices in Bochum, Herne or Gütersloh, and their families",General population,Children/adolescents ≤18 years,18,0,Convenience sample,Participants,2090,2100,2021-02-01,2021-02-15,,,,,,Seroprevalence of children and adolescents who visited a pediatrician's practice in the Ruhr area for screening in the period of February 2021,https://doi.org/10.3390/idr13040088,2021-11-12,Peer-reviewed Publikation,,anti Nucleocapsid,Multiple antibodies,Elektrochemolumineszenz (ECL)-Immunassay; LIPS,ROCHE N,,,,,,,ROCHE N,Population-weighted,,,0.08,,,,2022-01-27,
COVID19/ SARS-CoV-2 seroconversion in kids (CorKid),Local/Regional,North Rhine-Westphalia,Bochum,Herne,Gütersloh,Ruhr Area,,,"Ruhr area (Bochum, Herne, Gütersloh)",Universitätskinderklinik Bochum,"St. Josef-Hospital, Klinikum der Ruhr-Universität-Bochum",,,,,,,"Universitätskinderklinik Bochum, St. Josef-Hospital, Klinikum der Ruhr-Universität-Bochum",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022434,https://corkid.de/,Cross sectional and selective longitudinal,Persons seeking care for non-COVID reasons,"Children (6 months and older) and adolescents presenting for scheduled screening at participating pediatric practices, and their families",General population,Children/adolescents ≤18 years,18,0,Convenience sample,Participants,2090,,2020-06-15,2020-06-30,,,,,,Seroprevalence of children and adolescents who visited a pediatrician's practice in the Ruhr area for screening in the period of June 2020,https://doi.org/10.3390/idr13040088,2021-11-12,Peer-reviewed Publikation,,anti Nucleocapsid,Multiple antibodies,Elektrochemolumineszenz (ECL)-Immunassay; LIPS,ROCHE N,,,,,,,ROCHE N,Population-weighted,,,0.005,,,,2022-02-01,
"Prevalence of SARS-CoV-2 (COVID-19) in pregnancy and at delivery in Franconia, Germany (SCENARIO)",Local/Regional,Bavaria,Franconia,,,,,,Franconia,Universitätsfrauenklinik Erlangen,,,,,,,,Universitätsfrauenklinik Erlangen,https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022088,http://www.covid19scenario.de,Repeated cross-sectional,Other groups,Pregnant women and obstetric staff of maternity hospitals in Franconia,Selected population groups,Adults,,18,Convenience sample,Participants,,2600,2020-06-02,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Bevölkerungsbasierte infektionsepidemiologische SARS-CoV-2 Surveillance in Mecklenburg-Vorpommern (SHIP-COVID),Local/Regional,Mecklenburg-Western Pomerania,Western Pomerania,,,,,,Western Pomerania except the islands,Universitätsmedizin Greifswald,,,,,,,,Universitätsmedizin Greifswald KöR,,https://www.regierung-mv.de/Landesregierung/wm/Aktuell/?id=165334&processor=processor.sa.pressemitteilung,Longitudinal/Prospectice cohort study,Household and Community Samples,Participants already included in the SHIP (Study of Health in Pomerania) cohort and additional participants,General population,Adults,,40,Cohort-sample - Sampling from existing cohort study in the general population,Participants,,1000,2020-10-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Berliner Corona Schul-und Kitastudie (BECOSS),Local/Regional,Berlin,Berlin,,,,,,Berlin,"Charité - Universitätsmedizin Berlin, Institut für Tropenmedizin und Internationale Gesundheit",Charité - Universitätsmedizin Berlin,,,,,,,"Institut für Tropenmedizin und Internationale Gesundheit, Charité - Universitätsmedizin Berlin",,https://www.charite.de/klinikum/themen_klinikum/themenschwerpunkt_coronavirus/teststrategie/wissenschaftliche_studien/,Repeated cross-sectional,"School, Kindergarten/Daycare","Pupils, daycare children, their household members and pedagogical staff from Berlin schools and daycare centers",General population and selected population groups,Multiple,,,"Multistage, partial random sampling",Participants,,2000,2020-06-01,,https://doi.org/10.1101/2020.12.08.20245910,https://doi.org/10.3390/ijerph18052739,https://doi.org/10.1093/eurpub/ckab079,,,,,,,,,,,,,,,,,,,,,,,,,,2021-09-28,
Berliner Corona Schul-und Kitastudie (BECOSS-Kita),Local/Regional,Berlin,Berlin,,,,,,Berlin,"Charité - Universitätsmedizin Berlin, Institut für Tropenmedizin und Internationale Gesundheit",Charité - Universitätsmedizin Berlin,,,,,,,"Institut für Tropenmedizin und Internationale Gesundheit, Charité - Universitätsmedizin Berlin",,https://www.charite.de/klinikum/themen_klinikum/themenschwerpunkt_coronavirus/teststrategie/wissenschaftliche_studien/,Repeated cross-sectional,"School, Kindergarten/Daycare",Pre-school children from kindergartens in Berlin for the period from September to October 2020,General population,Children/adolescents ≤18 years,6,1,"Multistage, partial random sampling",Participants,155,200,2020-09-28,2020-10-02,,,,,,Seroprevalence among pre-school children from kindergartens in Berlin for the period from September to October 2020,https://doi.org/10.1093/eurpub/ckab079,2021-05-06,Peer-reviewed Publikation,capillary blood,anti -S1 domain,IgG,"ELISA ",EUROIMMUN,,,,,,,EUROIMMUN,Not adjusted,,,0,,,,2021-09-28,
Berliner Corona Schul-und Kitastudie (BECOSS-Schule),Local/Regional,Berlin,Berlin,,,,,,Berlin,"Charité - Universitätsmedizin Berlin, Institut für Tropenmedizin und Internationale Gesundheit",Charité - Universitätsmedizin Berlin,,,,,,,"Institut für Tropenmedizin und Internationale Gesundheit, Charité - Universitätsmedizin Berlin",,,Repeated cross-sectional,"School, Kindergarten/Daycare",Students from schools in Berlin June 2020,Selected population groups,Children/adolescents ≤18 years,18,8,"Multistage, partial random sampling",Participants,385,400,2020-06-11,2020-06-19,,,,,,Seroprevalence among students from schools in Berlin for the period of June 2020,https://doi.org/10.3390/ijerph18052739,2021-08-26,Peer-reviewed Publikation,capillary blood,anti -S1 domain,IgG,"ELISA ",EUROIMMUN,,,,,,,EUROIMMUN,Not adjusted,,,0.013,,,,2021-11-03,
Berliner Corona Schul-und Kitastudie (BECOSS-Schule),Local/Regional,Berlin,Berlin,,,,,,Berlin,"Charité - Universitätsmedizin Berlin, Institut für Tropenmedizin und Internationale Gesundheit",Charité - Universitätsmedizin Berlin,,,,,,,"Institut für Tropenmedizin und Internationale Gesundheit, Charité - Universitätsmedizin Berlin",,,Repeated cross-sectional,"School, Kindergarten/Daycare",Students from schools in Berlin November 2020,Selected population groups,Children/adolescents ≤18 years,18,9,"Multistage, partial random sampling",Participants,352,400,2020-11-02,2020-11-16,,,,,,Seroprevalence among students from schools in Berlin for the period of November 2020,https://doi.org/10.2807/1560-7917.ES.2021.26.34.2100184,2021-08-26,Peer-reviewed Publikation,capillary blood,anti -S1 domain,IgG,"ELISA ",EUROIMMUN,,,,,,,EUROIMMUN,Not adjusted,,,0.02,0.008,0.041,,2021-11-03,
Seroepidemiologische Studie zur Verbreitung von SARS-CoV-2 in der Bevölkerung an besonders betroffenen Orten in Deutschland - Bad Feilnbach (CORONA-MONITORING lokal),Local/Regional,Bavaria,Bad Feilnbach,,,,,,Bad Feilnbach,"Robert Koch-Institut, Berlin",,,,,,,,"Robert Koch-Institut, Berlin",,https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/cml-studie/cml-studie_node.html,Cross sectional and selective longitudinal,Household and Community Samples,Residents of Bad Feilnbach,General population,Adults,98,18,Random sampling (central registration-based),Participants,2150,2200,2020-06-23,2020-07-04,http://dx.doi.org/10.25646/7053,https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/cml-studie/Factsheet_Bad_Feilnbach.html,,,,Seroprevalence among inhabitants of Bad Feilnbach,https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/cml-studie/Factsheet_Bad_Feilnbach.html,2021-09-15,Webseite,whole blood,anti -S1 domain,IgG,"ELISA ",EUROIMMUN,,,,,,,EUROIMMUN,Adjusted for test-specificity/test-sensitivity and population-weighted,0.883,0.994,0.065,0.052,0.081,,2021-11-01,3
Seroepidemiologische Studie zur Verbreitung von SARS-CoV-2 in der Bevölkerung an besonders betroffenen Orten in Deutschland - Berlin-Mitte (CORONA-MONITORING lokal),Local/Regional,Berlin,Berlin,,,,,,Berlin-Mitte,"Robert Koch-Institut, Berlin",,,,,,,,"Robert Koch-Institut, Berlin",,https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/cml-studie/cml-studie_node.html,Cross sectional and selective longitudinal,Household and Community Samples,Residents of Berlin Mitte,General population,Adults,,18,Random sampling (central registration-based),Participants,2287,2300,2020-11-17,,http://dx.doi.org/10.25646/7053,https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/cml-studie/Factsheet_Berlin-Mitte.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Seroepidemiologische Studie zur Verbreitung von SARS-CoV-2 in der Bevölkerung an besonders betroffenen Orten in Deutschland - Berlin-Mitte (CORONA-MONITORING lokal),Local/Regional,Berlin,Berlin,,,,,,Berlin-Mitte,"Robert Koch-Institut, Berlin",,,,,,,,"Robert Koch-Institut, Berlin",,https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/cml-studie/cml-studie_node.html,Cross sectional and selective longitudinal,Household and Community Samples,Residents of Berlin-Mitte,General population,Adults,92,18,Random sampling (central registration-based),Participants,2285,2300,2020-11-17,2020-12-05,,,,,,Seroprevalence among inhabitants of Berlin-Mitte,https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/cml-studie/Factsheet_Berlin-Mitte.html,2021-09-15,Webseite,whole blood,anti -S1 domain,IgG,"ELISA ",EUROIMMUN,,,,,,,EUROIMMUN,Adjusted for test-specificity/test-sensitivity and population-weighted,,,0.029,0.02,0.042,,2021-11-01,1.4
Seroepidemiologische Studie zur Verbreitung von SARS-CoV-2 in der Bevölkerung an besonders betroffenen Orten in Deutschland - Kupferzell (CORONA-MONITORING lokal),Local/Regional,Baden-Wuerttemberg,Kupferzell,,,,,,Kupferzell,"Robert Koch-Institut, Berlin",,,,,,,,"Robert Koch-Institut, Berlin",,https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/cml-studie/cml-studie_node.html,Cross sectional and selective longitudinal,Household and Community Samples,Residents of Kupferzell,General population,Adults,94,18,Random sampling (central registration-based),Participants,2203,2200,2020-05-20,2020-06-09,http://dx.doi.org/10.25646/7053,https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/cml-studie/Factsheet_Kupferzell.html,https://doi.org/10.2807/1560-7917.es.2020.25.47.2001752,,,Seroprevalence among inhabitants of Kupferzell,https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/cml-studie/Dokumente/Factsheet_Kupferzell.pdf?__blob=publicationFile,2021-09-15,Webseite,whole blood,anti -S1 domain,IgG,"ELISA ",EUROIMMUN,,,,,,,EUROIMMUN,Adjusted for test-specificity/test-sensitivity and population-weighted,0.883,0.992,0.1,0.085,0.118,,2021-11-01,5
Seroepidemiologische Studie zur Verbreitung von SARS-CoV-2 in der Bevölkerung an besonders betroffenen Orten in Deutschland - Straubing (CORONA-MONITORING lokal),Local/Regional,Bavaria,Straubing,,,,,,Straubing,"Robert Koch-Institut, Berlin",,,,,,,,"Robert Koch-Institut, Berlin",,https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/cml-studie/cml-studie_node.html,Cross sectional and selective longitudinal,Household and Community Samples,Residents of Straubing,General population,Adults,96,18,Random sampling (central registration-based),Participants,2361,2400,2020-09-08,2020-09-26,http://dx.doi.org/10.25646/7053,https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/cml-studie/Factsheet_Straubing.html,,,,Seroprevalence among inhabitants of Straubing,https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/cml-studie/Dokumente/Factsheet_Straubing.pdf?__blob=publicationFile,2021-09-15,Webseite,whole blood,anti -S1 domain,IgG,"ELISA ",EUROIMMUN,,,,,,,EUROIMMUN,Adjusted for test-specificity/test-sensitivity and population-weighted,,,0.022,0.014,0.033,,2021-11-01,2
Corona-Monitoring bundesweit (RKI-SOEP-Studie),Nationwide,Nationwide,Germany,,,,,,Nationwide,"Robert Koch-Institut, Berlin","Deutsches Institut für Wirtschaftsforschung, Berlin",,,,,,,"Robert Koch-Institut, Berlin; Deutsches Institut für Wirtschaftsforschung, Berlin",,https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/lid/lid_node.html,Cross sectional and selective longitudinal,Household and Community Samples,"Participants from the Socio-Economic Panel (SOEP) core sample and the SOEP innovation sample, who are taking part in the ""Living in Germany"" survey",General population,Adults,,18,Cohort-sample - Sampling from existing cohort study in the general population,Participants,11162,11200,2021-11-11,2022-02-28,,,,,,Prevalence of antibodies against the spike protein among adult participants from the core and innovation samples of the Soco-Economic Panel (SOEP) for the period November 2021 to February 2022,https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/lid/Factsheet-CoMoBu-Welle-2.pdf?__blob=publicationFile,2022-07-21,Institutional report,capillary blood,anti -S1 domain,IgG,"ELISA ",EUROIMMUN,,,,,,,EUROIMMUN,Adjusted for test-specificity/test-sensitivity and population-weighted,,,0.916,0.907,0.925,2022-07-22,2022-07-25,
Corona-Monitoring bundesweit (RKI-SOEP-Studie),Nationwide,Nationwide,Germany,,,,,,Nationwide,"Robert Koch-Institut, Berlin","Deutsches Institut für Wirtschaftsforschung, Berlin",,,,,,,"Robert Koch-Institut, Berlin; Deutsches Institut für Wirtschaftsforschung, Berlin",,https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/lid/lid_node.html,Cross sectional and selective longitudinal,Household and Community Samples,"Participants from the Socio-Economic Panel (SOEP) core sample and the SOEP innovation sample, who are taking part in the ""Living in Germany"" survey",General population,Adults,,60,Cohort-sample - Sampling from existing cohort study in the general population,Participants,,,2021-11-11,2022-02-28,,,,,,Prevalence of antibodies against the spike protein among adult participants 60 years and older from the core and innovation samples of the Soco-Economic Panel (SOEP) for the period November 2021 to February 2022,https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/lid/Factsheet-CoMoBu-Welle-2.pdf?__blob=publicationFile,2022-07-21,Institutional report,capillary blood,anti -S1 domain,IgG,"ELISA ",EUROIMMUN,,,,,,,EUROIMMUN,Adjusted for test-specificity/test-sensitivity and population-weighted,,,0.905,0.89,0.919,2022-07-22,2022-07-25,
Corona-Monitoring bundesweit (RKI-SOEP-Studie),Nationwide,Nationwide,Germany,,,,,,Nationwide,"Robert Koch-Institut, Berlin","Deutsches Institut für Wirtschaftsforschung, Berlin",,,,,,,"Robert Koch-Institut, Berlin; Deutsches Institut für Wirtschaftsforschung, Berlin",,https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/lid/lid_node.html,Cross sectional and selective longitudinal,Household and Community Samples,"Participants from the Socio-Economic Panel (SOEP) core sample and the SOEP innovation sample, who are taking part in the ""Living in Germany"" survey",General population,Adults,59,18,Cohort-sample - Sampling from existing cohort study in the general population,Participants,,,2021-11-11,2022-02-28,,,,,,Prevalence of antibodies against the spike protein among participants aged 18 to 59 yearsfrom the core and innovation samples of the Soco-Economic Panel (SOEP) for the period November 2021 to February 2022,https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/lid/Factsheet-CoMoBu-Welle-2.pdf?__blob=publicationFile,2022-07-21,Institutional report,capillary blood,anti -S1 domain,IgG,"ELISA ",EUROIMMUN,,,,,,,EUROIMMUN,Adjusted for test-specificity/test-sensitivity and population-weighted,,,0.922,0.91,0.933,2022-07-22,2022-07-25,
Corona-Monitoring bundesweit (RKI-SOEP-Studie),Nationwide,Nationwide,Germany,,,,,,Nationwide,"Robert Koch-Institut, Berlin","Deutsches Institut für Wirtschaftsforschung, Berlin",,,,,,,"Robert Koch-Institut, Berlin; Deutsches Institut für Wirtschaftsforschung, Berlin",,https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/lid/lid_node.html,Cross sectional and selective longitudinal,Household and Community Samples,"Participants from the Socio-Economic Panel (SOEP) core sample and the SOEP innovation sample, who are taking part in the ""Living in Germany"" survey",General population,Adults,17,14,Cohort-sample - Sampling from existing cohort study in the general population,Participants,,,2021-11-11,2022-02-28,,,,,,Prevalence of antibodies against the spike protein among participants aged 14 to 17 years from the core and innovation samples of the Soco-Economic Panel (SOEP) for the period November 2021 to February 2022,https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/lid/Factsheet-CoMoBu-Welle-2.pdf?__blob=publicationFile,2022-07-21,Institutional report,capillary blood,anti -S1 domain,IgG,"ELISA ",EUROIMMUN,,,,,,,EUROIMMUN,Adjusted for test-specificity/test-sensitivity and population-weighted,,,0.864,0.821,0.898,2022-07-22,2022-07-25,
Corona-Monitoring bundesweit (RKI-SOEP-Studie),Nationwide,Nationwide,Germany,,,,,,Nationwide,"Robert Koch-Institut, Berlin","Deutsches Institut für Wirtschaftsforschung, Berlin",,,,,,,"Robert Koch-Institut, Berlin; Deutsches Institut für Wirtschaftsforschung, Berlin",,https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/lid/lid_node.html,Cross sectional and selective longitudinal,Household and Community Samples,"Participants from the Socio-Economic Panel (SOEP) core sample and the SOEP innovation sample, who are taking part in the ""Living in Germany"" survey",General population,Adults,,18,Cohort-sample - Sampling from existing cohort study in the general population,Participants,14781,14800,2020-10-06,2020-12-15,https://www.rki.de/DE/Content/Gesundheitsmonitoring/JoHM/2021/JoHM_Inhalt_21_S01.html,https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/lid/Ergebnisse.pdf?__blob=publicationFile,https://doi.org/10.1136/jech-2021-217653,https://doi.org/10.3238/arztebl.m2021.0376,https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/lid/Factsheet-CoMoBu-Welle-2.pdf?__blob=publicationFile,Seroprevalence of adult participants from the core and innovation samples of the Soco-Economic Panel (SOEP) for the period October - November 2020,http://dx.doi.org/10.25646/8999; https://jech.bmj.com/content/early/2021/09/27/jech-2021-217653,2021-06-09,Institutional report,capillary blood,anti -S1 domain,IgG,"ELISA ",EUROIMMUN,,,,,,,EUROIMMUN,Adjusted for test-specificity/test-sensitivity and population-weighted,0.883,0.994,0.017,0.012,0.023,,2022-02-21,1.8
Serologische Untersuchungen von Blutspenden auf Antikörper gegen SARS-CoV-2 (SeBluCo-Studie),Nationwide,Nationwide,Germany,,,,,,Nationwide,"Robert Koch-Institut, Berlin",,,,,,,,"Robert Koch-Institut, Berlin",,,Repeated cross-sectional,Blood donors,Blood donors from 28 regions,General population,Adults,74,18,Blood donation,Samples of participants,115256,115300,2020-04-15,2021-04-27,https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2020/29/Art_02.html,https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Projekte_RKI/SeBluCo_Zwischenbericht.html,,,,,,,,,,,,,,,,,,,,,,,,,,,2021-10-17,
Serologische Untersuchungen von Blutspenden auf Antikörper gegen SARS-CoV-2 (SeBluCo-Studie),Nationwide,Nationwide,Germany,,,,,,Nationwide,"Robert Koch-Institut, Berlin",,,,,,,,"Robert Koch-Institut, Berlin",,,Repeated cross-sectional,Blood donors,Blood donors from 28 regions,General population,Adults,74,18,Blood donation,Samples of participants,75079,75100,2020-04-15,2020-12-31,,,,,,Seroprevalence among blood donors for the period of April to December 2020,https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Projekte_RKI/SeBluCo_Zwischenbericht.html,2021-06-10,Institutional report,whole blood,anti -S1 domain,IgG,"ELISA ",EUROIMMUN,,,,,,,EUROIMMUN,Adjusted for test-specificity/test-sensitivity and population-weighted,0.883,0.994,0.011,0.0105,0.0121,,2021-10-17,
Serologische Untersuchungen von Blutspenden auf Antikörper gegen SARS-CoV-2 (SeBluCo-Studie),Nationwide,Nationwide,Germany,,,,,,Nationwide,"Robert Koch-Institut, Berlin",,,,,,,,"Robert Koch-Institut, Berlin",,,Repeated cross-sectional,Blood donors,Blood donors from 28 regions,General population,Adults,74,18,Blood donation,Samples of participants,9320,9300,2021-01-01,2021-01-31,,,,,,Seroprevalence among blood donors for the period of January 2021,https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Projekte_RKI/SeBluCo_Zwischenbericht.html,2021-06-10,Institutional report,whole blood,anti -S1 domain,IgG,"ELISA ",EUROIMMUN,,,,,,,EUROIMMUN,Adjusted for test-specificity/test-sensitivity and population-weighted,0.883,0.994,0.0379,0.0342,0.042,,2021-10-17,
Serologische Untersuchungen von Blutspenden auf Antikörper gegen SARS-CoV-2 (SeBluCo-Studie),Nationwide,Nationwide,Germany,,,,,,Nationwide,"Robert Koch-Institut, Berlin",,,,,,,,"Robert Koch-Institut, Berlin",,,Repeated cross-sectional,Blood donors,Blood donors from 28 regions,General population,Adults,74,18,Blood donation,Samples of participants,9921,9900,2021-02-01,2021-02-28,,,,,,Seroprevalence among blood donors for the period of February 2021,https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Projekte_RKI/SeBluCo_Zwischenbericht.html,2021-06-10,Institutional report,whole blood,anti -S1 domain,IgG,"ELISA ",EUROIMMUN,,,,,,,EUROIMMUN,Adjusted for test-specificity/test-sensitivity and population-weighted,0.883,0.994,0.079,0.0739,0.0845,,2021-10-17,
Serologische Untersuchungen von Blutspenden auf Antikörper gegen SARS-CoV-2 (SeBluCo-Studie),Nationwide,Nationwide,Germany,,,,,,Nationwide,"Robert Koch-Institut, Berlin",,,,,,,,"Robert Koch-Institut, Berlin",,,Repeated cross-sectional,Blood donors,Blood donors from 28 regions,General population,Adults,74,18,Blood donation,Samples of participants,9603,9600,2021-03-01,2021-03-31,,,,,,Seroprevalence among blood donors for the period of March 2021,https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Projekte_RKI/SeBluCo_Zwischenbericht.html,2021-06-10,Institutional report,whole blood,anti -S1 domain,IgG,"ELISA ",EUROIMMUN,,,,,,,EUROIMMUN,Adjusted for test-specificity/test-sensitivity and population-weighted,0.883,0.994,0.1124,0.1124,0.1253,,2021-10-17,
Serologische Untersuchungen von Blutspenden auf Antikörper gegen SARS-CoV-2 (SeBluCo-Studie),Nationwide,Nationwide,Germany,,,,,,Nationwide,"Robert Koch-Institut, Berlin",,,,,,,,"Robert Koch-Institut, Berlin",,,Repeated cross-sectional,Blood donors,Blood donors from 28 regions,General population,Adults,74,18,Blood donation,Samples of participants,11333,11300,2021-04-01,2021-04-30,,,,,,Seroprevalence among blood donors for the period of April 2021,https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Projekte_RKI/SeBluCo_Zwischenbericht.html,2021-06-10,Institutional report,whole blood,anti -S1 domain,IgG,"ELISA ",EUROIMMUN,,,,,,,EUROIMMUN,Adjusted for test-specificity/test-sensitivity and population-weighted,0.883,0.994,0.1922,0.1851,0.1996,,2021-10-17,
Serologische Untersuchungen von Blutspenden auf Antikörper gegen SARS-CoV-2 (SeBluCo-Studie),Nationwide,Nationwide,Germany,,,,,,Nationwide,"Robert Koch-Institut, Berlin",,,,,,,,"Robert Koch-Institut, Berlin",,,Repeated cross-sectional,Blood donors,Blood donors from 28 regions,General population,Adults,74,18,Blood donation,Samples of participants,3400,3400,2021-08-30,2021-09-12,,,,,,Seroprevalence among blood donors for the period of Semptember 2021,https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Projekte_RKI/SeBluCo_Zwischenbericht.html,2021-12-16,Institutional report,whole blood,anti -S1 domain,IgG,"ELISA ",EUROIMMUN,,,,,,,EUROIMMUN,Not adjusted,0.883,0.994,0.876,,,,2022-01-21,
SARS-CoV-2 spezifische Immunität und Serokonversion von Rettungsdienst,Local/Regional,North Rhine-Westphalia,Essen,,,,,,Essen,"Institut für Virologie, Essen",Universitätsklinikum Essen,,,,,,,"Klinik für Infektiologie, Institut für Virologie, Essen",,,Cross sectional,Essential non-healthcare workers,Employees of the rescue service of the city of Essen,Selected population groups,Adults,,18,Convenience sample,Participants,732,700,2020-05-27,2020-05-29,https://doi.org/10.1007/s10049-021-00948-z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SARS-CoV-2 spezifische Immunität und Serokonversion von COVID-Kontaktpersonen,Local/Regional,North Rhine-Westphalia,Essen,,,,,,Essen,"Institut für Virologie, Essen",Universitätsklinikum Essen,,,,,,,"Klinik für Infektiologie, Institut für Virologie, Essen",,,Cross sectional,Known Contacts of COVID Patients,Medical personnel in contact with COVID-19 patients,Selected population groups,Adults,,18,Convenience sample,Participants,,300,2020-05-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Bundesliga-Prävalenzstudie,Local/Regional,Multilocal,Germany,,,,,,Multilocal,Universität des Saarlandes,,,,,,,,"Universität des Saarlandes, Labor Bioscientia Ingelheim",,,Longitudinal/Prospectice cohort study,Non-essential workers and unemployed persons,Players and support staff of the 36 clubs of the 1st and 2nd German soccer league,Selected population groups,Adults,69,20,Convenience sample,Samples of participants,,2200,2020-05-01,,http://dx.doi.org/10.1136/bjsports-2020-103150,https://doi.org/10.1016/j.cmi.2020.11.033,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Serologisch-epidemiologische Erhebung von Antikörpern bei Krankenhausmitarbeiterinnen und -mitarbeitern während der SARS-CoV-2-Epidemie in Brandenburg,Local/Regional,Brandenburg,Lauchhammer,Senftenberg,,,,,Lauchhammer and Senftenberg,Klinikum Niederlausitz,Brandenburgische Technische Universität Cottbus-Senftenberg,Medizinische Hochschule Brandenburg,,,,,,"Klinikum Niederlausitz, Brandenburgische Technische Universität Cottbus-Senftenberg, Medizinische Hochschule Brandenburg",,,Longitudinal/Prospectice cohort study,Healthcare workers and caregivers,Clinic staff with different exposure levels of the Niederlausitz clinic,Selected population groups,Adults,65,18,Convenience sample,Participants,171,200,2020-07-01,2020-07-31,https://doi.org/10.21203/rs.3.rs-84703/v1,https://doi.org/10.3390/ijerph182010999,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Freiwillige interne Unternehmensstudie zur Unterstützung der Transparenz und des betrieblichen Schutzkonzeptes im Rahmen der COVID19 Pandemie,Local/Regional,Hamburg,Hamburg,,,,,,Hamburg,"OHLY GmbH, Hamburg",,,,,,,," OHLY GmbH, Hamburg ",,,Cross sectional,Non-essential workers and unemployed persons,Employees at a production site of OHLY GmbH,Selected population groups,Adults,65,20,Convenience sample,Participants,,100,2020-05-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Antibody assessment for COVID-19 prevalence two months after outbreak in the hot spot Region of Tirschenreuth / Bavaria,Local/Regional,Bavaria,Tirschenreuth,,,,,,Tirschenreuth,Kliniken Nordoberpfalz AG,,,,,,,,Kliniken Nordoberpfalz AG,https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00021813,,Cross sectional,Other groups,"Employees from various departments and professional groups of Kliniken Oberpfalz AG and a large, medium-sized company in the Tirschenreuth/Weiden region",Selected population groups,Adults,,18,Convenience sample,Participants,1838,1800,2020-06-29,2020-07-29,https://doi.org/10.1007/s00063-020-00761-5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Serological screening and metabolic analysis for evaluation of the immune response to SARS-CoV2 (COVID-19),Local/Regional,Baden-Wuerttemberg,Freiburg,,,,,,Freiburg,Universitätsklinikum Freiburg,,,,,,,,"Klinik für Innere Medizin I, Universitätsklinikum Freiburg",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022292,,Cross sectional and selective longitudinal,Other groups,"Employees of the Universitätsklinikum Freiburg, the Universitätsherzzentrum Freiburg and their family members",Selected population groups,Adults,,5,Convenience sample,Participants,,300,2020-06-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Investigation of the immune status against SARS-CoV-2 of medical professionals in Doctor's Practices in Thuringia (COVID-PraxImmun),Local/Regional,Thuringia,Thuringia,,,,,,Thuringia,Kassenärztliche Vereinigung Thüringen,Zentralinstitut für die kassenärztliche Versorgung (Zi),,,,,,,"Kassenärztliche Vereinigung Thüringen, Zentralinstitut für die kassenärztliche Versorgung (Zi)",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00021815,https://www.coronatest-thueringen.de/,Repeated cross-sectional,Healthcare workers and caregivers,Physicians and employees in panel doctors' practices of the Thuringian Association of Panel Physicians,Selected population groups,Adults,,18,Convenience sample,Medical practices with participants,,3000,2020-07-29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Seroprevalence of SARS-CoV-2 in employees of a clinic with COVID-centre (COVID-19),Local/Regional,Baden-Wuerttemberg,Heilbronn,,,,,,Heilbronn,SLK-Kliniken Heilbronn GmbH,,,,,,,," SLK-Kliniken Heilbronn GmbH",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022226,,Cross sectional,Healthcare workers and caregivers,Employees of the clinic association,Selected population groups,Multiple,,16,Entire sample,Participants,3066,3100,2020-07-01,2020-07-21,https://doi.org/10.3390/ijerph18137057,,,,,,,,,,,,,,,,,,,,,,,,,,,,2021-09-14,
LübEcker Längsschnittuntersuchung zu Infektionen mit SARS–CoV-2 (ELISA),Local/Regional,Schleswig-Holstein,Lübeck,,,,,,Lübeck and neighbouring postcode areas,"Universitätsklinikum Schleswig-Holstein (UKSH), Institut für Epidemiologie und Sozialmedizin","Universitätsklinikum Schleswig-Holstein (UKSH), Klinik für Infektiologie und Mikrobiologie","Universitätsklinikum Schleswig-Holstein (UKSH), Institut für Neurogenetik, Campus Lübeck",Universität zu Lübeck,Universitätsklinikum Schleswig-Holstein (UKSH),,,,"Institut für Epidemiologie und Sozialmedizin, Klinik für Infektiologie und Mikrobiologie und Institut für Neurogenetik des UKSH Campus Lübeck und der Universität zu Lübeck",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00023418,https://elisa-luebeck.de,Longitudinal/Prospectice cohort study,Household and Community Samples,Lübeck residents who had registered via an app and were divided into two groups according to risk their behavior,General population,Adults,79,18,Convenience sample,Participants,3051,3100,2020-05-06,2021-02-27,https://elisa-luebeck.de/einjaehrige-corona-studie-zu-antikoerpern-mit-rund-3000-probandinnen-und-probanden-zeigt-dunkelziffer-ist-deutlich-zurueckgegangen/,https://doi.org/10.1101/2021.05.10.21256966,https://doi.org/10.1126/sciadv.abm5016,https://doi.org/10.1186/s12889-022-13666-z,,Seroprevalence for the total cohort for the period May 2020 to February 2021,https://doi.org/10.1126/sciadv.abm5016,2022-04-15,Peer-reviewed Publikation,whole blood,anti -S1 domain,IgG,"ELISA ",EUROIMMUN,,,,,,,EUROIMMUN,,,,0.035,,,2022-05-04,2022-05-10,
LübEcker Längsschnittuntersuchung zu Infektionen mit SARS–CoV-2 (ELISA),Local/Regional,Schleswig-Holstein,Lübeck,,,,,,Lübeck and neighbouring postcode areas,"Universitätsklinikum Schleswig-Holstein (UKSH), Institut für Epidemiologie und Sozialmedizin","Universitätsklinikum Schleswig-Holstein (UKSH), Klinik für Infektiologie und Mikrobiologie","Universitätsklinikum Schleswig-Holstein (UKSH), Institut für Neurogenetik, Campus Lübeck",Universität zu Lübeck,Universitätsklinikum Schleswig-Holstein (UKSH),,,,"Institut für Epidemiologie und Sozialmedizin, Klinik für Infektiologie und Mikrobiologie und Institut für Neurogenetik des UKSH Campus Lübeck und der Universität zu Lübeck",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00023418,https://elisa-luebeck.de,Longitudinal/Prospectice cohort study,Household and Community Samples,Lübeck residents who had registered via an app and were divided into two groups according to risk their behavior,General population,Adults,79,18,Convenience sample,Participants,3051,3100,2020-05-06,2020-05-31,,,,,,"Seroprevalence in the cohort for the month of May 2020 ",https://doi.org/10.1126/sciadv.abm5016,2022-04-15,Peer-reviewed Publikation,whole blood,anti -S1 domain,IgG,"ELISA ",EUROIMMUN,,,,,,,EUROIMMUN,,,,0.0079,,,2022-05-04,,
LübEcker Längsschnittuntersuchung zu Infektionen mit SARS–CoV-2 (ELISA),Local/Regional,Schleswig-Holstein,Lübeck,,,,,,Lübeck and neighbouring postcode areas,"Universitätsklinikum Schleswig-Holstein (UKSH), Institut für Epidemiologie und Sozialmedizin","Universitätsklinikum Schleswig-Holstein (UKSH), Klinik für Infektiologie und Mikrobiologie","Universitätsklinikum Schleswig-Holstein (UKSH), Institut für Neurogenetik, Campus Lübeck",Universität zu Lübeck,Universitätsklinikum Schleswig-Holstein (UKSH),,,,"Institut für Epidemiologie und Sozialmedizin, Klinik für Infektiologie und Mikrobiologie und Institut für Neurogenetik des UKSH Campus Lübeck und der Universität zu Lübeck",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00023418,https://elisa-luebeck.de,Longitudinal/Prospectice cohort study,Household and Community Samples,Lübeck residents who had registered via an app and were divided into two groups according to risk their behavior,General population,Adults,79,18,Convenience sample,Participants,2894,2900,2020-07-01,2020-07-31,,,,,,"Seroprevalence in the cohort for the month of July 2020 ",https://doi.org/10.1126/sciadv.abm5016,2022-04-15,Peer-reviewed Publikation,whole blood,anti -S1 domain,IgG,"ELISA ",EUROIMMUN,,,,,,,EUROIMMUN,,,,0.0017,,,2022-05-04,,
LübEcker Längsschnittuntersuchung zu Infektionen mit SARS–CoV-2 (ELISA),Local/Regional,Schleswig-Holstein,Lübeck,,,,,,Lübeck and neighbouring postcode areas,"Universitätsklinikum Schleswig-Holstein (UKSH), Institut für Epidemiologie und Sozialmedizin","Universitätsklinikum Schleswig-Holstein (UKSH), Klinik für Infektiologie und Mikrobiologie","Universitätsklinikum Schleswig-Holstein (UKSH), Institut für Neurogenetik, Campus Lübeck",Universität zu Lübeck,Universitätsklinikum Schleswig-Holstein (UKSH),,,,"Institut für Epidemiologie und Sozialmedizin, Klinik für Infektiologie und Mikrobiologie und Institut für Neurogenetik des UKSH Campus Lübeck und der Universität zu Lübeck",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00023418,https://elisa-luebeck.de,Longitudinal/Prospectice cohort study,Household and Community Samples,Lübeck residents who had registered via an app and were divided into two groups according to risk their behavior,General population,Adults,79,18,Convenience sample,Participants,2659,2700,2020-09-01,2020-09-30,,,,,,"Seroprevalence in the cohort for the month of September 2020 ",https://doi.org/10.1126/sciadv.abm5016,2022-04-15,Peer-reviewed Publikation,whole blood,anti -S1 domain,IgG,"ELISA ",EUROIMMUN,,,,,,,EUROIMMUN,,,,0.003,,,2022-05-04,,
LübEcker Längsschnittuntersuchung zu Infektionen mit SARS–CoV-2 (ELISA),Local/Regional,Schleswig-Holstein,Lübeck,,,,,,Lübeck and neighbouring postcode areas,"Universitätsklinikum Schleswig-Holstein (UKSH), Institut für Epidemiologie und Sozialmedizin","Universitätsklinikum Schleswig-Holstein (UKSH), Klinik für Infektiologie und Mikrobiologie","Universitätsklinikum Schleswig-Holstein (UKSH), Institut für Neurogenetik, Campus Lübeck",Universität zu Lübeck,Universitätsklinikum Schleswig-Holstein (UKSH),,,,"Institut für Epidemiologie und Sozialmedizin, Klinik für Infektiologie und Mikrobiologie und Institut für Neurogenetik des UKSH Campus Lübeck und der Universität zu Lübeck",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00023418,https://elisa-luebeck.de,Longitudinal/Prospectice cohort study,Household and Community Samples,Lübeck residents who had registered via an app and were divided into two groups according to risk their behavior,General population,Adults,79,18,Convenience sample,Participants,2580,2600,2020-12-01,2020-12-31,,,,,,"Seroprevalence in the cohort for the month of December 2020 ",https://doi.org/10.1126/sciadv.abm5016,2022-04-15,Peer-reviewed Publikation,whole blood,anti -S1 domain,IgG,"ELISA ",EUROIMMUN,,,,,,,EUROIMMUN,,,,0.0112,,,2022-05-04,,
LübEcker Längsschnittuntersuchung zu Infektionen mit SARS–CoV-2 (ELISA),Local/Regional,Schleswig-Holstein,Lübeck,,,,,,Lübeck and neighbouring postcode areas,"Universitätsklinikum Schleswig-Holstein (UKSH), Institut für Epidemiologie und Sozialmedizin","Universitätsklinikum Schleswig-Holstein (UKSH), Klinik für Infektiologie und Mikrobiologie","Universitätsklinikum Schleswig-Holstein (UKSH), Institut für Neurogenetik, Campus Lübeck",Universität zu Lübeck,Universitätsklinikum Schleswig-Holstein (UKSH),,,,"Institut für Epidemiologie und Sozialmedizin, Klinik für Infektiologie und Mikrobiologie und Institut für Neurogenetik des UKSH Campus Lübeck und der Universität zu Lübeck",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00023418,https://elisa-luebeck.de,Longitudinal/Prospectice cohort study,Household and Community Samples,Lübeck residents who had registered via an app and were divided into two groups according to risk their behavior,General population,Adults,79,18,Convenience sample,Participants,2057,2100,2021-02-01,2021-02-27,,,,,,Seroprevalence in the cohort for the month of February 2021,https://doi.org/10.1126/sciadv.abm5016,2022-04-15,Peer-reviewed Publikation,whole blood,anti -S1 domain,IgG,"ELISA ",EUROIMMUN,,,,,,,EUROIMMUN,,,,0.011,,,2022-05-04,2022-05-10,
Prevalence of serum IgG antibodies against SARS-CoV-2 among clinic staff,Local/Regional,Lower Saxony,Hessian Oldendorf,,,,,,Hessian Oldendorf,"BDH-Klinik Hessisch Oldendorf, Institut für neurorehabilitative Forschung (InFo)",BDH-Klinik Hessisch Oldendorf,,,,,,,"BDH-Klinik Hessisch Oldendorf, Institut für neurorehabilitative Forschung (InFo)",,,Cross sectional,Healthcare workers and caregivers,Employees of a neurological rehabilitation clinic,Selected population groups,Adults,,18,Entire sample,Participants,385,400,2020-04-20,2020-04-30,https://doi.org/10.1371/journal.pone.0235417,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
COVID Kids Bavaria Studie,Local/Regional,Bavaria,Bavaria,,,,,,Institutions from all 46 electoral districts in Bavaria,Ludwig-Maximilians-Universität (LMU) München,Kinderklinik und Kinderpoliklinik im Dr. von Haunerschen Kinderspital,Dr. von Haunersches Kinderspital,,,,,,"Kinderklinik und Kinderpoliklinik im Dr. von Haunerschen Kinderspital, Ludwig-Maximilians-Universität (LMU) München",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022380,https://www.covid-kids-bavaria.de/covid-kids,Cross sectional,"School, Kindergarten/Daycare",Students in 15 selected elementary schools from all 46 electoral districts in Bavaria,General population,Children/adolescents ≤18 years,12,6,Convenience sample,Participants,511,500,2020-06-15,2020-07-15,,,,,,Seroprevalence of children attending elementary school in Bavaria for the period of June/July 2021,https://doi.org/10.3389/fped.2022.888498,2022-07-06,Peer-reviewed Publikation,capillary blood,anti Nucleocapsid,Multiple antibodies,Elektrochemolumineszenz (ECL)-Immunassay; LIPS,ROCHE N,,,,,,,ROCHE N,,,,0.076,0.055,0.103,2022-01-27,2022-08-09,
Teilprojekt der COVID Kids Bavaria Studie,Local/Regional,Bavaria,Bavaria,Munich,,,,,"Bavaria, focus on Munich",Ludwig-Maximilians-Universität (LMU) München,Kinderklinik und Kinderpoliklinik im Dr. von Haunerschen Kinderspital,Dr. von Haunersches Kinderspital,,,,,,"Kinderklinik und Kinderpoliklinik im Dr. von Haunerschen Kinderspital, Ludwig-Maximilians-Universität (LMU) München",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022380,https://www.covid-kids-bavaria.de/covid-kids,Cross sectional,"School, Kindergarten/Daycare",Students and teachers at selected elementary schools in Bavaria,General population and selected population groups,Multiple,,5,Convenience sample,Participants,,1000,2021-04-15,,"https://doi.org/10.1101/2022.01.18.22269445 ",https://dx.doi.org/10.3389/fped.2022.888498,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"SARS-CoV-2: Eine dynamische, bundesweit-repräsentative Untersuchung (Corona-BUND-Studie)",Nationwide,Nationwide,Germany,,,,,,Nationwide,Charité - Universitätsmedizin Berlin,PI Health Solutions GmbH Berlin,Forsa Gesellschaft für Sozialforschung und statistische Analysen mbH Berlin,Cologne Center for Genomics (CCG) der Universität zu Köln,Atlas Biolabs GmbH Berlin,ifo Institut für Wirtschaftsforschung München,,,"Charité - Universitätsmedizin Berlin, PI Health Solutions GmbH Berlin, Forsa Gesellschaft für Sozialforschung und statistische Analysen mbH Berlin, Cologne Center for Genomics (CCG) der Universität zu Köln, Atlas Biolabs GmbH Berlin, ifo Institut für Wirtschaftsforschung München ",,https://pi-healthsolutions.com/de/forschung-entwicklung/,Longitudinal/Prospectice cohort study,Household and Community Samples,Participants from the long-established representative forsa cohort of the adult population,General population,Adults,,18,Cohort-sample - Sampling from existing cohort study in the general population,Participants,,11000,2020-06-30,2020-08-12,https://www.ifo.de/publikationen/2020/monographie-autorenschaft/die-deutschen-und-corona,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"SARS-CoV-2: Eine dynamische, bundesweit-repräsentative Untersuchung (Corona-BUND-Studie)",Nationwide,Nationwide,Germany,,,,,,Nationwide,Charité - Universitätsmedizin Berlin,PI Health Solutions GmbH Berlin,Forsa Gesellschaft für Sozialforschung und statistische Analysen mbH Berlin,Cologne Center for Genomics (CCG) der Universität zu Köln,Atlas Biolabs GmbH Berlin,ifo Institut für Wirtschaftsforschung München,,,"Charité - Universitätsmedizin Berlin, PI Health Solutions GmbH Berlin, Forsa Gesellschaft für Sozialforschung und statistische Analysen mbH Berlin, Cologne Center for Genomics (CCG) der Universität zu Köln, Atlas Biolabs GmbH Berlin, ifo Institut für Wirtschaftsforschung München ",,https://pi-healthsolutions.com/de/forschung-entwicklung/,Longitudinal/Prospectice cohort study,Household and Community Samples,Participants from the long-established representative forsa cohort of the adult population,General population,Adults,,18,Cohort-sample - Sampling from existing cohort study in the general population,Participants,10221,10200,2020-06-30,2020-08-12,,,,,,Seroprevalence from the first study wave of participants in the forsa cohort,https://www.ifo.de/publikationen/2020/monographie-autorenschaft/die-deutschen-und-corona,2020-11-27,Institutional report,whole blood,anti Nucleocapsid,Total antibody,"ELISA ",ROCHE N,,,,,,,ROCHE N,Population-weighted,,,0.005,0.0038,0.0065,2021-08-06,2021-11-01,1.8
"SARS-CoV-2: Eine dynamische, bundesweit-repräsentative Untersuchung (Corona-BUND-Studie)",Nationwide,Nationwide,Germany,,,,,,Nationwide,Charité - Universitätsmedizin Berlin,PI Health Solutions GmbH Berlin,Forsa Gesellschaft für Sozialforschung und statistische Analysen mbH Berlin,Cologne Center for Genomics (CCG) der Universität zu Köln,Atlas Biolabs GmbH Berlin,ifo Institut für Wirtschaftsforschung München,,,"Charité - Universitätsmedizin Berlin, PI Health Solutions GmbH Berlin, Forsa Gesellschaft für Sozialforschung und statistische Analysen mbH Berlin, Cologne Center for Genomics (CCG) der Universität zu Köln, Atlas Biolabs GmbH Berlin, ifo Institut für Wirtschaftsforschung München ",,https://pi-healthsolutions.com/de/forschung-entwicklung/,Longitudinal/Prospectice cohort study,Household and Community Samples,Participants from the long-established representative forsa cohort of the adult population,General population,Adults,,18,Cohort-sample - Sampling from existing cohort study in the general population,Participants,9929,9900,2020-10-26,2020-11-18,,,,,,Seroprevalence from the second study wave of participants in the forsa cohort,https://www.ifo.de/publikationen/2020/monographie-autorenschaft/die-deutschen-und-corona,2020-11-27,Institutional report,whole blood,anti Nucleocapsid,Total antibody,"ELISA ",ROCHE N,,,,,,,ROCHE N,Population-weighted,,,0.0111,0.0092,0.0133,2021-08-06,2021-11-03,
"Prospektive, sero-epidemiologische Längsschnittstudie zur SARS-CoV-2 Prävalenz bei Kita-, Kindergarten- und Schulkindern – Eine Tübinger Modellstudie (Coro-Buddy)",Local/Regional,Baden-Wuerttemberg,Tübingen,,,,,,Tübingen,"Eberhard Karls Universität Tübingen, Institut für Tropenmedizin",Eberhard Karls Universität Tübingen,,,,,,,"Institut für Tropenmedizin, Eberhard Karls Universität Tübingen",https://clinicaltrials.gov/ct2/show/NCT04581889,https://www.medizin.uni-tuebingen.de/de/covid-19-studie,Longitudinal/Prospectice cohort study,"School, Kindergarten/Daycare","Children and teenagers from Tübingen daycare centers, kindergartens and schools",General population,Children/adolescents ≤18 years,17,1,Convenience sample,Participants,1850,1900,2020-07-02,2020-12-02,https://doi.org/10.2196/27739,https://doi.org/10.3389/fimmu.2021.753435,,,,,,,,,,,,,,,,,,,,,,,,,,,2021-10-04,
"Prospektive, sero-epidemiologische Längsschnittstudie zur SARS-CoV-2 Prävalenz bei Kita-, Kindergarten- und Schulkindern – Eine Tübinger Modellstudie (Coro-Buddy)",Local/Regional,Baden-Wuerttemberg,Tübingen,,,,,,Tübingen,"Eberhard Karls Universität Tübingen, Institut für Tropenmedizin",Eberhard Karls Universität Tübingen,,,,,,,"Institut für Tropenmedizin, Eberhard Karls Universität Tübingen",https://clinicaltrials.gov/ct2/show/NCT04581889,https://www.medizin.uni-tuebingen.de/de/covid-19-studie,Longitudinal/Prospectice cohort study,"School, Kindergarten/Daycare","Children and teenagers from Tübingen daycare centers, kindergartens and schools",General population,Children/adolescents ≤18 years,10,1,Convenience sample,Participants,837,800,2020-09-09,2020-12-02,,,,,,"Seroprevalence among children aged 1-10 years from Tübingen daycare centers, kindergartens and schools",https://doi.org/10.3389/fimmu.2021.753435,2021-10-08,Peer-reviewed Publikation,"no blood, sputum",anti -RBD domain,IgG,"ELISA ",In-house,,,,,,,Inhouse,Adjusted for test-specificity/test-sensitivity,0.87,1,0.016,0.009,0.029,2022-01-09,2022-02-01,3
UKGM-Mitarbeiter-Reihenuntersuchung zur Entwicklung eines SARS-CoV-2 („Coronavirus“)-Antikörpertiters,Local/Regional,Hesse,Marburg,,,,,,Marburg,Universitätsklinikum Marburg,Universitätsklinikum Gießen und Marburg,,,,,,,"Universitätsklinikum Marburg (UKGM, Standort Marburg)",,,Cross sectional,Healthcare workers and caregivers,Employees of UKGM,Selected population groups,Adults,,18,Entire sample,Participants,,3600,2020-06-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Häufigkeit und Einflussfaktoren auf frühe STadien A und B der Herzinsuffizienz in der Bevölkerung (STAAB) – COVID-Programm,Local/Regional,Bavaria,Würzburg,,,,,,Würzburg,Deutsches Zentrum für Herzinsuffizienz,"Universität Würzburg, Institut für Klinische Epidemiologie und Biometrie",Universität Würzburg,,,,,,"Institut für Klinische Epidemiologie und Biometrie Würzburg, Deutsches Zentrum für Herzinsuffizienz",,https://www.ukw.de/behandlungszentren/dzhi/ambulante-behandlung/staab-covid-programm/,Cross sectional and selective longitudinal,Household and Community Samples,Participants already included in the STAAB cohort,General population,Adults,87,32,Cohort-sample - Sampling from existing cohort study in the general population,Participants,3001,3000,2020-06-15,2020-10-15,https://www.uni-wuerzburg.de/aktuelles/einblick/single/news/ergebnisse-aus-staab-covid/,https://www.thieme-connect.de/products/ejournals/pdf/10.1055/a-1630-7601.pdf,,,,Participants already included in the STAAB cohort,https://doi.org/10.1055/a-1630-7601,2021-10-12,Peer-reviewed Publikation,whole blood,anti Nucleocapsid,Total antibody,Elektrochemolumineszenz (ECL)-Immunassay; LIPS,ROCHE N,,,,,,,ROCHE N,Adjusted for test-specificity/test-sensitivity and population-weighted,0.995,0.998,0.011,0.007,0.015,,2021-11-01,
Prospective SARS-CoV-2 seroprevalence study of schoolchildren after the lockdown March 2020 (SchoolCoviDD19),Local/Regional,Saxony,Saxony,,,,,,Eastern Saxony,Technische Universität Dresden,,,,,,,,Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden,https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022455,,Repeated cross-sectional,"School, Kindergarten/Daycare",Teachers of the grades 8-11,Selected population groups,Adults,56,34,Convenience sample,Participants,364,400,2021-03-15,2021-04-15,,,,,,Seroprevalence of teachers for the classes 8-11 in selected schools in Saxony for the period of March to April 2021,https://doi.org/10.1007/s15010-022-01824-9,2022-04-23,Peer-reviewed Publikation,whole blood,multiple,IgG,Mehrere/andere,DIASORIN,ABBOTT,EUROIMMUN,,,,,"DIASORIN, ABBOTT, EUROIMMUN",,,,0.096,0.066,0.126,,2022-04-05,
Prospective SARS-CoV-2 seroprevalence study of schoolchildren after the lockdown March 2020 (SchoolCoviDD19),Local/Regional,Saxony,Dresden,,,,,,Dresden,Technische Universität Dresden,,,,,,,,Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden,https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022455,,Repeated cross-sectional,"School, Kindergarten/Daycare",Teachers of the grades 8-11,Selected population groups,Adults,56,34,Convenience sample,Participants,275,300,2021-03-15,2021-04-15,,,,,,Seroprevalence of teachers for the classes 8-11 in selected schools in Dresden for the period of March to April 2021,https://doi.org/10.1007/s15010-022-01824-9,2022-04-23,Peer-reviewed Publikation,whole blood,multiple,IgG,Mehrere/andere,DIASORIN,ABBOTT,EUROIMMUN,,,,,"DIASORIN, ABBOTT, EUROIMMUN",,,,0.091,0.058,0.127,,2022-04-05,
Prospective SARS-CoV-2 seroprevalence study of schoolchildren after the lockdown March 2020 (SchoolCoviDD19),Local/Regional,Saxony,Bautzen,,,,,,Bautzen,Technische Universität Dresden,,,,,,,,Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden,https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022455,,Repeated cross-sectional,"School, Kindergarten/Daycare",Teachers of the grades 8-11,Selected population groups,Adults,56,34,Convenience sample,Participants,73,100,2021-03-15,2021-04-15,,,,,,Seroprevalence of teachers for the classes 8-11 in selected schools in Bautzen for the period of March to April 2021,https://doi.org/10.1007/s15010-022-01824-9,2022-04-23,Peer-reviewed Publikation,whole blood,multiple,IgG,Mehrere/andere,DIASORIN,ABBOTT,EUROIMMUN,,,,,"DIASORIN, ABBOTT, EUROIMMUN",,,,0.137,0.068,0.219,,2022-04-05,
Prospective SARS-CoV-2 seroprevalence study of schoolchildren after the lockdown March 2020 (SchoolCoviDD19),Local/Regional,Saxony,Saxony,,,,,,Eastern Saxony,Technische Universität Dresden,,,,,,,,Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden,https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022455,,Repeated cross-sectional,"School, Kindergarten/Daycare",Students of the grades 8-11,General population,Children/adolescents ≤18 years,17,14,Convenience sample,Participants,1580,1600,2021-03-15,2021-04-15,,,,,,Seroprevalence of students of the classes 8-11 in selected schools in Saxony for the period of March to April 2021,https://doi.org/10.1007/s15010-022-01824-9,2022-04-23,Peer-reviewed Publikation,whole blood,multiple,IgG,Mehrere/andere,DIASORIN,ABBOTT,EUROIMMUN,,,,,"DIASORIN, ABBOTT, EUROIMMUN",,,,0.128,0.113,0.146,,2022-04-05,
Prospective SARS-CoV-2 seroprevalence study of schoolchildren after the lockdown March 2020 (SchoolCoviDD19),Local/Regional,Saxony,Dresden,,,,,,Dresden,Technische Universität Dresden,,,,,,,,Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden,https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022455,,Repeated cross-sectional,"School, Kindergarten/Daycare",Students of the grades 8-11,General population,Children/adolescents ≤18 years,17,14,Convenience sample,Participants,1369,1400,2021-03-15,2021-04-15,,,,,,Seroprevalence of students of the classes 8-11 in selected schools in Dresden for the period of March to April 2021,https://doi.org/10.1007/s15010-022-01824-9,2022-04-23,Peer-reviewed Publikation,whole blood,multiple,IgG,Mehrere/andere,DIASORIN,ABBOTT,EUROIMMUN,,,,,"DIASORIN, ABBOTT, EUROIMMUN",,,,0.112,0.096,0.129,,2022-04-05,
Prospective SARS-CoV-2 seroprevalence study of schoolchildren after the lockdown March 2020 (SchoolCoviDD19),Local/Regional,Saxony,Bautzen,,,,,,Bautzen,Technische Universität Dresden,,,,,,,,Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden,https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022455,,Repeated cross-sectional,"School, Kindergarten/Daycare",Students of the grades 8-11,General population,Children/adolescents ≤18 years,17,14,Convenience sample,Participants,196,200,2021-03-15,2021-04-15,,,,,,Seroprevalence of students of the classes 8-11 in selected schools in Bautzen for the period of March to April 2021,https://doi.org/10.1007/s15010-022-01824-9,2022-04-23,Peer-reviewed Publikation,whole blood,multiple,IgG,Mehrere/andere,DIASORIN,ABBOTT,EUROIMMUN,,,,,"DIASORIN, ABBOTT, EUROIMMUN",,,,0.25,0.184,0.316,,2022-04-05,
Prospective SARS-CoV-2 seroprevalence study of schoolchildren after the lockdown March 2020 (SchoolCoviDD19),Local/Regional,Saxony,Saxony,,,,,,Eastern Saxony,Technische Universität Dresden,,,,,,,,Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden,https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022455,,Repeated cross-sectional,"School, Kindergarten/Daycare",Teachers of the grades 8-11,Selected population groups,Adults,59,35,Convenience sample,Participants,46,50,2021-06-15,2021-07-15,,,,,,Seroprevalence of teachers for the classes 8-11 in selected schools in Saxony for the period of June to July 2021,https://doi.org/10.1007/s15010-022-01824-9,2022-04-23,Peer-reviewed Publikation,whole blood,multiple,IgG,Mehrere/andere,DIASORIN,ABBOTT,EUROIMMUN,,,,,"DIASORIN, ABBOTT, EUROIMMUN",,,,0.304,0.174,0.435,,2022-04-05,
Prospective SARS-CoV-2 seroprevalence study of schoolchildren after the lockdown March 2020 (SchoolCoviDD19),Local/Regional,Saxony,Dresden,,,,,,Dresden,Technische Universität Dresden,,,,,,,,Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden,https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022455,,Repeated cross-sectional,"School, Kindergarten/Daycare",Teachers of the grades 8-11,Selected population groups,Adults,59,35,Convenience sample,Participants,54,100,2021-06-15,2021-07-15,,,,,,Seroprevalence of teachers for the classes 8-11 in selected schools in Dresden for the period of June to July 2021,https://doi.org/10.1007/s15010-022-01824-9,2022-04-23,Peer-reviewed Publikation,whole blood,multiple,IgG,Mehrere/andere,DIASORIN,ABBOTT,EUROIMMUN,,,,,"DIASORIN, ABBOTT, EUROIMMUN",,,,0.222,0.111,0.333,,2022-04-05,
Prospective SARS-CoV-2 seroprevalence study of schoolchildren after the lockdown March 2020 (SchoolCoviDD19),Local/Regional,Saxony,Bautzen,,,,,,Bautzen,Technische Universität Dresden,,,,,,,,Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden,https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022455,,Repeated cross-sectional,"School, Kindergarten/Daycare",Teachers of the grades 8-11,Selected population groups,Adults,59,35,Convenience sample,Participants,6,5,2021-06-15,2021-07-15,,,,,,Seroprevalence of teachers for the classes 8-11 in selected schools in Bautzen for the period of June to July 2021,https://doi.org/10.1007/s15010-022-01824-9,2022-04-23,Peer-reviewed Publikation,whole blood,multiple,IgG,Mehrere/andere,DIASORIN,ABBOTT,EUROIMMUN,,,,,"DIASORIN, ABBOTT, EUROIMMUN",,,,0.333,0,0.667,,2022-04-05,
Prospective SARS-CoV-2 seroprevalence study of schoolchildren after the lockdown March 2020 (SchoolCoviDD19),Local/Regional,Saxony,Saxony,,,,,,Eastern Saxony,Technische Universität Dresden,,,,,,,,Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden,https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022455,,Repeated cross-sectional,"School, Kindergarten/Daycare",Students of the grades 8-11,General population,Children/adolescents ≤18 years,16,13,Convenience sample,Participants,841,800,2021-06-15,2021-07-15,,,,,,Seroprevalence of students of the classes 8-11 in selected schools in Saxony for the period of June to July 2021,https://doi.org/10.1007/s15010-022-01824-9,2022-04-23,Peer-reviewed Publikation,whole blood,multiple,IgG,Mehrere/andere,DIASORIN,ABBOTT,EUROIMMUN,,,,,"DIASORIN, ABBOTT, EUROIMMUN",,,,0.215,0.188,0.244,,2022-04-05,
Prospective SARS-CoV-2 seroprevalence study of schoolchildren after the lockdown March 2020 (SchoolCoviDD19),Local/Regional,Saxony,Dresden,,,,,,Dresden,Technische Universität Dresden,,,,,,,,Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden,https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022455,,Repeated cross-sectional,"School, Kindergarten/Daycare",Students of the grades 8-11,General population,Children/adolescents ≤18 years,16,13,Convenience sample,Participants,670,700,2021-06-15,2021-07-15,,,,,,Seroprevalence of students of the classes 8-11 in selected schools in Dresden for the period of June to July 2021,https://doi.org/10.1007/s15010-022-01824-9,2022-04-23,Peer-reviewed Publikation,whole blood,multiple,IgG,Mehrere/andere,DIASORIN,ABBOTT,EUROIMMUN,,,,,"DIASORIN, ABBOTT, EUROIMMUN",,,,0.2,0.17,0.233,,2022-04-05,
Prospective SARS-CoV-2 seroprevalence study of schoolchildren after the lockdown March 2020 (SchoolCoviDD19),Local/Regional,Saxony,Bautzen,,,,,,Bautzen,Technische Universität Dresden,,,,,,,,Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden,https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022455,,Repeated cross-sectional,"School, Kindergarten/Daycare",Students of the grades 8-11,General population,Children/adolescents ≤18 years,16,13,Convenience sample,Participants,133,100,2021-06-15,2021-07-15,,,,,,Seroprevalence of students of the classes 8-11 in selected schools in Bautzen for the period of June to July 2021,https://doi.org/10.1007/s15010-022-01824-9,2022-04-23,Peer-reviewed Publikation,whole blood,multiple,IgG,Mehrere/andere,DIASORIN,ABBOTT,EUROIMMUN,,,,,"DIASORIN, ABBOTT, EUROIMMUN",,,,0.293,0.218,0.376,,2022-04-05,
Prospective SARS-CoV-2 seroprevalence study of schoolchildren after the lockdown March 2020 (SchoolCoviDD19),Local/Regional,Saxony,Saxony,,,,,,Eastern Saxony,Technische Universität Dresden,,,,,,,,Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden,https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022455,,Repeated cross-sectional,"School, Kindergarten/Daycare",Students of the grades 8-11 and teachers,General population and selected population groups,Multiple,57,14,Convenience sample,Participants,2045,2045,2020-05-25,2020-06-30,,,,,,Seroprevalence of students and teachers of the classes 8-11 in selected schools in Saxony for the period of May to June 2020,http://dx.doi.org/10.1136/bmjopen-2021-049876,2021-06-10,Peer-reviewed Publikation,whole blood,multiple,IgG,Mehrere/andere,N/A,,,,,,,N/A,,,,0.006,,,,2021-10-17,
Prospective SARS-CoV-2 seroprevalence study of schoolchildren after the lockdown March 2020 (SchoolCoviDD19),Local/Regional,Saxony,Saxony,,,,,,Eastern Saxony,Technische Universität Dresden,,,,,,,,"Universitätsklinikum Carl Gustav Carus, an der Technischen Universität Dresden",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022455,https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022455,Repeated cross-sectional,"School, Kindergarten/Daycare","Students of the grades 8-11 ",General population,Children/adolescents ≤18 years,16,14,Convenience sample,Participants,1538,1538,2020-05-25,2020-06-30,,,,,,Seroprevalence of students of the classes 8-11 in selected schools in Saxony for the period of May to June 2020,http://dx.doi.org/10.1136/bmjopen-2021-049876,2021-06-10,Peer-reviewed Publikation,whole blood,multiple,IgG,Mehrere/andere,N/A,,,,,,,N/A,Not adjusted,,,0.007,,,,2021-10-17,
Prospective SARS-CoV-2 seroprevalence study of schoolchildren after the lockdown March 2020 (SchoolCoviDD19),Local/Regional,Saxony,Saxony,,,,,,Eastern Saxony,Technische Universität Dresden,,,,,,,,"Universitätsklinikum Carl Gustav Carus, an der Technischen Universität Dresden",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022455,https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022455,Repeated cross-sectional,"School, Kindergarten/Daycare",Teachers of the grades 8-11,Selected population groups,Adults,57,37,Convenience sample,Participants,507,500,2020-05-25,2020-06-30,,,,,,Seroprevalence among teachers of the grades 8-11 in selected schools in Saxony for the period of May to June 2020,http://dx.doi.org/10.1136/bmjopen-2021-049876,2021-06-10,Peer-reviewed Publikation,whole blood,multiple,IgG,Mehrere/andere,DIASORIN,ABBOTT,EUROIMMUN,,,,,"DIASORIN, ABBOTT, EUROIMMUN",,,,0.002,,,,2021-10-17,
Prospective SARS-CoV-2 seroprevalence study of schoolchildren after the lockdown March 2020 (SchoolCoviDD19),Local/Regional,Saxony,Saxony,,,,,,Eastern Saxony,Technische Universität Dresden,,,,,,,,Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden,https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022455,,Repeated cross-sectional,"School, Kindergarten/Daycare",Students of the grades 8-11 and teachers,General population and selected population groups,Multiple,57,14,Convenience sample,Participants,1779,1800,2020-09-15,2020-10-13,,,,,,Seroprevalence of students and teachers of the classes 8-11 in selected schools in Saxony for the period of September to October 2020,http://dx.doi.org/10.1136/bmjopen-2021-049876,2021-06-10,Peer-reviewed Publikation,whole blood,multiple,IgG,Mehrere/andere,N/A,,,,,,,N/A,,,,0.007,,,,2021-10-17,
Prospective SARS-CoV-2 seroprevalence study of schoolchildren after the lockdown March 2020 (SchoolCoviDD19),Local/Regional,Saxony,Saxony,,,,,,Eastern Saxony,Technische Universität Dresden,,,,,,,,Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden,https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022455,,Repeated cross-sectional,"School, Kindergarten/Daycare",Students of the grades 8-11,General population,Children/adolescents ≤18 years,16,14,Convenience sample,Participants,1334,1300,2020-09-15,2020-10-13,,,,,,Seroprevalence of students of the classes 8-11 in selected schools in Saxony for the period of September to October 2020,http://dx.doi.org/10.1136/bmjopen-2021-049876,2021-06-10,Peer-reviewed Publikation,whole blood,multiple,IgG,Mehrere/andere,N/A,,,,,,,N/A,Not adjusted,,,0.008,,,,2021-10-17,
Prospective SARS-CoV-2 seroprevalence study of schoolchildren after the lockdown March 2020 (SchoolCoviDD19),Local/Regional,Saxony,Saxony,,,,,,Eastern Saxony,Technische Universität Dresden,,,,,,,,Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden,https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022455,,Repeated cross-sectional,"School, Kindergarten/Daycare",Teachers of the grades 8-11,Selected population groups,Adults,57,37,Convenience sample,Participants,1779,1800,2020-09-15,2020-10-13,,,,,,Seroprevalence of teachers for the classes 8-11 in selected schools in Saxony for the period of September to October 2020,http://dx.doi.org/10.1136/bmjopen-2021-049876,2021-06-10,Peer-reviewed Publikation,whole blood,multiple,IgG,Mehrere/andere,N/A,,,,,,,N/A,,,,0.002,,,,2021-10-17,
Prospective SARS-CoV-2 seroprevalence study of schoolchildren after the lockdown March 2020 (SchoolCoviDD19),Local/Regional,Saxony,Saxony,,,,,,Eastern Saxony,Technische Universität Dresden,,,,,,,,Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden,https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022455,,Repeated cross-sectional,"School, Kindergarten/Daycare",Students of the grades 8-11 and teachers,General population and selected population groups,Multiple,59,13,Convenience sample,Participants,2045,2000,2020-05-25,2021-07-15,https://dx.doi.org/10.1136/bmjopen-2021-049876,https://tu-dresden.de/med/mf/die-fakultaet/newsuebersicht/schulen-sind-keine-silent-hotspots,http://dx.doi.org/10.1136/bmjpo-2021-001036,https://doi.org/10.1007/s15010-022-01824-9,,,,,,,,,,,,,,,,,,,,,,,,,,
Infection rate of Covid-19 among medical staff in GP practices in North Rhine-Westphalia (Germany),Local/Regional,North Rhine-Westphalia,North Rhine-Westphalia,,,,,,North Rhine-Westphalia,Universitätsklinikum Essen,,,,,,,,Institut für Allgemeinmedizin des Universitätsklinikums Essen,https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00021788,,Cross sectional,Healthcare workers and caregivers,"Medical staff (physicians, medical assistants, trainees) from more than 180 practices (existing supraregional teaching practice network of the Institute of General Medicine at Essen University Hospital)",Selected population groups,Adults,,18,Convenience sample,Participants,,900,2020-06-10,,https://dx.doi.org/10.1002/jmv.27385,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"Prevalence of SARS-CoV-2 Infections in the employees of the Pius-Hospital Oldenburg, confirmed through virus antibody testing - COVID-19 (Co-KI-Ak)",Local/Regional,Lower Saxony,Oldenburg,,,,,,Oldenburg,Pius-Hospital Oldenburg,,,,,,,,Pius-Hospital Oldenburg,https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022259,,Longitudinal/Prospectice cohort study,Healthcare workers and caregivers,Employees from all professional groups of the hospital,Selected population groups,Adults,,18,Convenience sample,Participants,,1300,2020-06-22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Survey of the seroprevalence and infection status of SARS-CoV-2 among employees of the University Hospital Jena,Local/Regional,Thuringia,Jena,,,,,,Jena,"Universitätsklinikum Jena, Institut für Infektionsmedizin und Krankenhaushygiene",Universitätsklinikum Jena,,,,,,,"Institut für Infektionsmedizin und Krankenhaushygiene, Universitätsklinikum Jena",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022432,,Cross sectional,Healthcare workers and caregivers,Employees of the University Hospital Jena,Selected population groups,Adults,,18,Convenience sample,Participants,660,700,2020-05-19,2020-06-19,https://doi.org/10.1101/2020.09.29.20203737,https://dx.doi.org/10.1111/tbed.14041,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Studie der DB Fernverkehr AG zu Corona-Infektionen und Corona-Immunitäten ihrer Mitarbeiter,Local/Regional,Multilocal,Frankfurt,Berlin,Munich,Hamburg,,,"Frankfurt, Berlin, Munich, Hamburg",Deutsche Bahn AG,,,,,,,,Deutsche Bahn AG,https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022359,,Repeated cross-sectional,Non-essential workers and unemployed persons,"Employees of three occupational groups (train crews, train drivers, plant craftsmen) at four locations",Selected population groups,Multiple,65,18,Convenience sample,Participants,,3200,2020-06-29,,https://www.deutschebahn.com/de/presse/pressestart_zentrales_uebersicht/Wissenschaftliche-Studie-Keine-Anzeichen-fuer-erhoehte-Corona-Gefahr-bei-Zugpersonal--5581064,https://www.deutschebahn.com/de/presse/pressestart_zentrales_uebersicht/Abschluss-Charit%C3%A9-Langzeitstudie-Kein-erhoehtes-Corona-Risiko-im-Fernverkehr-6189116,,,,,,,,,,,,,,,,,,,,,,,,,,,,
National Covid-19 Surveillance Physicians (NAT-COV-SURV),Local/Regional,Multilocal,Germany,,,,,,Multilocal,"Heinrich-Heine Universität, Düsseldorf",,,,,,,,"Klinik für Anästhesiologie, Heinrich-Heine Universität, Düsseldorf ",https://clinicaltrials.gov/ct2/show/NCT04459312,,Cross sectional,Healthcare workers and caregivers,Intensive care and emergency physicians from different federal states of Germany,Selected population groups,Adults,,18,Convenience sample,Participants,516,500,2020-06-16,2020-07-02,https://doi.org/10.1371/journal.pone.0248813,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states,Local/Regional,North Rhine-Westphalia,North Rhine-Westphalia,Hesse,Lower Saxony,,,,"Northrhine-Westfalia, Hesse and Lower Saxony",Herz- und Diabeteszentrum NRW,,,,,,,,"Herz- und Diabeteszentrum NRW, Bad Oeynhausen ",,,Repeated cross-sectional,Blood donors,"Blood donors from North Rhine-Westphalia, Hesse, and Lower Saxony",General population,Adults,,18,Blood donation,Participants,3759,3200,2020-06-15,2021-07-15,,,,,,"Total seroprevalence of antibodies against the nucleocapsid among blood donors (North Rhine-Westphalia, Hesse, Lower Saxony) for the period from June 2020 to July 2021","https://doi.org/10.1101/2022.02.11.22270833 ",2022-02-15,Preprint,whole blood,multiple,IgG,"ELISA ",EUROIMMUN,ABBOTT N,DIASORIN,,,,,"EUROIMMUN; ABBOTT N; DIASORIN ",,,,0.0548,0.0477,0.0625,2022-03-15,2022-03-23,
SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states,Local/Regional,North Rhine-Westphalia,North Rhine-Westphalia,Hesse,Lower Saxony,,,,"Northrhine-Westfalia, Hesse and Lower Saxony",Herz- und Diabeteszentrum NRW,,,,,,,,"Herz- und Diabeteszentrum NRW, Bad Oeynhausen ",,,Repeated cross-sectional,Blood donors,"Blood donors from North Rhine-Westphalia, Hesse, and Lower Saxony",General population,Adults,65,18,Blood donation,Samples of participants,3186,3200,2020-03-09,2020-06-03,,,,,,"Total seroprevalence of blood donors (North Rhine-Westphalia, Hesse, Lower Saxony) for the period from March to June 2020",https://dx.doi.org/10.2807/1560-7917.ES.2020.25.28.2001285,2020-07-16,Peer-reviewed Publikation,whole blood,multiple,IgG,"ELISA ",EUROIMMUN,ABBOTT N,DIASORIN,,,,,"EUROIMMUN; ABBOTT N; DIASORIN ",Adjusted for test-specificity/test-sensitivity,,,0.009,0.006,0.012,,2021-10-21,
SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states (Hesse),Local/Regional,Hesse,Hesse,,,,,,Hesse,Herz- und Diabeteszentrum NRW,,,,,,,,"Herz- und Diabeteszentrum NRW, Bad Oeynhausen ",,,Repeated cross-sectional,Blood donors,Blood donors from Hessen,General population,Adults,,18,Blood donation,Participants,1271,600,2020-06-15,2021-07-15,,,,,,Seroprevalence of antibodies against the nucleocapsid among blood donors in Lower Saxony for the period from June 2020 to July 2021,"https://doi.org/10.1101/2022.02.11.22270833 ",2022-02-15,Preprint,whole blood,multiple,IgG,"ELISA ",EUROIMMUN,ABBOTT N,DIASORIN,,,,,"EUROIMMUN; ABBOTT N; DIASORIN ",,,,0.0551,0.0432,0.0691,2022-03-15,2022-03-23,
SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states (Hesse),Local/Regional,Hesse,Hesse,,,,,,Hesse,Herz- und Diabeteszentrum NRW,,,,,,,,"Herz- und Diabeteszentrum NRW, Bad Oeynhausen ",,,Cross sectional,Blood donors,Blood donors from Hessen,General population,Adults,65,18,Blood donation,Participants,576,600,2020-03-09,2020-06-03,,,,,,Seroprevalence of blood donors in Lower Saxony for the period from March to June 2020,https://dx.doi.org/10.2807/1560-7917.ES.2020.25.28.2001285,2020-07-16,Peer-reviewed Publikation,whole blood,multiple,IgG,"ELISA ",EUROIMMUN,ABBOTT N,DIASORIN,,,,,"EUROIMMUN; ABBOTT N; DIASORIN ",Adjusted for test-specificity/test-sensitivity,,,0.012,0.003,0.021,,2021-09-10,
SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states (Hesse),Local/Regional,Hesse,Hesse,,,,,,Hesse,Herz- und Diabeteszentrum NRW,,,,,,,,"Herz- und Diabeteszentrum NRW, Bad Oeynhausen ",,,Cross sectional,Blood donors,Blood donors from Hessen,General population,Adults,65,18,Blood donation,Participants,576,600,2020-03-09,2021-07-15,https://doi.org/10.2807/1560-7917.ES.2020.25.28.2001285,"https://doi.org/10.1101/2022.02.11.22270833 ",,,,,,,,,,,,,,,,,,,,,,,,,,,2022-03-23,
SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states (Lower Saxony),Local/Regional,Lower Saxony,Lower Saxony,,,,,,Lower Saxony,Herz- und Diabeteszentrum NRW,,,,,,,,"Herz- und Diabeteszentrum NRW, Bad Oeynhausen ",,,Repeated cross-sectional,Blood donors,Blood donors from Lower Saxony,General population,Adults,,18,Blood donation,Participants,816,900,2020-06-15,2021-07-15,,,,,,Seroprevalence of antibodies against the nucleocapsid among blood donors in Hesse for the period from June 2020 to July 2021,"https://doi.org/10.1101/2022.02.11.22270833 ",2022-02-15,Preprint,whole blood,multiple,IgG,"ELISA ",EUROIMMUN,ABBOTT N,DIASORIN,,,,,"EUROIMMUN; ABBOTT N; DIASORIN ",,,,0.0515,0.0373,0.0689,2022-03-15,2022-03-23,
SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states (Lower Saxony),Local/Regional,Lower Saxony,Lower Saxony,,,,,,Lower Saxony,Herz- und Diabeteszentrum NRW,,,,,,,,"Herz- und Diabeteszentrum NRW, Bad Oeynhausen ",,,Cross sectional,Blood donors,Blood donors from Lower Saxony,General population,Adults,65,18,Blood donation,Participants,910,900,2020-03-09,2020-06-03,,,,,,Seroprevalence of blood donors in Hesse for the period from March to June 2020,https://dx.doi.org/10.2807/1560-7917.ES.2020.25.28.2001285,2020-07-16,Peer-reviewed Publikation,whole blood,multiple,IgG,"ELISA ",EUROIMMUN,ABBOTT N,DIASORIN,,,,,"EUROIMMUN; ABBOTT N; DIASORIN ",Adjusted for test-specificity/test-sensitivity,,,0.007,0.001,0.012,,2021-09-10,
SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states (Lower Saxony),Local/Regional,Lower Saxony,Lower Saxony,,,,,,Lower Saxony,Herz- und Diabeteszentrum NRW,,,,,,,,"Herz- und Diabeteszentrum NRW, Bad Oeynhausen ",,,Cross sectional,Blood donors,Blood donors from Lower Saxony,General population,Adults,65,18,Blood donation,Participants,910,900,2020-03-09,2021-07-15,https://doi.org/10.2807/1560-7917.ES.2020.25.28.2001285,"https://doi.org/10.1101/2022.02.11.22270833 ",,,,,,,,,,,,,,,,,,,,,,,,,,,2022-03-24,
SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states (Nord Rhine-Westphalia),Local/Regional,North Rhine-Westphalia,North Rhine-Westphalia,,,,,,North Rhine-Westphalia,Herz- und Diabeteszentrum NRW,,,,,,,,"Herz- und Diabeteszentrum NRW, Bad Oeynhausen ",,,Repeated cross-sectional,Blood donors,"Blood donors from North Rhine-Westphalia ",General population,Adults,,18,Blood donation,Participants,1672,1700,2020-06-15,2021-07-15,,,,,,Seroprevalence of antibodies against the nucleocapsid among blood donors in North Rhine-Westphalia for the period from June 2020 to July 2021,"https://doi.org/10.1101/2022.02.11.22270833 ",2022-02-15,Preprint,whole blood,multiple,IgG,"ELISA ",EUROIMMUN,ABBOTT N,DIASORIN,,,,,"EUROIMMUN; ABBOTT N; DIASORIN ",,,,0.0562,0.0457,0.0684,2022-03-15,2022-03-23,
SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states (Nord Rhine-Westphalia),Local/Regional,North Rhine-Westphalia,North Rhine-Westphalia,,,,,,North Rhine-Westphalia,Herz- und Diabeteszentrum NRW,,,,,,,,"Herz- und Diabeteszentrum NRW, Bad Oeynhausen ",,,Cross sectional,Blood donors,"Blood donors from North Rhine-Westphalia ",General population,Adults,65,18,Blood donation,Participants,1700,1700,2020-03-09,2020-06-03,,,,,,Seroprevalence of blood donors in North Rhine-Westphalia for the period from March to June 2020,https://dx.doi.org/10.2807/1560-7917.ES.2020.25.28.2001285,2020-07-16,Peer-reviewed Publikation,whole blood,multiple,IgG,"ELISA ",EUROIMMUN,ABBOTT N,DIASORIN,,,,,"EUROIMMUN; ABBOTT N; DIASORIN ",Adjusted for test-specificity/test-sensitivity,,,0.009,0.005,0.014,,2021-09-10,
SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states (Nord Rhine-Westphalia),Local/Regional,North Rhine-Westphalia,North Rhine-Westphalia,,,,,,North Rhine-Westphalia,Herz- und Diabeteszentrum NRW,,,,,,,,"Herz- und Diabeteszentrum NRW, Bad Oeynhausen ",,,Cross sectional,Blood donors,"Blood donors from North Rhine-Westphalia ",General population,Adults,65,18,Blood donation,Participants,1700,1700,2020-03-09,2021-07-15,https://doi.org/10.2807/1560-7917.ES.2020.25.28.2001285,"https://doi.org/10.1101/2022.02.11.22270833 ",,,,,,,,,,,,,,,,,,,,,,,,,,,2022-03-25,
SARS-CoV-2 Surveillance in Day Care Centers (KiTaCoviDD19),Local/Regional,Saxony,Dresden,,,,,,Dresden,Technische Universität Dresden,,,,,,,,Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden,https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022729,,Longitudinal/Prospectice cohort study,"School, Kindergarten/Daycare",Pedagogical staff from day care centers of the city of Dresden and the parents of the children cared for there,Selected population groups,Adults,,18,Convenience sample,Participants,,800,2020-07-15,,https://dx.doi.org/10.1016/j.jpeds.2021.07.054,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Mitarbeiterstudie COVID-19 Klinik St. Hedwig,Local/Regional,Bavaria,Regensburg,,,,,,Regensburg,Krankenhaus Barmherzige Brüder Regensburg,,,,,,,,"Klinik St. Hedwig, Krankenhaus Barmherzige Brüder Regensburg",,,Cross sectional and selective longitudinal,Healthcare workers and caregivers,Employees of the St. Hedwig Clinic who had participated in the PCR series testing performed in the context of an outbreak,Selected population groups,Adults,65,18,Convenience sample,Participants,201,200,2020-03-15,2020-06-07,https://doi.org/10.1111/pai.13278,https://dx.doi.org/10.1016%2Fj.jcv.2020.104575,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SARS-CoV-2 serology in HIV PrEP users during the COVID-19 pandemic (PrEP-Co-Study),Local/Regional,Bavaria,Munich,,,,,,Munich,Technische Universität München,"Klinikum rechts der Isar ",,,,,,,Klinik und Poliklinik für Innere Medizin II des Klinikums rechts der Isar der Technischen Universität (TU) München,https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022403,,Longitudinal/Prospectice cohort study,Persons seeking care for non-COVID reasons,Patients of the infectious disease outpatient clinic who take HIV-PrEP,Selected population groups,Adults,,18,Convenience sample,Participants,,300,2020-05-18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Seroprevalence of SARS-CoV-2 antibodies among hospital workers in a German tertiary care center: A sequential follow-up study,Local/Regional,Hamburg,Hamburg,,,,,,Hamburg,Universitätsklinikum Hamburg-Eppendorf,,,,,,,,University Medical Center Hamburg-Eppendorf,,,Longitudinal/Prospectice cohort study,Healthcare workers and caregivers,Employees of the Universitätsklinikum Hamburg-Eppendorf,Selected population groups,Adults,69,16,Convenience sample,Participants,1253,1300,2020-03-20,2021-05-31,https://doi.org/10.1101/2020.07.31.20165936,https://dx.doi.org/10.1016/j.ijheh.2020.113671,https://doi.org/10.1101/2021.08.02.21260667,https://doi.org/10.3390/vaccines10071086,,,,,,,,,,,,,,,,,,,,,,,,,2021-08-27,
"Prospective Study initiated by University Hospital Rostock concerning COVID-19 in mothers, nursery and school teachers of children in Rostock",Local/Regional,Mecklenburg-Western Pomerania,Rostock,,,,,,Rostock,"Universitätsmedizin Rostock, Zentrum für Innere Medizin, Abteilung für Infektionskrankheiten und Tropenmedizin","Universitätsmedizin Rostock ",,,,,,,Abteilung für Tropenmedizin und Infektionskrankheiten; Klinik für Innere Medizin Universitätsmedizin Rostock,https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022504,,Cross sectional and selective longitudinal,Other groups,"Mothers of children aged 1 to 10 years (RoKiCo A), caregivers of children (RoKiCo B), and those affected by COVID-19 (RoKiCo C)",Selected population groups,Adults,,18,Convenience sample,Participants,,600,2020-08-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Seroprävalenz COVID-19 Düsseldorf: Rettungsdienst (SERODUS II),Local/Regional,North Rhine-Westphalia,Dusseldorf,,,,,,Dusseldorf,Universitätsklinikum Düsseldorf,Stadt Düsseldorf,"Ministerium für Arbeit, Gesundheit und Soziales Nordrhein-Westfalen",,,,,,"Universitätsklinikum Düsseldorf; Stadt Düsseldorf; Ministerium für Arbeit, Gesundheit und Soziales Nordrhein-Westfalen",,https://www.uniklinik-duesseldorf.de/patienten-besucher/klinikeninstitutezentren/institut-fuer-medizinische-soziologie/das-institut/forschung/serodus,Cross sectional,Essential non-healthcare workers,Employees of the rescue service of the city of Düsseldorf,Selected population groups,Adults,65,18,Random sampling (not central registration-based),Participants,745,700,2020-11-27,2021-12-04,https://doi.org/10.1093/occmed/kqab164,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Gutenberg COVID-19 Studie,Local/Regional,Rhineland-Palatinate,Hesse,,,,,,Rhine Hesse,Johannes Gutenberg Universität Mainz,,,,,,,,Universitätsmedizin der Johannes Gutenberg-Universität Mainz,,https://www.unimedizin-mainz.de/gcs/uebersicht.html,Cross sectional and selective longitudinal,Household and Community Samples,Predominantly participants from the Gutenberg Health Study cohort and newly recruited study participants,General population,Adults,88,25,Cohort-sample - Sampling from existing cohort study in the general population,Participants,10250,10300,2020-10-15,2021-06-15,https://www.unimedizin-mainz.de/GCS/dashboard/,,,,,Proportion of SARS-CoV-2 infections (PCR or antibody positive) among the population sample for the period October 2020 - June 2021,https://www.unimedizin-mainz.de/GCS/dashboard/#/app/pages/AktuelleErgebnisse/ergebnisse,2021-12-20,Presentation,whole blood,,,"ELISA ",ABBOTT N,ROCHE,,,,,,"ABBOTT N, ROCHE",,,,0.049,0.045,0.053,,2022-02-11,1.6
Corona-Virus bei Kindern in Bayern (CoKiBa),Local/Regional,Bavaria,Rosenheim,Tirschenreuth,Regensburg,,,,"Rosenheim, Tirschenreuth, Regensburg",Krankenhaus Barmherzige Brüder Regensburg,,,,,,,,"Klinik und Poliklinik für Kinder- und Jugendmedizin der Universität Regensburg (KUNO), Klinik St. Hedwig, Krankenhaus Barmherzige Brüder Regensburg",,,Cross sectional,Patients seeking care for non-COVID-19 reasons,Children and adolescents who attended routine checkups in pediatric offices and children and adolescents with possible COVID-19 symptoms/contacts,General population,Children/adolescents ≤18 years,14,1,Convenience sample,Participants,,2800,2020-05-22,2020-07-22,https://doi.org/10.22541/au.160776187.78854537/v1,https://doi.org/10.3389/fped.2021.678937,,,,,,,,,,,,,,,,,,,,,,,,,,,2021-09-27,
Corona-Virus bei Kindern in Bayern (CoKiBa),Local/Regional,Bavaria,Tirschenreuth,,,,,,Tirschenreuth,Krankenhaus Barmherzige Brüder Regensburg,,,,,,,,"Klinik und Poliklinik für Kinder- und Jugendmedizin der Universität Regensburg (KUNO), Klinik St. Hedwig, Krankenhaus Barmherzige Brüder Regensburg",,,Cross sectional,Persons seeking care for non-COVID reasons,Children and adolescents who attended routine checkups in pediatric offices and children and adolescents with possible COVID-19 symptoms/contacts,General population,Children/adolescents ≤18 years,14,1,Convenience sample,Participants,,,2020-05-22,2020-07-22,,,,,,"Seroprevalence among children and adolescents, attending routine checkups in pediatric offices in Tirschenreuth",https://www.frontiersin.org/articles/10.3389/fped.2021.678937/full,2020-12-12,Peer-reviewed Publikation,whole blood,multiple,Multiple antibodies,Mehrere/andere,ROCHE N,In-house ELISA,,,,,,"ROCHE, In-house ELISA",,,,0.072,,,,2021-10-17,
Corona-Virus bei Kindern in Bayern (CoKiBa),Local/Regional,Bavaria,Regensburg,,,,,,Regensburg,Krankenhaus Barmherzige Brüder Regensburg,,,,,,,,"Klinik und Poliklinik für Kinder- und Jugendmedizin der Universität Regensburg (KUNO), Klinik St. Hedwig, Krankenhaus Barmherzige Brüder Regensburg",,,Cross sectional,Persons seeking care for non-COVID reasons,Children and adolescents who attended routine checkups in pediatric offices and children and adolescents with possible COVID-19 symptoms/contacts,General population,Children/adolescents ≤18 years,14,1,Convenience sample,Participants,,,2020-05-22,2020-07-22,,,,,,"Seroprevalence among children and adolescents, attending routine checkups in pediatric offices in Regensburg",https://www.frontiersin.org/articles/10.3389/fped.2021.678937/full,2020-12-12,Peer-reviewed Publikation,whole blood,multiple,Multiple antibodies,Mehrere/andere,ROCHE N,In-house ELISA,,,,,,"ROCHE, In-house ELISA",,,,0.031,,,,2021-10-17,
Corona-Virus bei Kindern in Bayern (CoKiBa),Local/Regional,Bavaria,Bavaria,,,,,,Upper Bavaria/The Alps,Krankenhaus Barmherzige Brüder Regensburg,,,,,,,,"Klinik und Poliklinik für Kinder- und Jugendmedizin der Universität Regensburg (KUNO), Klinik St. Hedwig, Krankenhaus Barmherzige Brüder Regensburg",,,Cross sectional,Persons seeking care for non-COVID reasons,Children and adolescents who attended routine checkups in pediatric offices and children and adolescents with possible COVID-19 symptoms/contacts,General population,Children/adolescents ≤18 years,14,1,Convenience sample,Participants,,,2020-05-22,2020-07-22,,,,,,"Seroprevalence among children and adolescents, attending routine checkups in pediatric offices in Upper Bavaria and the Alps region",https://www.frontiersin.org/articles/10.3389/fped.2021.678937/full,2020-12-12,Peer-reviewed Publikation,whole blood,multiple,Multiple antibodies,Mehrere/andere,ROCHE N,In-house ELISA,,,,,,"ROCHE, In-house ELISA",,,,0.018,,,,2021-10-17,
Corona-Virus bei Kindern in Bayern (CoKiBa),Local/Regional,Bavaria,Tirschenreuth,,,,,,Tirschenreuth,Krankenhaus Barmherzige Brüder Regensburg,,,,,,,,"Klinik und Poliklinik für Kinder- und Jugendmedizin der Universität Regensburg (KUNO), Klinik St. Hedwig, Krankenhaus Barmherzige Brüder Regensburg",,,Cross sectional,Persons seeking care for non-COVID reasons,Children and adolescents who attended routine checkups in pediatric offices and children and adolescents with possible COVID-19 symptoms/contacts,General population,Children/adolescents ≤18 years,18,1,Convenience sample,Participants,,,2020-05-22,2020-07-22,,,,,,"Seroprevalence amoong children and adolescents with possible COVID-19 symptoms/contacts in Tirschenreugth, who were interested in taking part in the CoKiBa study",https://www.frontiersin.org/articles/10.3389/fped.2021.678937/full,2020-12-12,Peer-reviewed Publikation,whole blood,multiple,Multiple antibodies,Mehrere/andere,ROCHE N,In-house ELISA,,,,,,"ROCHE, In-house ELISA",,,,0.159,,,,2021-10-17,
Corona-Virus bei Kindern in Bayern (CoKiBa),Local/Regional,Bavaria,Regensburg,,,,,,Regensburg,Krankenhaus Barmherzige Brüder Regensburg,,,,,,,,"Klinik und Poliklinik für Kinder- und Jugendmedizin der Universität Regensburg (KUNO), Klinik St. Hedwig, Krankenhaus Barmherzige Brüder Regensburg",,,Cross sectional,Persons seeking care for non-COVID reasons,Children and adolescents who attended routine checkups in pediatric offices and children and adolescents with possible COVID-19 symptoms/contacts,General population,Children/adolescents ≤18 years,18,1,Convenience sample,Participants,,,2020-05-22,2020-07-22,,,,,,"Seroprevalence amoong children and adolescents with possible COVID-19 symptoms/contacts in Regensburg, who were interested in taking part in the CoKiBa study",https://www.frontiersin.org/articles/10.3389/fped.2021.678937/full,2020-12-12,Peer-reviewed Publikation,whole blood,multiple,Multiple antibodies,Mehrere/andere,ROCHE N,In-house ELISA,,,,,,"ROCHE, In-house ELISA",,,,0.023,,,,2021-10-17,
Corona-Virus bei Kindern in Bayern (CoKiBa),Local/Regional,Bavaria,Bavaria,,,,,,Upper Bavaria/The Alps,Krankenhaus Barmherzige Brüder Regensburg,,,,,,,,"Klinik und Poliklinik für Kinder- und Jugendmedizin der Universität Regensburg (KUNO), Klinik St. Hedwig, Krankenhaus Barmherzige Brüder Regensburg",,,Cross sectional,Persons seeking care for non-COVID reasons,Children and adolescents who attended routine checkups in pediatric offices and children and adolescents with possible COVID-19 symptoms/contacts,General population,Children/adolescents ≤18 years,18,1,Convenience sample,Participants,,,2020-05-22,2020-07-22,,,,,,"Seroprevalence amoong children and adolescents with possible COVID-19 symptoms/contacts in Upper Bavaria and the Alps region, who were interested in taking part in the CoKiBa study",https://www.frontiersin.org/articles/10.3389/fped.2021.678937/full,2020-12-12,Peer-reviewed Publikation,whole blood,multiple,Multiple antibodies,Mehrere/andere,ROCHE N,In-house ELISA,,,,,,"ROCHE, In-house ELISA",,,,0.078,,,,2021-10-17,
COVID-19: Hotspot hospital?- Epidemiological analysis time shifted antibody tests of hospital employees,Local/Regional,North Rhine-Westphalia,Datteln,Waltrop,,,,,Datteln and Waltrop,St. Vincenz Krankenhaus Datteln,,,,,,,,St. Vincenz Krankenhaus Datteln,https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022941,,Cross sectional and selective longitudinal,Healthcare workers and caregivers,"Employees of three peripheral hospital providing basic and standard care, as well as from the local fire brigade",Selected population groups,Adults,65,18,Convenience sample,Participants,1842,1800,2020-06-15,2021-06-15,https://doi.org/10.1016/j.ijheh.2021.113771,https://doi.org/10.3390/ijerph19042402,,,,,,,,,,,,,,,,,,,,,,,,,,,2022-03-23,
Infection with SARS-CoV2 in primary care health care workers assessed by antibody testing,Local/Regional,Bavaria,Dachau,Fürstenfeldbruck,Munich,,,,"District of Dachau, Fürstenfeldbruck and Munich",Ludwig-Maximilians-Universität (LMU) München,"Medizinisches Versorgungszentrum Dachau, München",Labor Augsburg MVZ GmbH,Medizinische Klinik und Poliklinik I der Ludwigs-Maximilians-Universität (LMU),,,,,"Medizinische Klinik und Poliklinik I der Ludwig-Maximilians-Universität (LMU) München; Medizinisches Versorgungszentrum Dachau, München; Labor Augsburg MVZ GmbH",,,Cross sectional,Healthcare workers and caregivers,"Medical staff (physicians, medical assistants) of the MVZ Dachau",Selected population groups,Adults,,18,Convenience sample,Participants,151,200,2020-04-02,2020-04-06,https://doi.org/10.1093/fampra/cmaa078,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Seroprevalence of SARS CoV-2 infections/Covid-19 in blood donors and patients of the University Hospitals in Leipzig (CovSeroUKL),Local/Regional,Saxony,Leipzig,,,,,,Leipzig,"Universitätsklinikum Leipzig, Institut für Medizinische Mikrobiologie und Virologie","Universitätsklinikum Leipzig, Institut für Transfusionsmedizin","Universitätsklinikum Leipzig, Institut für Laboratoriumsmedizin","Universitätsklinikum Leipzig, Neurologische Klinik und Poliklinik",Universitätsklinikum Leipzig,,,,"Institut für Medizinische Mikrobiologie und Virologie, Institut für Transfusionsmedizin, Institut für Laboratoriumsmedizin, Neurologische Klinik und Poliklinik, Universitätsklinikum Leipzig",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00023364,,Repeated cross-sectional,Blood donors and non-COVID-patients,Blood donors and patients of the University Hospital who have had blood serum drawn for a medical examination,Selected population groups,Adults,,18,Convenience sample,Participants,,2000,2020-06-20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Determination of SARS-CoV2 Antibody Prevalence in Pediatric Patients (SARS-CoV2_KIDS),Local/Regional,Bavaria,Erlangen,,,,,,Erlangen,"University of Erlangen-Nürnberg Medical School, Children and Youth Clinic",University of Erlangen-Nürnberg Medical School,"Friedrich-Alexander-Universität Erlangen-Nürnberg ",,,,,,"Children and Youth Clinic, University of Erlangen-Nürnberg Medical School",https://clinicaltrials.gov/ct2/show/NCT04581148,,Repeated cross-sectional,Persons seeking care for non-COVID reasons,"Inpatients and outpatients of the Children and Youth Clinic, University of Erlangen-Nürnberg Medical School",Selected population groups,Children/adolescents ≤18 years,17,0,Entire sample,Participants,872,900,2020-10-16,2020-11-16,,,,,,"Seroprevalence of antibodies against the spike protein among children and adolescents, who presented themselves during the period of October to November 2020 at the department of pediatrics and adolescent medicine of the University Hospital Erlangen for non-COVID reasons",https://doi.org/10.1515/cclm-2022-0037,2022-02-25,Peer-reviewed Publikation,blood plasma,anti -S1 domain,Total antibody,Elektrochemolumineszenz (ECL)-Immunassay; LIPS,ROCHE S,,,,,,,ROCHE S,,,,0.0138,,,2022-03-15,,5.66
Determination of SARS-CoV2 Antibody Prevalence in Pediatric Patients (SARS-CoV2_KIDS),Local/Regional,Bavaria,Erlangen,,,,,,Erlangen,"University of Erlangen-Nürnberg Medical School, Children and Youth Clinic",University of Erlangen-Nürnberg Medical School,"Friedrich-Alexander-Universität Erlangen-Nürnberg ",,,,,,"Children and Youth Clinic, University of Erlangen-Nürnberg Medical School",https://clinicaltrials.gov/ct2/show/NCT04581148,,Repeated cross-sectional,Persons seeking care for non-COVID reasons,"Inpatients and outpatients of the Children and Youth Clinic, University of Erlangen-Nürnberg Medical School",Selected population groups,Children/adolescents ≤18 years,17,0,Entire sample,Participants,808,800,2021-04-01,2021-04-30,,,,,,"Seroprevalence of antibodies against the spike protein among children and adolescents, who presented themselves during April 2021 at the department of pediatrics and adolescent medicine of the University Hospital Erlangen for non-COVID reasons",https://doi.org/10.1515/cclm-2022-0037,2022-02-25,Peer-reviewed Publikation,blood plasma,anti -S1 domain,Total antibody,Elektrochemolumineszenz (ECL)-Immunassay; LIPS,ROCHE S,,,,,,,ROCHE S,,,,0.0916,,,2022-03-15,,4.35
Determination of SARS-CoV2 Antibody Prevalence in Pediatric Patients (SARS-CoV2_KIDS),Local/Regional,Bavaria,Erlangen,,,,,,Erlangen,"University of Erlangen-Nürnberg Medical School, Children and Youth Clinic",University of Erlangen-Nürnberg Medical School,"Friedrich-Alexander-Universität Erlangen-Nürnberg ",,,,,,"Children and Youth Clinic, University of Erlangen-Nürnberg Medical School",https://clinicaltrials.gov/ct2/show/NCT04581148,,Repeated cross-sectional,Persons seeking care for non-COVID reasons,"Inpatients and outpatients of the Children and Youth Clinic, University of Erlangen-Nürnberg Medical School",Selected population groups,Children/adolescents ≤18 years,17,0,Entire sample,Participants,946,900,2021-06-15,2021-07-15,,,,,,"Seroprevalence of antibodies against the spike protein among children and adolescents, who presented themselves during the period of June to July 2021 at the department of pediatrics and adolescent medicine of the University Hospital Erlangen for non-COVID reasons",https://doi.org/10.1515/cclm-2022-0037,2022-02-25,Peer-reviewed Publikation,blood plasma,anti -S1 domain,Total antibody,Elektrochemolumineszenz (ECL)-Immunassay; LIPS,ROCHE S,,,,,,,ROCHE S,,,,0.1459,,,2022-03-15,,3.93
Determination of SARS-CoV2 Antibody Prevalence in Pediatric Patients (SARS-CoV2_KIDS),Local/Regional,Bavaria,Erlangen,,,,,,Erlangen,"University of Erlangen-Nürnberg Medical School, Children and Youth Clinic",University of Erlangen-Nürnberg Medical School,"Friedrich-Alexander-Universität Erlangen-Nürnberg ",,,,,,"Children and Youth Clinic, University of Erlangen-Nürnberg Medical School",https://clinicaltrials.gov/ct2/show/NCT04581148,,Repeated cross-sectional,Persons seeking care for non-COVID reasons,"Inpatients and outpatients of the Children and Youth Clinic, University of Erlangen-Nürnberg Medical School",Selected population groups,Children/adolescents ≤18 years,17,0,Entire sample,Participants,872,900,2020-10-16,2020-11-16,,,,,,"Seroprevalence of antibodies against the nucleocapsid among children and adolescents, who presented themselves during the period of October to November 2020 at the department of pediatrics and adolescent medicine of the University Hospital Erlangen for non-COVID reasons",https://doi.org/10.1515/cclm-2022-0037,2022-02-25,Peer-reviewed Publikation,blood plasma,anti Nucleocapsid,Total antibody,Elektrochemolumineszenz (ECL)-Immunassay; LIPS,ROCHE N,,,,,,,ROCHE N,,,,0.0126,,,2022-03-15,,
Determination of SARS-CoV2 Antibody Prevalence in Pediatric Patients (SARS-CoV2_KIDS),Local/Regional,Bavaria,Erlangen,,,,,,Erlangen,"University of Erlangen-Nürnberg Medical School, Children and Youth Clinic",University of Erlangen-Nürnberg Medical School,"Friedrich-Alexander-Universität Erlangen-Nürnberg ",,,,,,"Children and Youth Clinic, University of Erlangen-Nürnberg Medical School",https://clinicaltrials.gov/ct2/show/NCT04581148,,Repeated cross-sectional,Persons seeking care for non-COVID reasons,"Inpatients and outpatients of the Children and Youth Clinic, University of Erlangen-Nürnberg Medical School",Selected population groups,Children/adolescents ≤18 years,17,0,Entire sample,Participants,808,800,2021-04-01,2021-04-30,,,,,,"Seroprevalence of antibodies against the nucleocapsid among children and adolescents, who presented themselves during April 2021 at the department of pediatrics and adolescent medicine of the University Hospital Erlangen for non-COVID reasons",https://doi.org/10.1515/cclm-2022-0037,2022-02-25,Peer-reviewed Publikation,blood plasma,anti Nucleocapsid,Total antibody,Elektrochemolumineszenz (ECL)-Immunassay; LIPS,ROCHE N,,,,,,,ROCHE N,,,,0.0619,,,2022-03-15,,
Determination of SARS-CoV2 Antibody Prevalence in Pediatric Patients (SARS-CoV2_KIDS),Local/Regional,Bavaria,Erlangen,,,,,,Erlangen,"University of Erlangen-Nürnberg Medical School, Children and Youth Clinic",University of Erlangen-Nürnberg Medical School,"Friedrich-Alexander-Universität Erlangen-Nürnberg ",,,,,,"Children and Youth Clinic, University of Erlangen-Nürnberg Medical School",https://clinicaltrials.gov/ct2/show/NCT04581148,,Repeated cross-sectional,Persons seeking care for non-COVID reasons,"Inpatients and outpatients of the Children and Youth Clinic, University of Erlangen-Nürnberg Medical School",Selected population groups,Children/adolescents ≤18 years,17,0,Entire sample,Participants,946,900,2021-06-15,2021-07-15,,,,,,"Seroprevalence of antibodies against the nucleocapsid among children and adolescents, who presented themselves during the period of June to July 2021 at the department of pediatrics and adolescent medicine of the University Hospital Erlangen for non-COVID reasons",https://doi.org/10.1515/cclm-2022-0037,2022-02-25,Peer-reviewed Publikation,blood plasma,anti Nucleocapsid,Total antibody,Elektrochemolumineszenz (ECL)-Immunassay; LIPS,ROCHE N,,,,,,,ROCHE N,,,,0.0856,,,2022-03-15,,
Determination of SARS-CoV2 Antibody Prevalence in Pediatric Patients (SARS-CoV2_KIDS),Local/Regional,Bavaria,Erlangen,,,,,,Erlangen,"University of Erlangen-Nürnberg Medical School, Children and Youth Clinic",University of Erlangen-Nürnberg Medical School,"Friedrich-Alexander-Universität Erlangen-Nürnberg ",,,,,,"Children and Youth Clinic, University of Erlangen-Nürnberg Medical School",https://clinicaltrials.gov/ct2/show/NCT04581148,,Repeated cross-sectional,Persons seeking care for non-COVID reasons,"Inpatients and outpatients of the Children and Youth Clinic, University of Erlangen-Nürnberg Medical School",Selected population groups,Children/adolescents ≤18 years,17,,Entire sample,Participants,2626,2600,2020-10-15,2021-07-15,https://www.degruyter.com/document/doi/10.1515/cclm-2022-0037/html,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Prevalence of Severe Acute Respiratory Syndrome Coronavirus-2-specific Antibodies in German Blood Donors during the COVID-19 Pandemic,Local/Regional,Rhineland-Palatinate,Rhine-Main area,,,,,,Rhineland-Palatinate and Rhine-Main area,Johannes Gutenberg Universität Mainz,,,,,,,,"Universitätsmedizin der Johannes Gutenberg Universität Mainz, Transfusionszentrale",,,Repeated cross-sectional,Blood donors,Blood donors from Rhineland-Palatinate and the Rhine-Main region,General population,Adults,71,18,Blood donation,Participants,3880,3900,2020-03-15,2020-06-15,https://doi.org/10.7754/clin.lab.2020.200915,,,,,Seroprevalence among blood donors from Rhineland-Palatinate and the Rhine-Main region for the period from March to June 2020,https://doi.org/10.7754/clin.lab.2020.200915,2020-10-01,Peer-reviewed Publikation,whole blood,anti Nucleocapsid,IgG,Mehrere/andere,ABBOTT N,ROCHE,,,,,,"ABBOTT N, ROCHE",Adjusted for test-specificity/test-sensitivity,,,0.0039,,,2021-08-06,2021-10-17,
COVID Study on Educational Personnel (COVID-STEP),Local/Regional,Schleswig-Holstein,Lübeck,,,,,,Lübeck,Gesundheitsamt der Hansestadt Lübeck,,,,,,,,Gesundheitsamt der Hansestadt Lübeck,,https://www.luebeck.de/covid-step,Repeated cross-sectional,"School, Kindergarten/Daycare",Teachers and educators of schools and day care centers,Selected population groups,Adults,,18,Convenience sample,Participants,,1500,2020-06-29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Longitudinal SARS-CoV-2-infection study with medical and dental students at Ulm University (COVID-19 MedStud Ulm),Local/Regional,Baden-Wuerttemberg,Ulm,,,,,,Ulm,Universität Ulm,,,,,,,,Institut für Anatomie und Zellbiologie und Medizinisches Dekanat der Universität Ulm,https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00024860,,Cross sectional,Students,Students and teachers of medicine and dentistry,Selected population groups,Adults,,18,Convenience sample,Participants,868,900,2020-11-05,,https://doi.org/10.1101/2021.05.04.21256382,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
COVID-19 Infection Rate in the Construction- and Cleaning Industry,Local/Regional,Multilocal,Germany,,,,,,"15 centres of occupational medicine, nationwide",Arbeitsmedizinischer Dienst der Berufsgenossenschaft für Bauwirtschaft GmbH,,,,,,,,Arbeitsmedizinischer Dienst der Berufsgenossenschaft für Bauwirtschaft GmbH,https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00024860,,Cross sectional,Non-essential workers and unemployed persons,Employees in the construction and cleaning trades who attend an occupational health screening appointment,Selected population groups,Adults,,18,Convenience sample,Participants,,3000,2020-11-20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"Screening for COVID-19 in Teachers, Childcare Educators, Pupils and Preschoolers (COKITS)",Local/Regional,Mecklenburg-Western Pomerania,Greifswald,,,,,,Western Pomerania - Greifswald,Universitätsmedizin Greifswald,Friedrich-Loeffler-Institut,Friedrich-Loeffler-Institut für Medizinische Mikrobiologie,"Friedrich-Loeffler-Institut, Zentralbereich Hygiene",,,,,"Universitätsmedizin Greifswald, Friedrich-Loeffler-Institut für Medizinische Mikrobiologie und Zentralbereich Hygiene",https://clinicaltrials.gov/ct2/show/NCT04619407,http://www2.medizin.uni-greifswald.de/mikrobio/index.php?id=556,Longitudinal/Prospectice cohort study,"School, Kindergarten/Daycare","Pedagogical staff, daycare children and students in the district of Vorpommern-Greifswald",General population,Multiple,67,3,Convenience sample,Participants,142,100,2020-11-04,2021-03-26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"SARS-CoV-2 IgG-Screening bei asymptomatischen ambulanten Patienten ",Local/Regional,North Rhine-Westphalia,Bochum,,,,,,Bochum,"Innere Medizin und Labormedizin; Prof. Dr. Herrmann, Bochum",,,,,,,,"Innere Medizin und Labormedizin; Prof. Dr. Herrmann, Bochum",,,Cross sectional,Persons seeking care for non-COVID reasons,Asymptomatic patients in an outpatient medical practice,Selected population groups,Multiple,78,10,Convenience sample,Participants,415,400,2020-03-26,2020-06-04,https://dx.doi.org/10.1007%2Fs15006-020-0750-y,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"Assessment, Surveillance and Testing in Students' Accommodations (SARS-CoV-2 ASTA)",Local/Regional,North Rhine-Westphalia,Bochum,,,,,,Bochum,Ruhr-Universität Bochum,St. Josef Hospital Bochum,"Medizinische Klinik I, Ruhr-Universität Bochum","Abteilung für medizinische Informatik, Biometrie und Epidemiologie, Ruhr-Universität Bochum","Abteilung für Molekulare und Medizinische Virologie, Ruhr-Universität Bochum",,,,"Ruhr-Universität Bochum, St. Josef Hospital Bochum, Medizinische Klinik I, Abteilung für medizinische Informatik, Biometrie und Epidemiologie, Abteilung für Molekulare und Medizinische Virologie",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00024143,https://news.rub.de/presseinformationen/wissenschaft/2020-10-13-covid-19-forschung-studie-zum-ansteckungsrisiko-von-studierenden-mit-sars-cov-2,Repeated cross-sectional,Students,Students in living in student halls,Selected population groups,Adults,39,18,Convenience sample,Participants,810,800,2020-11-02,2021-02-15,https://doi.org/10.3390/covid1010029,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"Prospective Longitudinal Serosurvey of Health Care Workers in the First Wave of the SARS-CoV-2 Pandemic in a Quaternary Care Hospital in Munich, Germany",Local/Regional,Bavaria,Munich,,,,,,Munich,Ludwig-Maximilians-Universität (LMU) München,,,,,,,,Ludwigs-Maximilians-Universität München,,,Longitudinal/Prospectice cohort study,Healthcare workers and caregivers,Employees from four different organizational units of the hospital,Selected population groups,Adults,69,18,Convenience sample,Participants,300,300,2020-03-24,2020-07-07,https://doi.org/10.1093/cid/ciaa1935,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"Serokonversion gegen SARS-CoV-2 bei Beschäftigten in ambulanten Pflegeeinrichtungen: Inzidenz, Klinik und Risikofaktoren",Local/Regional,Hamburg,Hamburg,,,,,,Hamburg,"Universitätsklinikum Hamburg-Eppendorf, Competenzzentrum Epidemiologie und Versorgungsforschung bei Pflegeberufen (CVcare)","Universitätsklinikum Hamburg-Eppendorf, Zentralinstitut für Arbeitsmedizin und Maritime Medizin",Universitätsklinikum Hamburg-Eppendorf (UKE),,,,,,"Competenzzentrum Epidemiologie und Versorgungsforschung bei Pflegeberufen (CVcare) und Zentralinstitut für Arbeitsmedizin und Maritime Medizin, Universitätsklinikum Hamburg-Eppendorf",,https://www.uke.de/kliniken-institute/institute/versorgungsforschung-in-der-dermatologie-und-bei-pflegeberufen/bereiche/cvcare/cvcare-projektseite.html,Longitudinal/Prospectice cohort study,Healthcare workers and caregivers,Employees in outpatient care services,Selected population groups,Adults,,18,Convenience sample,Participants,,600,2020-06-15,2021-08-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Analyzing the incidence of SARS-Cov-2 infected children and teenager in Western Pomerania,Local/Regional,Mecklenburg-Western Pomerania,Western Pomerania,,,,,,Western Pomerania,Universitätsmedizin Greifswald,Kinderportalpraxisklinik Wolgast,Asklepios Klinik Pasewalk,Sana Krankenhaus Rügen Bergen,Helios Hanseklinikum Stralsund,Kreiskrankenhaus Demmin,Ameos Klinikum Anklam,University Medicine Greifswald,Klinik und Poliklinik für Kinder- und Jugenmedizin der Universitätsmedizin Greifswald; Kinderportalpraxisklinik Wolgast; Klinik für Kinder- und Jugendmedizin der Asklepios Klinik Pasewalk; Kinderklinik Sana Krankenhaus Rügen Bergen; Klinik für Kinder- und Jugendmedizin Helios Hanseklinikum Stralsund; Klinik für Kinder- und Jugendmedizin Kreiskrankenhaus Demmin; Klinik für Kinder- und Jugendmedizin Ameos Klinikum Anklam,https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00024635,,Repeated cross-sectional,Persons seeking care for non-COVID reasons,Children and adolescents treated on an outpatient basis in the children's hospitals and medical practices of Western Pomerania,Selected population groups,Children/adolescents ≤18 years,17,1,Convenience sample,Participants,,4000,2020-12-10,,"https://www.ndr.de/nachrichten/mecklenburg-vorpommern/Corona-Studie-Die-meisten-Jugendlichen-haben-Antikoerper,coronazahlen1848.html",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Study to investigate the risk of Corona infection (COVID-19) in local public transport,Local/Regional,Hesse,Rhine-Main area,,,,,,Rhine-Main area,Charité Research Organisation GmbH,INFRA DIALOG Deutschland GmbH,,,,,,,Charité Research Organisation GmbH/ INFRA DIALOG Deutschland GmbH,https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00024104,,Longitudinal/Prospectice cohort study,Travellers in public transport and other travellers,Commuters who use public transport or a private vehicle,Selected population groups,Multiple,65,16,Convenience sample,Participants,,800,2020-02-15,2021-04-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Freder1k-Studie: Typ-1-Diabetes-Risiko früh erkennen,Local/Regional,Bavaria,Bavaria,,,,,,Bavaria,"Helmholtz Zentrum München, Institut für Diabetesforschung",Helmholtz Zentrum München,,,,,,,"Institut für Diabetesforschung, Helmholtz Zentrum München",,,Repeated cross-sectional,Household and Community Samples,Participating infants of the Freder1k study (cohort of infants for early detection of type 1 diabetes),General population,Children/adolescents ≤18 years,1,0,Cohort-sample - Sampling from existing cohort study in the general population,Participants,1916,1900,2020-04-15,2020-06-15,https://doi.org/10.1016/j.medj.2020.10.003,,,,,Total seroprevalence of participating infants of the Freder1k study (cohort of infants for early detection of type 1 diabetes) for the period from April to June 2020,https://doi.org/10.1016/j.medj.2020.10.003,2021-02-12,Peer-reviewed Publikation,capillary blood,multiple,Total antibody,Elektrochemolumineszenz (ECL)-Immunassay; LIPS,Author designed,,,,,,,Author designed,,0.973,1,0.0047,,,,2021-10-17,
Freder1k-Studie: Typ-1-Diabetes-Risiko früh erkennen,Local/Regional,Bavaria,Bavaria,,,,,,Bavaria,"Helmholtz Zentrum München, Institut für Diabetesforschung",Helmholtz Zentrum München,,,,,,,"Institut für Diabetesforschung, Helmholtz Zentrum München",,,Cross sectional,Household and Community Samples,Participating infants of the Freder1k study (cohort of infants for early detection of type 1 diabetes) April 2020,General population,Children/adolescents ≤18 years,1,0,Cohort-sample - Sampling from existing cohort study in the general population,Participants,757,800,2020-04-15,2020-04-30,,,,,,Seroprevalence of participating infants of the Freder1k study (cohort of infants for early detection of type 1 diabetes) for the period of April 2020,https://doi.org/10.1016/j.medj.2020.10.003,2021-02-12,Peer-reviewed Publikation,capillary blood,multiple,Total antibody,Elektrochemolumineszenz (ECL)-Immunassay; LIPS,Author designed,,,,,,,Author designed,,0.973,1,0.0013,0,0.0073,2021-09-24,2021-10-17,
Freder1k-Studie: Typ-1-Diabetes-Risiko früh erkennen,Local/Regional,Bavaria,Bavaria,,,,,,Bavaria,"Helmholtz Zentrum München, Institut für Diabetesforschung",Helmholtz Zentrum München,,,,,,,"Institut für Diabetesforschung, Helmholtz Zentrum München",,,Cross sectional,Household and Community Samples,Participating infants of the Freder1k study (cohort of infants for early detection of type 1 diabetes) May 2020,General population,Children/adolescents ≤18 years,1,0,Cohort-sample - Sampling from existing cohort study in the general population,Participants,784,800,2020-05-15,2020-05-15,,,,,,Seroprevalence of participating infants of the Freder1k study (cohort of infants for early detection of type 1 diabetes) for the period of May 2020,https://doi.org/10.1016/j.medj.2020.10.003,2021-02-12,Peer-reviewed Publikation,capillary blood,multiple,Total antibody,Elektrochemolumineszenz (ECL)-Immunassay; LIPS,Author designed,,,,,,,Author designed,,0.973,1,0.0038,0.0008,0.0111,2021-09-24,2021-10-17,
Freder1k-Studie: Typ-1-Diabetes-Risiko früh erkennen,Local/Regional,Bavaria,Bavaria,,,,,,Bavaria,"Helmholtz Zentrum München, Institut für Diabetesforschung",Helmholtz Zentrum München,,,,,,,"Institut für Diabetesforschung, Helmholtz Zentrum München",,,Cross sectional,Household and Community Samples,Participating infants of the Freder1k study (cohort of infants for early detection of type 1 diabetes) June 2020,General population,Children/adolescents ≤18 years,1,0,Cohort-sample - Sampling from existing cohort study in the general population,Participants,375,400,2020-06-15,2020-06-30,,,,,,Seroprevalence of participating infants of the Freder1k study (cohort of infants for early detection of type 1 diabetes) for the period of June 2020,https://doi.org/10.1016/j.medj.2020.10.003,2021-02-12,Peer-reviewed Publikation,capillary blood,multiple,Total antibody,Elektrochemolumineszenz (ECL)-Immunassay; LIPS,Author designed,,,,,,,Author designed,,0.973,1,0.0133,0.0043,0.0308,2021-09-24,2021-10-17,
SARS-CoV-2 seroconversions and chains of infection in healthcare professionals in a German maximum care provider (The CoSHeP study),Local/Regional,North Rhine-Westphalia,Bonn,,,,,,Bonn,Universitätsklinikum Bonn,"Universitätsklinikum Bonn, Medizinische Klinik I","Universitätsklinikum Bonn, Infektiologische Ambulanz",,,,,,"Universitätsklinikum Bonn, Medizinische Klinik I, Infektiologische Ambulanz",,,Longitudinal/Prospectice cohort study,Healthcare workers and caregivers,"Employees from emergency room, internal medicine intensive care unit, infectious diseases ward, and infectious diseases outpatient clinic",Selected population groups,Adults,68,19,Convenience sample,Participants,150,200,2020-05-15,2021-01-15,https://doi.org/10.1007/s15010-021-01641-6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Bicentric exploratory healthcare worker cohort study in two centers of a medical school in the federal state of Brandenburg in Germany (Test-SARS-CoV-2-BB),Local/Regional,Brandenburg,Brandenburg/Havel,Neuruppin,,,,,Brandenburg/Havel and Neuruppin,Brandenburg Medical School Theodor Fontane,,,,,,,,Brandenburg Medical School Theodor Fontane,,,Longitudinal/Prospectice cohort study,Healthcare workers and caregivers,Health care workers of the University Hospital in Brandenburg/Havel and Neuruppin,Selected population groups,Adults,65,19,Convenience sample,Participants,1013,1000,2020-03-30,2020-04-07,https://doi.org/10.3390/healthcare9050498,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SARS-CoV-2 Seroprevalence among Health Care Workers—A Voluntary Screening Study in a Regional Medical Center in Southern Germany,Local/Regional,Baden-Wuerttemberg,Ortenaukreis,,,,,,Ortenaukreis,Bundeswehr Institute of Microbiology in Munich,,,,,,,,Bundeswehr Institute of Microbiology in Munich,,,Cross sectional,Healthcare workers and caregivers,"Medical staff with direct contact to laboratory-confirmed COVID-19 patients from the Ortenau-Klinikum Offenburg, from various medical practices and from a pharmacy in the region",Selected population groups,Adults,,18,Convenience sample,Participants,198,200,2020-04-02,2020-04-08,https://doi.org/10.3390/ijerph18083910,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"SARS‑CoV‑2 seroprevalence among healthcare workers at children’s hospital ",Local/Regional,Hamburg,Hamburg,,,,,,"Hamburg, Altona","Altona Children’s Hospital, Universität Hamburg",,,,,,,,"Altona Children’s Hospital, Universität Hamburg",,,Cross sectional,Healthcare workers and caregivers,Employees of the Altona Children’s Hospital,Selected population groups,Adults,,18,Convenience sample,Participants,616,600,2020-08-19,2020-09-18,https://doi.org/10.1007/s12519-021-00447-8,,,,,,,,,,,,,,,,,,,,,,,,,,,2021-09-02,,
All-Corona-Care-Studie (ACC-Studie),Local/Regional,Bavaria,Munich,,,,,,Munich,Max von Pettenkofer-Institut,Ludwig-Maximilians-Universität (LMU) München,Medizinische Klinik und Poliklinik I der Ludwigs-Maximilians-Universität (LMU),,,,,,"Max von Pettenkofer-Institut, Medizinische Klinik und Poliklinik I der Ludwigs-Maximilians-Universität (LMU) München",,https://www.lmu-klinikum.de/aktuelles/pressemitteilungen/grosse-all-corona-care-studie-am-lmu-klinikum/7f18eb645e957774,Cross sectional,Healthcare workers and caregivers,Employees of the Ludwig-Maximilians Universität (LMU) Munich,Selected population groups,Adults,,,Convenience sample,Participants,7554,7600,2020-05-27,2020-08-12,https://doi.org/10.1007/s15010-021-01672-z,,,,,,,,,,,,,,,,,,,,,,,,,,,2021-10-04,,
The occurrence of psychosocial stress related to the COVID-19 pandemic and SARS-CoV-2 prevalence in care facilities,Local/Regional,Baden-Wuerttemberg,Ulm,Alb-Donau-Kreis,,,,,"Ulm, Alb-Donau-Kreis",Universitätsklinikum Ulm,,,,,,,,Universitätsklinikum Ulm,,,Cross sectional,Assisted living and long-term care facilities,Employees and residents from 7 care facilities in the Alb-Donau region and in the city of Ulm,Selected population groups,Adults,104,17,Convenience sample,Participants,494,500,2020-07-27,2020-08-25,https://doi.org/10.1007/s00391-021-01931-6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Covid-19-Antibody-Level-Monitoring-Universitätsklinikum Augsburg (CALM-UKA),Local/Regional,Bavaria,Augsburg,,,,,,Augsburg,Universitätsklinikum Augsburg,,,,,,,,Universitätsklinikum Augsburg,,,Longitudinal/Prospectice cohort study,Healthcare workers and caregivers,Employees of the Universitätsklinikum Augsburg,Selected population groups,Adults,82,17,Convenience sample,Participants,,1500,2021-01-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Low incidence of SARS-CoV-2 infections in healthcare workers at a tertiary care hospital,Local/Regional,Bavaria,Regensburg,,,,,,Regensburg,University Hospital Regensburg,,,,,,,,University Hospital Regensburg,,,Longitudinal/Prospectice cohort study,Healthcare workers and caregivers,Employees with contact to  COVID-19 patients and treating COVID-19 patients,Selected population groups,Adults,,18,Convenience sample,Participants,205,200,2020-03-15,2021-02-15,https://doi.org/10.1007/s00063-021-00890-5,,,,,,,,,,,,,,,,,,,,,,,,,,,,2022-02-01,
Prevalence of SARS-CoV-2 IgG antibodies among dental teams in Germany,Local/Regional,Multilocal,Berlin,Hamburg,Dresden,Stuttgart,Cologne,Düsseldorf,"Berlin, Hamburg, Dresden, Stuttgart, Cologne/Düsseldorf","University Medicine Greifswald, Department of Oral and Maxillofacial Surgery/Plastic Surgery",University Medicine Greifswald,Universitätsmedizin Greifswald,,,,,,"Department of Oral and Maxillofacial Surgery/Plastic Surgery, University Medicine Greifswald",,,Cross sectional,Healthcare workers and caregivers,"Employees and Employers of Dentistries in Berlin, Hamburg, Dresden, Stuttgart, and Cologne/Düsseldorf",Selected population groups,Adults,,,Convenience sample,Medical practices with participants,2784,2800,2021-01-15,2021-04-15,https://doi.org/10.1007/s00784-021-04363-z,,,,,,,,,,,,,,,,,,,,,,,,,,,2022-01-27,2022-02-01,
Combined Prospective Seroconversion and PCR Data of Selected Cohorts Indicate a High Rate of Subclinical SARS-CoV-2 Infections,Local/Regional,Lower Saxony,Hannover,Göttingen,,,,,"Hannover, Göttingen",Leibniz University Hannover,,,,,,,,"Institute for Technical Chemistry, Leibniz University Hannover",,,Repeated cross-sectional,Other groups,"Employees out of universities, schools, city administration of Hannover, theater, employees from a
biotechnological company in Goettingen, and residents and employees of two nursing homes in Hannover",Selected population groups,Multiple,104,15,Convenience sample,Participants,1883,1900,2020-04-15,2020-11-15,https://doi.org/10.1128/spectrum.01512-21,,,,,,,,,,,,,,,,,,,,,,,,,,,2022-03-15,,
Cumulative Incidence of SARS-CoV-2 in Healthcare Workers at a General Hospital in Germany during the Pandemic—A Longitudinal Analysis,Local/Regional,North Rhine-Westphalia,Eschweiler,,,,,,Eschweiler,St. Antonius Hospital Eschweiler,,,,,,,,"Clinik for Acute and Emergency Medicine, St. Antonius Hospital Eschweiler",,,Longitudinal/Prospectice cohort study,Healthcare workers and caregivers,Medical staff of the St. Antonius hospital in Eschweiler,Selected population groups,Adults,75,18,Convenience sample,Participants,1212,1200,2020-04-15,2021-04-15,https://doi.org/10.1183/13993003.congress-2021.PA3187,https://doi.org/10.3390/ijerph19042429,,,,,,,,,,,,,,,,,,,,,,,,,,,2022-05-10,
Prevalence of COVID-19 in children in Baden-Württemberg - Sample A,Local/Regional,Baden-Wuerttemberg,Heidelberg,Ulm,Freiburg,Tübingen,,,"Heidelberg, Ulm, Freiburg, Tübingen",Universitätsklinikum Heidelberg,Universitätsklinikum Freiburg,Universitätsklinikum Ulm,Universitätsklinikum Tübingen,"Zentrum für Infektionskrankheiten und Zentrum für Kinder- und Jugendmedizin, Universitätsklinikum Heidelberg","Centrum für Chronische Immundefizienz im Zentrum für Translationale Zellforschung, Universitätsklinikum Freiburg","Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Ulm","Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Tübingen","Zentrum für Infektionskrankheiten und Zentrum für Kinder- und Jugendmedizin, Universitätsklinikum Heidelberg; Centrum für Chronische Immundefizienz im Zentrum für Translationale Zellforschung, Universitätsklinikum Freiburg; Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Ulm; Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Tübingen",,,Cross sectional,Household and Community Samples,Children aged 1-10 years,General population,Children/adolescents ≤18 years,10,1,Convenience sample,Participants,2482,2482,2020-04-22,2020-05-15,,,,,,Seroprevalence of children 1-10 years of age,https://doi.org/10.1001/jamapediatrics.2021.0001,2021-01-22,Peer-reviewed Publikation,whole blood,multiple,IgG,Mehrere/andere,EUROIMMUN,ROCHE,In-house,,,,,"EUROIMMUN, ROCHE, In-house",Adjusted for test-specificity/test-sensitivity,,,0.006,0.003,0.01,2021-08-20,2021-10-17,
Prevalence of COVID-19 in children in Baden-Württemberg,Local/Regional,Baden-Wuerttemberg,Heidelberg,Ulm,Freiburg,Tübingen,,,"Heidelberg, Ulm, Freiburg, Tübingen",Universitätsklinikum Heidelberg,Universitätsklinikum Freiburg,Universitätsklinikum Ulm,Universitätsklinikum Tübingen,"Zentrum für Infektionskrankheiten und Zentrum für Kinder- und Jugendmedizin, Universitätsklinikum Heidelberg","Centrum für Chronische Immundefizienz im Zentrum für Translationale Zellforschung, Universitätsklinikum Freiburg","Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Ulm","Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Tübingen","Zentrum für Infektionskrankheiten und Zentrum für Kinder- und Jugendmedizin, Universitätsklinikum Heidelberg; Centrum für Chronische Immundefizienz im Zentrum für Translationale Zellforschung, Universitätsklinikum Freiburg; Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Ulm; Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Tübingen",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00021521,,Cross sectional,Household and Community Samples,Children aged 1 to 10 years and one related parent,General population,Multiple,,,Convenience sample,Participants,2000,2000,2020-04-22,2020-05-15,https://www.klinikum.uni-heidelberg.de/fileadmin/pressestelle/Kinderstudie/Prevalence_of_COVID-19_in_BaWu__.pdf,https://doi.org/10.1001/jamapediatrics.2021.0001,,,,,,,,,,,,,,,,,,,,,,,,,,,2021-09-27,
Prevalence of COVID-19 in children in Baden-Württemberg,Local/Regional,Baden-Wuerttemberg,Heidelberg,Ulm,Freiburg,Tübingen,,,"Heidelberg, Ulm, Freiburg, Tübingen",Universitätsklinikum Heidelberg,Universitätsklinikum Freiburg,Universitätsklinikum Ulm,Universitätsklinikum Tübingen,"Zentrum für Infektionskrankheiten und Zentrum für Kinder- und Jugendmedizin, Universitätsklinikum Heidelberg","Centrum für Chronische Immundefizienz im Zentrum für Translationale Zellforschung, Universitätsklinikum Freiburg","Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Ulm","Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Tübingen","Zentrum für Infektionskrankheiten und Zentrum für Kinder- und Jugendmedizin, Universitätsklinikum Heidelberg; Centrum für Chronische Immundefizienz im Zentrum für Translationale Zellforschung, Universitätsklinikum Freiburg; Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Ulm; Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Tübingen",https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00021521,,Longitudinal/Prospectice cohort study,Household and Community Samples,Households with at least one adult and one child <18 years of age in which at least one member was confirmed to be infected by SRAS-CoV-2,Selected population groups,Multiple,,,Convenience sample,Households with participants,328,300,2020-05-15,2020-05-15,https://doi.org/10.1101/2021.07.20.21260863,,,,,,,,,,,,,EUROIMMUN,Roche Elecsys,Mikrogen,In-house,,,,Euroimmun; Roche Elecsys' Mikrogen in-house,,,,,,,,,